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Deciphering protein interaction and compartmentalization is crucial to 
understanding the molecular mechanisms that drive biological processes. Using 
various high throughput approaches, we have managed to score subcellular dynamic 
protein re-organization into supramolecular structures and map physical association 
networks to discover protein complexes on a proteome-wide level. However, the case 
by case studies of some of these novel structures and interactions reveal difficulties 
in interpreting their biological basis. This study offers insights into limits inherent 
in the molecular techniques used to investigate subcellular structures and protein 
interactions, describing a set of cautionary tales and critical analysis for deciphering 
cases of confounding data from orthogonal approaches. This study also offers a new 
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1 
Introduction 
The inner workings of a cell are driven by a choreographed dance of proteins 
organizing into dynamically assembling and dissembling complexes. These 
interactions underlie essentially all biological processes within the cell, and the 
spatiotemporal regulation of protein expression and partnerships are linked to each 
protein’s unique function. Thus, in order to understand biological processes, we first 
must elucidate the behaviors of each protein. As such, fundamental questions to 
address are the identities of protein complexes, their compositions and characteristics 
of behavior, and ultimately their functional roles within the cell. 
 
Proteins rarely act on their own and usually require the interactions of specific 
partner proteins to carry out their designated roles. Large-scale biochemical and 
curation efforts to map physical interaction and functional interaction networks have 
provided broad insight into new protein functions (Wan et al. 2015, Huttlin et al. 
2015, Ewing et al. 2007, Ruepp et al. 2010, Szklarczyk et al. 2015, Hein et al. 2015). 
Extensive repositories of these interaction datasets consist of millions of protein 
interactions (Oughtred et al. 2016). Although these high-throughput protein 
interaction assays and databases suffer from both false-positive (false observations) 
and false-negative (true interactions not observed) errors (von Mering et al. 2002, 
Bader and Hogue 2002), they serve as valuable starting points for uncovering new 
protein functions through physical and functional linkages. Within this manuscript, 
I explore case examples of putative novel protein complexes supported from such 
high-throughput assays. A putative complex consisting of the purine biosynthesis 
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pathway explored in Chapter 3 was proposed to underlie regulation of purine 
biosynthesis (and, as explained later, is subject to other interpretations). 
Furthermore, the prediction of an uncharacterized protein, TTC4, as a novel member 
of an established molecular cargo trafficking complex named the retromer is explored 
in Appendix C (and, as shown later, is likely involved in other complexes). 
 
Cellular processes are often compartmentalized within the cell (for example, 
in eukaryotes, within membrane-bound organelles). Therefore, the subcellular 
localization of particular proteins or protein complexes can give clues as to their 
functional roles within the cell. As such, large-scale microscopy efforts to map global 
protein expression, subcellular localization (Uhlen et al. 2005, Mazumder et al. 2013, 
Huh et al. 2003), and context-specific re-organization of proteins (Narayanaswamy, 
Levy, et al. 2009, Narayanaswamy, Moradi, et al. 2009, Lam et al. 2014, Tkach et 
al. 2012) have provided insight into elucidating particular protein functions. Many 
of such studies rely on automated microscopy platforms that allow for systematic 
screening (Glory and Murphy 2007, Murphy 2008). In Chapter 1, I present a novel 
experimental method well-suited for high-throughput cell microscopy adapted from 
genomic-scale microscopy screens in yeast. The adapted technique involves printing 
cultured human cells onto spotted cell microarrays, or cell chips, and demonstrate 
the capacity to determine cellular state by reporting activation states, subcellular 
localizations, and/or relative abundances of target proteins.  
 
The same biophysical properties that drive protein interactions crucial for 
biological processes can also give rise to deleterious protein mis-interactions. 
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Specifically, the mis-regulation of protein expression and/or the mis-folding of 
proteins can lead to their unruly accumulation and aggregation, becoming toxic 
species that cause cell damage and which can manifest into tissue and organ 
destruction. Such misfolding, aggregation, and accumulation of a wide range of 
proteins is the hallmark of a variety of “protein conformational diseases”, 
encompassing highly prevalent illnesses such as Alzheimer's disease (β-amyloid), 
Huntington’s disease (huntingtin and proteins with poly-glutamine expansions), 
Parkinson's disease (α-synuclein), Creutzfeldt–Jakob disease (PrPSc), amyotrophic 
lateral sclerosis (superoxide dismutase, TDP-43, and FUS), cataracts (crystallin), 
cystic fibrosis (CFTR), type II diabetes (amylin), and sickle cell anemia (mutant 
hemoglobin). Many of these disease-associated protein aggregates form visible 
intracellular deposits of various forms ranging from amorphous bodies like 
cytoplasmic foci (Krobitsch and Lindquist 2000, Wang et al. 2007) to ordered fibrils 
and fiber bundles (Cerami and Peterson 1975) which can be reconstituted in vitro 
(Vilar et al. 2008, Serpell 2000, Riesner 2003). For some cases, it has been both 
argued that these structures cause detriment to the cell and that they form as 
protective measures against smaller, more toxic species (Goure et al. 2014, Ahmed 
et al. 2010). 
 
Our in-house genomic-scale yeast microscopy screen identified hundreds of 
new assemblies of cytoplasmic foci and fibers composed of metabolic proteins 
(Narayanaswamy, Levy, et al. 2009). The newly discovered wide-spread assembling 
of yeast proteins are morphologically similar with the aforementioned disease-
associated protein aggregates, forming intracellular foci or fibers which, for many 
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cases (such as glutamine synthetase, cytidine triphosphate synthase, and inosine-5’-
monophosphate dehydrogenase 2), have also been reconstituted in vitro (Juda et al. 
2014, Ingerson-Mahar et al. 2010, Petrovska et al. 2014). Expounded upon in 
Chapter 2, such proteinaceous assemblies of metabolic proteins commonly serve as 
enzymatic compartmentalization in bacteria, yet its intriguing occurrence—and 
widespread extent—in eukaryotes largely remains a functional mystery. Case studies 
have suggested functionality of particular assemblies by their potential role as 
enzyme storage depots and thus a means for regulating enzymatic state (Petrovska 
et al. 2014, Barry et al. 2014), or as cytoskeletal elements regulating cell shape 
(Ingerson-Mahar et al. 2010). Other studies raise the possibility that a subset of these 
newly discovered protein assemblies represent stress-induced endemic misfolding and 
aggregation (O'Connell et al. 2014). Chapter 3 is a case study of intracellular 
assemblies comprising of the purine biosynthesis pathway proteins, in which I present 
a cautionary tale detailing how methods used to examine these intracellular foci and 
fibers, such as experimental design or fluorescent tagging, could sway interpretations 
between functionality and aggregation.  
 
A substantial set of these fluorescence microscopy imaging-based subcellular 
protein localization studies rely on libraries of cells expressing proteins modified with 
synthetic epitopes or fluorescent tags. While the fusion of these tags with a protein 
of interest have revolutionized the field of protein characterization (by facilitating 
visualization or immunologic assays such as purification), it can also lead to 
artifactual “discoveries” due to their interference with the labeled protein’s 
endogenous behavior, such as inducing severe mis-localization (Ramanathan, 
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Ayyavoo, and Weiner 2001, Skube, Chaverri, and Goodson 2010, Landgraf et al. 
2012, Palmer and Freeman 2004, Snapp 2005). A systematic analysis of >400 human 
proteins showed that one-fifth of subcellular distributions of fluorescently-fused 
proteins disagreed with that acquired by immunofluorescence against the native 
protein (Stadler et al. 2013). It has also been shown for a number of foci- and fiber-
forming proteins that they formed such assemblies only when fluorescently tagged 
(Swulius and Jensen 2012, Landgraf et al. 2012, Margolin 2012, Snapp 2005). Others 
have demonstrated that differential tagging produced differential characteristic 
phenotypes of foci and fibers (Bak, Cutting, and Milewski 2007, Landgraf et al. 
2012), even in the case of the highly-characterized CTP synthase fibers (Gou et al. 
2014). A theme within the latter parts of this manuscript highlights how fluorescent 
tags used for live cell imaging, as well as small epitope tags used for purification and 
immunofluorescent localization, are a double-edged sword. Thus, interpretations in 








1. Chapter 1: A human cell chip for high-throughput cell imaging1 
1.1 Abstract 
Spotted cell chips are a high-density imaging technology for determining 
cellular state across arrays of cells subjected to chemical or genetic perturbation. 
Cells are grown and treated under standard tissue culture conditions before being 
fixed and printed onto replicate glass slides, effectively decoupling the experimental 
conditions from the assay technique. Each slide is then probed using 
immunofluorescence or other optical reporter and assayed by automated microscopy. 
We show potential applications of the cell chip by assaying cultured human cells for 
changes in protein abundance, subcellular localization, and activation state in 
response to treatment by several chemical effectors. We demonstrate scalability by 
printing a single chip with ∼4,700 discrete samples. Coupling this technology to high-
throughput methods for culturing and treating cell lines could enable researchers to 
examine the impact of exogenous effectors on the same population of experimentally 
treated cells across multiple reporter targets representing a variety of molecular 
systems. This allows the systematic production of a highly multiplexed datasets with 
minimized experimental variance and at reduced reagent costs compared to 
alternative techniques. The ability to prepare and store chips also allows researchers 
to follow up on observations gleaned from initial screens with maximal repeatability. 
                                      
Chapter 1 has been previously published in: Hart, T., A. Zhao, A. Garg, S. Bolusani, and E. M. 
Marcotte. 2009. PLoS ONE 4 (10):e7088. doi: 10.1371/journal.pone.0007088. 
 
This work was supported by grants from the United States National Science Foundation, National 





1.2.1 Current platforms for compact high-content screening 
Despite enormous progress in the postgenomic era, large-scale 
characterization of mammalian genes remains a daunting challenge. The vast 
availability of libraries consisting of thousands of constituents that can be used to 
perturb or examine cells (examples include small molecules, siRNAs, or expression 
vectors containing shRNAs, sgRNAs, or ORFs) has driven the need for new 
techniques for researchers to utilize these tools efficiently. Classical perturbation 
experiments have been enabled by the creation of RNA interference (RNAi) and 
chemical libraries, but there exist few platforms able to conduct cell-based 
experiments on the scale of mammalian genomes, especially when multiple reporters 
are required (Michnick 2004, Albeck et al. 2006). Plate-based assays can be used for 
high-content screening of cell populations (MacKeigan, Murphy, and Blenis 2005) or 
to capture detailed cell morphology and state information (Abraham, Taylor, and 
Haskins 2004) – in fact a number of dedicated commercial platforms are on the 
market (Starkuviene and Pepperkok 2007) – but these latter applications come at a 
high reagent cost relative to miniaturized assays. High-throughput flow cytometry 
probing immunolabeled phosphoproteins (Krutzik et al. 2008, Krutzik et al. 2004) 
allows multiparameter sampling of protein activation state across a large cell 
population, but requires serial analysis of samples, hence performing sequential 
assays of every experimental condition or timepoint – a key limitation when 




Transfected cell microarrays (Ziauddin and Sabatini 2001, Wheeler, 
Carpenter, and Sabatini 2005, Castel et al. 2006, Wu, Bailey, and Sabatini 2002), 
where cells are grown over a glass slide printed with transfection constructs, allows 
screening of expression (Ziauddin and Sabatini 2001) or RNAi libraries (Wheeler, 
Carpenter, and Sabatini 2005) for functional genomics or drug screening (Castel et 
al. 2006, Wu, Bailey, and Sabatini 2002). Transfected cell arrays have been applied 
to various efforts from identifying genes involved in chromosome maintenance 
(Neumann et al. 2006) to detecting protein-protein interactions (Fiebitz and 
Vanhecke 2011). For transfection-based screens, however, the technique is limited to 
cell lines compatible with the transfection technique used, although Sabatini and 
colleagues created arrays based on lentiviral infection constructs to circumvent this 
problem (Bailey et al. 2006). Tissue microarray technology has enabled the 
multiplexed immunohistochemical analysis of tissue samples on a single array but 
thus far has been limited to tens or hundreds of samples per array (Camp, 
Neumeister, and Rimm 2008). Complementary technologies include small molecule 
microarrays which involves growing cells over a glass slide printed with molecules 
such as proteins. This has been previously used to measure the response of neural 
precursor cells to a variety of printed signaling molecules (Soen et al. 2006). Another 
similar technology is the cell lysate microarray, in which the protein repertoire of a 
number of cell populations are spotted in parallel on a slide and assayed for reporters 
of cellular state (Paweletz et al. 2001, Sevecka and MacBeath 2006), although all 
data are population averages rather than per-cell readouts. Thus, there is a clear role 
for a platform that enables analysis of multiple cell types and/or treatment 
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conditions in a manner that scales to thousands of samples, while minimizing reagent 
cost and experimental variance. 
 
My contributions to the work described in this Chapter include conducting 
experiments and analyzing data, including performing cell culture, drug treatments, 
western blotting, printing the cell chip and conducting high-throughput microscopy, 
with guidance from Traver Hart. Traver designed the experiments and developed 
analysis techniques for the cell chip, and was absolutely instrumental in overcoming 
every technical challenge. I acknowledge Vishy Iyer for custom building of the 
microarray printer and Ankit Garg who worked alongside me.  
 
1.2.2 Inspirations from yeast cell microarrays 
Previously, we have used a spotted cell microarray technique to identify 
pheromone response genes (Narayanaswamy, Moradi, et al. 2009) and to examine 
changes in protein localization (Narayanaswamy, Levy, et al. 2009) of the GFP-
tagged yeast strain collection (Huh et al. 2003). Building on the experience gained 
from applying cell chip technology to yeast functional genomic screens, we set out 
to develop a human cell chip: microsamples of cultured human cells printed in arrays 
onto glass slides. The human cell chip would allow for high-dimensional assays 
consisting of multiplexed cell lines, cell types, treatment conditions, and time-points 
on a single slide, as well as data integration across multiple cell chips. Given these 
features, we believe the cell chip provides a general platform for performing human 
cell functional genomic assays. 
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1.2.3 Advantages of the new platform of human cell microarrays 
Here we describe the application of spotted cell microarrays to the study of 
human cell lines. Spotted cell microarrays, hereafter referred to as “cell chips,” are 
constructed by growing and treating cells under normal tissue culture conditions, 
formaldehyde fixing, and printing microsamples of each culture onto replicate glass 
slides. Each slide is then assayed by immunofluorescence against a specific target 
and imaged by high-throughput microscopy. Entire collections of cells comprising 
hundreds to thousands of discrete samples can be assayed onto replicate slides. Each 
slide is probed with a single reporter in a single assay, reducing experimental variance 
compared to multi-well plate assays where each well is effectively an independent 
experiment. Reagent cost is similarly reduced, with less than 100 µL of diluted 
antibody sufficient to probe a slide, 10–100 fold less than that required for a single 
96-well plate assay. Importantly, cells from a wide variety of cell types (including 
both suspension and adherent cells), growth conditions, and treatments, can be 
arrayed on a single slide. Replicate slides allow researchers to conduct multiple assays 
against samples drawn from the same collection of treated cells, and to probe 
multiple pathways elements from the same sample of cells. Finally, slides can be 
stored after printing to facilitate generating replicates and following up on 
observations gleaned from initial screens with subsequent assays against samples 




1.3 Development of the cell printing process 
To print human cell lines, we used custom microarray pins with blunt tips 
and wide slots, and after experimenting with other adhesion protocols, we determined 
that printing biotin-decorated cells on streptavidin-coated glass slides ensured cell 
adhesion and reproducibility. An overview of the process is shown in Figure 1-1.  
To demonstrate achievable array densities, we printed eight replicate HeLa cultures 
repeatedly onto a slide. A total of 4,608 spots were successfully printed on a single 
slide (Figure 1-1B), using eight spotting pins and a spot pitch of 400 µm. Chips of 
much higher density, exceeding 8,000 spots per slide, could be achieved by decreasing 
spot pitch ∼10% and increasing to 12 spotting pins. 
 
1.3.1 Adapting microarray printing components 
Contact microarray technology, typically used to print DNA oligonucleotides 
or cDNA sequences for use in RNA hybridization assays, is optimized around printing 
the smallest spots that can be consistently delivered. Spotted cell microarrays were 
first developed and applied to functional genomic screens in Saccharomyces cerevisiae 
(Narayanaswamy et al. 2006) and bacteria  (Zhao et al. 2008). To print yeast cell 
chips, we used a contact microarray printing robot to draw a microsample from a 
suspension of fixed cells in a 96-well microplate (the “source plate”) and deposit it 
on a poly-L-lysine coated glass slide. During the development of the yeast spotted 
cell microarray technique it was observed that better performance was achieved using 
microarray pins that had been “blunted” by repeated use in printing cDNA arrays. 
The blunted pins gave a larger spot size, a greater volume of medium deposited and, 
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typically, a larger number of cells in the spot. However, the degree of blunting and 
therefore the quality of spots delivered varied widely among these well-used pins. 
 
 
Figure 1-1. Overview of spotted cell chip process. 
(A) Cells are grown and treated under normal cell culture conditions. Our recommended 
protocol (less successful early protocols are discussed in the text and in Figure 1-2) involves 
trypsinizing adherent cells and fixing with formaldehyde, decorating with WGA-biotin, and 
permeabilizing in −20°C methanol. Cells can be stored for several weeks in this state before 
resuspending in PBS and transferring to source plate for printing. Using a robotic microarray spotting 
device, cells are printed onto streptavidin-coated slides. To assay, each slide is probed by 
immunofluorescence against the target of choice and imaged by automated microscopy. (B) A high-
density cell chip. An 8-pin print of 4,608 replicate spots, each containing a microsample of HeLa cells, 
is shown by imaging with a microarray scanner (left; green signal is light scattering in the fluorescent 




 To adapt cell chips to human cells, we initially used the same microarray pins 
as in the yeast cell chip, and printed on poly-L-lysine (poly-K) coated slides. Early 
testing was conducted using the Jurkat T-cell leukemia cell line, as these cells are 
easy to grow in large quantities and a successful cell chip would provide a new 
platform for assaying suspension cells. We immediately observed that the larger 
human cells – which are typically spheroids 10–20 µm in diameter, many times larger 
than ovoid yeast cells that measure 3–8 µm on the long axis – did not print 
consistently onto poly-K coated slides, and that the inconsistency was in part 
attributable to how deformed the microarray pins were. To address this issue in a 
more systematic manner we acquired microarray pins with sharp or blunt tips in 
different sizes (Majer Precision MicroQuill 2000, part nos. 11077-1 and 11077-3). The 
11077-1 pins were sharp and yielded spots <100 µm in diameter, while the -3 pins 
had the largest blunt area and gave spots ∼200 µm across. Number of cells deposited 
per contact was further improved by using custom pins, based on the 11077-3 form 
factor, but with a slot width of 0.003 inch (76 µm) vs. the standard 0.0015 inch (38 
µm). The smaller slot is only 2–3 cell diameters in width and may have induced shear 
effects and clumping as cells were loaded and deposited by the pins; these effects 
appear to have been largely mitigated by using the wider slots. The custom 11077-3 
pin with 0.003 inch slot width consistently delivers a spot ∼200 µm in diameter and 
was used for all subsequent human cell chip prints. 
 
Although we achieved regularity in spot sizes by selecting the appropriate 
microarray pins, the number of spots delivered was found to be highly dependent on 
the concentration of cells in the 384-well source plate. Depositing 50 cells in a spot 
 
14 
∼1 nl in volume implies a concentration of ∼50,000 cells/µl, or 106 cells in 20 µl 
suspension in each well of the source plate. However, during the time required to 
print ∼100 samples onto each of 10–20 slides – roughly 30 minutes – the cell 
suspension settles into a loose pellet at the bottom of the well. In an effort to 
maintain the cells in suspension during printing, we increased the viscosity of print 
media using glycerol (15–50%) and sucrose (30–50%). 
 
1.3.2 Proof of concept: detecting cellular states with high density cell 
chip-based immunofluorescence 
We tested the cell chip's ability to detect cellular state by inducing apoptosis 
in Jurkat cells. We grew the cells under normal tissue culture conditions. Separate 
cultures were treated with staurosporine, a potent inhibitor of protein kinase C and 
other essential cellular kinases, and fixed with formaldehyde after 1, 2, or 4 hours. 
Treated and untreated cells were collected in several wells of a 384-well plate at a 
concentration of >105 cells/µl and printed on poly-L-lysine coated slides such that 
each sample was printed several times on each of several replicate slides.  
 
Immediately after printing, slides were imaged with transmitted light to 
analyze print quality; printed spots were discrete and typically contained 20–50 cells. 
Three slides were then probed for signs of apoptosis by immunofluorescence with 
antibodies against cleaved caspase 3, cleaved caspase 9, and cleaved PARP. Each 
slide was also labeled with a nuclear stain, and each spot was imaged using 
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automated microscopy. Images of Jurkat cells immediately after printing, and of 




Figure 1-2. Early print of Jurkat cells onto poly-L-lysine slides.  
A 30% sucrose print buffer prevented complete liquid evaporation after printing. Other panels 
show nuclear stain (center) and immunofluorescence (right) against cleaved caspase 3, an indicator 
of apoptosis. Left panels: DIC images acquired immediately after printing, before commencing 
immunofluorescence assay. Top row, untreated; bottom row, treated with staurosporine, 4 h. Yellow 
circles indicate one printed spot; arrows indicate cells outside the circle translocated during the 
immunofluorescence protocol. As a consequence, all subsequent prints were conducted with WGA-




1.3.3 Troubleshooting and optimization to increase robustness against 
assay-related mechanical insults 
Although the immunofluorescence data supported the prototype cell chip's 
ability to detect cellular state, we observed that a significant number of cells – 
perhaps 10% of the cells in some spots — had shifted on the slide during the wash 
steps of the immunofluorescence protocol. This translocation is evident in Figure 
1-2 when the pre-probe DIC images are compared to the fluorescent images (see 
arrows in figure). Given the relatively small numbers of cells in each spot, cross-
contamination of even individual cells could dramatically reduce the dynamic range 
of the cell chip as an assay tool. To alleviate this problem, we tested an alternate 
adherence technique involving an adaptor molecule instead of relying on electrostatic 
interaction. After fixation, we decorated cells with a biotinylated lectin, wheat germ 
agglutinin (WGA-biotin), and printed the cells on streptavidin-coated slides. Under 
this protocol, increased print buffer viscosity is not required; cells were resuspended 
at 106 cells in 20 µl PBS (without glycerol or sucrose) in each well of the 384-well 
source plate and allowed to settle into a loose pellet. The microarray robot was 
calibrated to dip the pins into the pellet during loading. We printed WGA-biotin-
labeled Jurkat and DG-75 suspension cells as well as trypsinized HeLa and HEK293 
adherent cells onto replicate chips. Using the wide-slot pins and a standard wash 
cycle between loads, we observed neither cell clumping in the pins nor cross-
contamination of cells into adjacent spots. After printing on a streptavidin-coated 
slide and allowing the print to dry, we observed no cell translocation throughout 
many repeated washing steps. The WGA-biotin/streptavidin slide combination was 
used for all subsequent prints.  
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1.4 Demonstration of cell chip multiplexing and utility 
To demonstrate the multiplex capability of the cell chip, we printed chips 
with both A549 non-small-cell lung cancer cells and HeLa cervical cancer cells. Each 
cell line was divided into three cultures: one treated with anisomycin (1 µM, 30 
minutes), one with tumor necrosis factor alpha (TNFα; 10 ng/ml, 60 minutes), and 
one untreated control. Anisomycin, a translation inhibitor, activates (by 
phosphorylation) both the p38 and c-Jun N-terminal kinase (JNK) stress kinases. 
Among the effects of TNFα exposure are JNK activation and NFκB translocation to 
the nucleus. NFκB is maximally concentrated in the nucleus at about an hour after 
TNFα exposure (Nelson et al. 2004), while JNK activation peaks after about 15 
minutes and degrades to background levels about half an hour later (Reuther-Madrid 
et al. 2002). Multiple replicate chips were printed, each carrying all six conditions 
printed in multiple replicate spots. 
 
Individual chips were probed for phospho-p38 kinase, phospho-JNK, and the 
p65/RelA subunit of NFκB. Each slide was counterstained with Hoechst 33342 
nucleic acid stain and a high resolution image of each spot was captured in the 
corresponding fluorescent wavelengths. Figure 1-3A illustrates representative 
nuclear stain and immunofluorescence images from the chip probed for phospho-p38; 
the two spots show the increase in signal in HeLa cells treated with anisomycin 
compared to controls. The translocation of NFκB-p65 subunit into the nucleus in 
response to TNFα in both cell lines was apparent in the images (Figure 1-3B shows 




Figure 1-3. Cell chips can be printed with multiple cell types, treatments, and time 
points on the same arrays, enabling extensive multiplexing of experiments. 
HeLa and A549 cells were grown in T-75 flasks collected after treatment with anisomycin, 
TNFα, or no treatment, and printed on replicate slides. (A) A slide was probed for phosphorylated 
p38 kinase; images show Hoechst 33342 nuclear stain (left) and IF spots of treated and untreated 
HeLa cells. (B) A slide from the HeLa/A549 print was probed for the p65/RelA subunit of NFκB. 
Right panels show overlay of brightest pixels from IF images onto nuclear stain, demonstrating 
cytoplasmic localization in untreated cells and nuclear translocation in response to TNFα. (C) A549 
cells were grown in T-75 flasks and collected without treatment and after treatment with interferon-
alpha (1000 U/ml) for 15 minutes or 18 hours. A chip was probed for phospho-STAT1; sample images 
of one 15-minute timepoint and one untreated spot show strong difference in signal. (D) A slide from 
the same print was probed for PKR; a weak signal is detected in the 18 hour timepoint, which 
corresponds to a ∼3-fold increase in protein level as detected by western blotting (data not shown). 
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We analyzed the set of treated spots from each cell line for an increase in 
signal relative to that cell type's control spots on the same slide by comparing the 
set of mean bias-corrected signal intensities of each set of spots (two-sample one-
tailed T-test; see Methods). Calculated p-values are shown in Table 1-1. JNK was 
phosphorylated in response to anisomycin treatment in both cell lines but TNFα-
treated cells showed a weak response only in HeLa, consistent with the expected 
dynamics of TNF-induced JNK activation and deactivation. Anisomycin also 
activated p38 in HeLa cells, as expected, but surprisingly the response was much 
weaker in A549s; the p-value of 0.01 is not significant after multiple-hypothesis 
correction. P65 translocation to the nucleus is represented as an increase in nuclear 
signal in HeLa cells. 
 
 
Table 1-1. Drug response measured from printed cells. 
Cellular response to drug treatments (anisomycin, 1 µM, 30 min; TNFα, 10 ng/ml, 60 min) 
on A549 and HeLa cells printed on the same chips. <I>, bias-corrected mean signal intensity (see 
Methods) for a given condition, with number of spots of that condition on the chip. SE, standard 
error of mean signal intensity for a given condition. Pval, p-value of difference between condition <I> 
and control <I>, measured by one-tailed, two-sample T-test. 
 

































































To explore the utility of cell chip technology for pathway analysis, we 
examined the chip's ability to recapitulate the interferon response of A549 cells. 
Exposure to interferon activates the JAK/STAT signal transduction cascade, 
resulting in up-regulation of interferon response genes, including dsRNA-activated 
protein kinase (PKR), the 2’-5’-oligoadenylate synthetases, and the myxovirus 
resistance gene Mx (Garcia-Sastre and Biron 2006). We chose two assay targets, 
PKR and phospho-STAT1, to further validate the accuracy of the cell chip 
technology and to explore its dynamic range. We grew cells and exposed them to 
IFN-α (1000 U/ml) for 15 minutes or 18 hours before trypsinizing and formaldehyde- 
fixing, along with untreated control cells. Technical and biological repeats were 
printed on the same slide (‘print 1’). At the same time, an equal number of cultures 
were prepared but stored in −20°C methanol for seven weeks before printing in an 
identical manner (‘print 2’). After printing, one slide from each print was 
immunoprobed for phosphorylated-STAT1, counterstained with nuclear stain, and 
each spot was imaged at 40X. A second slide from each print was probed for PKR. 
 
Figure 1-3C shows representative nuclear stain and immunofluorescence 
images of an individual spot from a slide probed for phospho-STAT1. Results of 
quantitative analysis are shown in Table 1-2. A fifteen-minute interferon exposure 
gave very strong signal for both prints, as well as weaker signal after 18 hours, 
indicating no loss of signal due to storage of fixed cells prior to printing. A third chip 
was probed after 30 days of storage at 4°C; it showed less overall signal strength 
across all spots but also less variance, resulting in p-values nearly identical to the 
other two chips. The slides probed for PKR showed a small increase in signal at the 
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18-hour timepoint (Figure 1-3D; Table 1-2), but, as expected, no response in the 
15-minute samples. The small increase probably reflects the fact that PKR under 
these conditions is only up-regulated ∼3-fold (measured by western blot; data not 




Table 1-2. Cellular response to interferon treatment and signal variance due to 
experimental methods. 
P-values of each condition are shown. Slide 1: Normal cell preparation followed by immediate 
printing and assay. Slide 2: Cells were fixed and stored for seven weeks at -20°C before printing. Slide 
2*: Printed cell chip was stored for 30 days at 4°C before assaying. For column headers, see legend 
for Table 1-1. 
 
The presence of multiple cell lines and treatment conditions on the same slide 
can be exploited as internal controls for both experimental conditions and probes. In 
the anisomycin/TNFα chips, for example, p38 kinase showed lower response to 
anisomycin treatment in A549 cells than in HeLa. The anti-phospho-p38 antibody 























































gave the expected response for the HeLa cells on the same slide, which serves as a 
positive control for the probe. JNK kinase responded to anisomycin in both the A549 
and HeLa cells, which are drawn from the same population as those probed for 
phospho-p38, indicating the drug treatment worked properly. Therefore it is 
reasonable to conclude that the observed difference in p38 activation reflects a 
biological phenomenon rather than an experimental artifact. This property of 
multiplex controls can in principle be applied to much larger screens including a 
wider variety of experimental conditions and probes. 
 
1.5 Discussion and Remarks 
We have demonstrated the capability of the cell chip to probe multiple aspects 
of cellular state using a variety of cell types and treatment conditions. Since cells are 
grown and treated under standard tissue culture conditions, treatment protocols such 
as transfections or drug exposure times can be optimized for each set of samples 
individually without affecting the assay. Furthermore, the adaptor molecule used to 
bind cells to the slide, WGA-biotin, targets a broad spectrum of human and other 
cell lines, but even this step could be optimized on a per-cell-line basis by using a 
specific biotinylated lectin. Also, the ability to store cells prior to printing allows 
researchers to perform large library transfections or other treatments asynchronously 
rather than all at once immediately before printing. Finally, although we analyzed 
images to gather population data across the cells in a printed spot, it is clear that 
single-cell data could be gleaned using more sophisticated image processing 
techniques (Carpenter et al. 2006, Glory and Murphy 2007). For transfection 
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experiments, adding optical reporters (e.g., green fluorescent protein) on the same 
expression vector as the clone of interest or by co-transfection allows the 
measurement of cellular response exclusively on successfully transfected cells (Bailey 
et al. 2006), mitigating the signal loss encountered when low transfection efficiency 
is averaged over a population. 
 
The cell chip is complementary to, and in some cases an advance over, current 
high-throughput cell-based assay technologies. It differs from transfected cell arrays 
in that it allows the analysis of multiple cell types and multiple growth and treatment 
conditions on a single slide, and it offers an order of magnitude increase in sample 
density over existing tissue microarray technology. Finally, in probing samples from 
diverse populations for a single reporter, the cell chip represents an orthogonal assay 
to the single-population, many-reporter gene expression DNA microarray. 
 
1.5.1 Constraints of the human cell chip 
A key constraint of the technology as described here is the considerable 
manual effort required to prepare a source plate for printing. While we consider it a 
major advantage of the cell chip that cells are grown under normal tissue culture 
conditions, pin-based printing requires very high cell density in the source plate, 
which is not easily achieved by automated cell handling techniques. The use of other 
printing technologies, for example inkjet or other microspray methods, might ease 
this burden and make microplate-based cell culture growth and treatments more 
compatible with cell chip printing. 
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1.5.2 Applicability of the technology across fields of study 
Such development to overcome the key constraints of the cell chip technology 
could make it readily applicable to functional genomics and chemogenomics. With 
the ability to probe an array of cells for target protein abundance, activation state, 
and subcellular localization, libraries of small molecule effectors could be screened 
for their impact on a variety of cellular systems. Furthermore, the technology could 
in principle be adapted for on-chip fluorescence in situ hybridization (FISH) assays 
against nucleic acid targets. The fact that multiple dosages and time-points can be 
printed on the same set of cell chips increases the depth to which researchers can 
investigate the impact of chemical libraries. Likewise, whereas typical functional 
genetic screens are designed around a single reporter or phenotype, the cell chip 
allows a different reporter for each replicate slide. Thus, each genetic perturbation 
could be assayed for impact on multiple cellular subsystems and/or for multiple 
reporters within the same system, greatly multiplying the data “bang” for the 
experimental “buck.” Taking into account all these features, we believe the cell chip 




1.6 Materials and Methods 
1.6.1 Cell culture 
A549, HEK293, HeLa, DG-75, and Jurkat cell lines were acquired from 
ATCC. HeLa and HEK293 cells were maintained in DMEM medium, A549 in F12-
K, and DG-75 and Jurkat in RPMI, each supplemented with 10% FBS 
(Gibco/Invitrogen). Cells were treated in culture flasks with staurosporine (Sigma), 
TNF-alpha (Sigma), anisomycin (Sigma), or interferon-alpha, as described. 
 
1.6.2 Printing cell arrays 
To prepare cells for printing, adherent cell lines were washed with PBS, 
trypsinized (0.25% trypsin in EDTA, Invitrogen) until detached, and resuspended in 
PBS. Adherent and suspension cells were fixed in ¼ vol 10% fresh paraformaldehyde 
(Sigma) (~2% final concentration) for 10 min, then washed in fresh PBS and 
transferred to 1.5 ml tubes for ease of handling. 
 
After fixation, cells were treated with biotinylated wheat germ agglutinin 
(WGA-biotin; Biomeda) at 4 µg/ml final concentration for 15 minutes, then washed 
3x in PBS. Finally, cells were pelleted, media was removed, and cells were 
resuspended in 100% methanol at −20°C. Cells were incubated at least 10 minutes, 




Immediately prior to printing, cells were pelleted, methanol was removed, and 
cells were resuspended in a minimum volume of PBS. A 20–50 µl of high-density cell 
suspension was transferred to a 384-well plate. Cells were allowed to settle to the 
bottom of the well, forming a loose pellet, before printing was initiated. Cells were 
printed on streptavidin-coated slides (TeleChem) with a custom-built DNA 
microarray printing robot (DeRisi, Iyer, and Brown 1997) using blunt-tipped, slotted 
steel custom microarray pins (Majer Precision, part no. 11077-3 with a custom 0.003 
inch slot width). Printed slides were assayed immediately or stored at 4° or −20°C 
for several weeks. 
 
1.6.3 Assaying printed slides 
1.6.3.1 Immunofluorescence and imaging 
Immunofluorescence labeling of target proteins was performed using 
antibodies against cleaved caspase 3, phospho-STAT1, phospho-JNK, phospho-p38, 
cleaved PARP, phospho-p65 (RelA) (Cell Signaling Technologies), p65/RelA, and 
histone H3 (Santa Cruz Biotechnology). First, a 16-well rubber gasket (Grace 
Biosystems) was trimmed to provide a single large reservoir on the slide around the 
array. The cells were blocked in 5% goat serum (Sigma) in PBS (30 min, ambient 
temperature), washed once with PBS, and incubated 2 hr (ambient temperature) or 
overnight (4°C) with primary antibody diluted to manufacturer's specification in 
PBS + 0.2% Triton X-100. Slides were washed in PBS 3x for 5 min each in coplin 
staining jars, then incubated with goat anti-rabbit (or anti-mouse, as necessary) IgG 
conjugated with Alexa Fluor 594 (Invitrogen; diluted 1∶1000) for 60 min at ambient 
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temperature in the dark. Slides were washed again 3x in PBS, with the final wash 
containing a 1∶10,000 dilution of Hoechst 33342 (Invitrogen). Slides were air-dried, 
mounted with ProLong Gold mounting medium and coverslipped before imaging.  
 
Imaging was performed on a Nikon TE2000 microscope with motorized XY 
stage and Z objective and a Photometrics Cascade II 16-bit CCD camera. Using the 
NIS Elements controller software, we generated a script that would automatically 
visit each spot, autofocus (in DIC), and capture fluorescent images for Hoechst 33342 
(nuclear) and immunostained labels. Imaging was performed using a 40x (0.95 NA) 
dry objective, and exposure times were selected to minimize the occurrence of 
saturated pixels under normal assay conditions. 
 
1.6.3.2 Image signal quantitation 
Quantitation was carried out using Matlab and the Image Processing Toolkit. 
For each spot, depending on the region of interest (nuclear or whole-cell) for the 
given probe, either the image of the nuclear label or the one of the immunolabel was 
background corrected and converted to a binary pixel mask. The mean signal 
intensity in the immunofluorescence channel of all pixels within the mask is 
calculated and recorded for each spot, along with the number of pixels in the mask. 
 
We discovered a pronounced linear bias in average pixel intensity that 
correlated with the number of pixels in the mask – which itself reflects the number 
of cells deposited in the spot. A correction for the size bias was applied by 
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normalizing signal to that found with wildtype (untreated) cells. A linear regression 
is applied to signal derived from wildtype cells, and the signal of a given spot is then 
measured as a distance from the regression line at the same mask size of that spot. 
This method is effective as long as the range of wildtype mask sizes meets or exceeds 
the range of mask sizes for treated cells; this was true for all cases discussed here. 
 
The bias-corrected mean signal intensity was determined for each spot of 
treated cells. These were compared to spots of untreated cells of the same type on 
that slide, yielding a distinct set of data for each cell type, even where multiple cell 
types are arrayed on a slide (bias-corrected mean signal intensity data are available 
online (Hart et al. 2009)). Treated and untreated spots were compared by unpaired 
one-tailed T-test for samples with different variances. By definition, the bias-





2 Chapter 2: Reorganization of metabolic enzymes into 
megastructures and compartments2 
2.1 Abstract 
Large-scale imaging-based studies have revealed that hundreds of metabolic 
enzymes across diverse organisms form large intracellular megastructures, or bodies. 
These proteinaceous bodies—such as those formed by enzymes of nitrogen and 
carbon utilization and of nucleotide biosynthesis—range in form from intracellular 
foci and fibers in eukaryotes to high-density packings inside bacterial micro-
compartments. Although many enzymes clearly form functional mega-assemblies, it 
is not yet clear for many recently discovered cases whether they represent functional 
entities, storage bodies, or aggregates. In this Chapter, we survey intracellular 
protein bodies formed by metabolic enzymes, asking when and why such bodies form 
and what their formation implies for the functionality—and dysfunctionality—of the 
enzymes that comprise them. The panoply of intracellular protein bodies also raises 
interesting questions regarding their evolution and maintenance within cells. We 
speculate on models for how such structures form in the first place and why they 
may be inevitable. 
  
                                      
Parts of Chapter 2 have been previously published in: O'Connell, J. D., A. Zhao, A. D. Ellington, 
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101011-155841.  
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In 2010, three research groups reported the startling discovery that cytidine 
triphosphate (CTP) synthase, the enzyme that catalyzes the last and rate-limiting 
step of de novo CTP biosynthesis, can reorganize into extended intracellular fibers 
in bacterial, fungal, and animal cells (Ingerson-Mahar et al. 2010, Liu 2010, Noree et 
al. 2010). It was questioned whether these fibers are enzymatically active, if they 
serve as cytoskeletal elements, or if they fulfill other, as yet undetermined, regulatory 
or structural roles. However, far from being a unique occurrence, these fibers are just 
the latest in a growing assortment of intracellular bodies formed by metabolic 
enzymes. 
 
In fact, observations of such bodies have increased markedly in recent years. 
The technological capacity to perform large-scale microscopy screens of protein 
localization has made possible cell-biological studies that focus on particular cellular 
conditions. Such screens have been further abetted by the availability of extensive 
libraries of bacterial, yeast, and mammalian cells expressing proteins fused to 
reporters. In parallel, biologists and bioengineers have begun constructing novel 
multi-enzyme complexes to alter or improve metabolic capacity. Thus, the cellular 
principles underlying the assembly of large protein bodies and their contribution to 
the dynamic regulation of metabolism are ripe for exploration and exploitation. 
 
This Chapter serves to survey classic and recent examples of intracellular 
protein bodies, focusing on those formed by metabolic enzymes. We then discuss the 
current understanding of when and why such bodies form and what their formation 
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implies for the functionality—and dysfunctionality—of the enzymes that comprise 
them. Finally, we speculate on more general models for how such complex quaternary 
structures form in the first place and why they may be inevitable. 
 
A significant portion of the work in this Chapter is indebted to Jeremy 
O’Connell, who experimentally investigated foci in yeast and extensively reviewed 
the historic literature on the panoply of intracellular protein assemblies. My primary 
contributions to this body of work are reviewing and interpreting these assemblies, 
especially in light of additional discoveries uncovered in more recent literature. I also 
experimentally investigated such assemblies formed by purine biosynthesis enzymes 
in human cells. 
 
2.3 Types of intracellular bodies 
There are a wide variety of intracellular bodies that can be classified roughly 
on the basis of their composition and structures. Bacteria, for the most part 
(although exceptions exist), do not have membranous compartments, and thus their 
intracellular bodies tend to be almost exclusively proteinaceous and serve as 
subcellular compartments with specialized interiors optimized for their relevant 
biological roles (bacterial micro-compartments)(Bobik, Lehman, and Yeates 2015). 
Originally called polyhedral bodies when discovered in electron micrographs of the 
cyanobacterium Phormidium uncinatum in 1956 (Drews and Niklowitz 1956), 
bacterial microcompartments are icosahedral-type polyhedrons of ~90–400 nm in 
diameter, composed of up to several thousand protein subunits of 10-20 different 
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types totaling up to more than a gigadalton in mass, and delimited by a protein shell 
(Figure 2-1) (Bobik, Lehman, and Yeates 2015). 
 
 
Figure 2-1. Bacterial microcompartments as exemplified by carboxysomes. 
Bacterial microcompartments as exemplified by carboxysomes. (a) Transmission electron 
micrographs of Halothiobacillus neapolitanus cells showing carboxysomes (arrows) as polyhedral, 
protein-dense bodies. Adapted from Yeates et al. (2007). (b) The major shell protein (CsoS1ABC in 
H. neapolitanus) is a hexagonal subunit that oligomerizes into massive sheets that are bent into joined 
facets at the vertices by a second, pentagonal protein (CsoS4AB) to complete the shell. The interior 
of the shell is packed with RuBisCO and carbonic anhydrase to maximize CO2 capture. Adapted from 
Bonacci et al. (2012). (c) Fluorescence microscopy of carboxysomes (green) shows that their in vivo 
location within cyanobacteria is regulated such that they are centrally aligned and evenly spaced 
roughly 0.5 µm apart. Adapted from Savage et al. (2010). 
 
In eukaryotes, the formation of membranous compartments is more the norm, 
and beyond mitochondria and chloroplasts a profusion of specialized intracellular 
metabolic compartments has been discovered in recent years. These compartments 
bear a particular relevance to studies of self-assembly of metabolic enzymes, as they 
frequently exhibit a high level of enzyme self-organization. It can be argued that the 
crystalline or quasi-crystalline organization of at least some metabolic enzymes 
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within intracellular membranous compartments is a direct result of their increased 
concentrations within these microbodies. 
 
Finally, beyond the microcompartments and microbodies discussed above, 
individual metabolic enzymes have been observed to form intracellular fibers and 
foci. Textbook cases for which the fiber is known to be the enzymatically active form 
include acetyl-CoA carboxylase and β-glucosidase. Many additional examples of 
fiber-forming metabolic enzymes have been identified recently, but their functionality 
is not yet established. 
 
2.4 Bacterial microcompartments 
The archetypal bacterial microcompartment, the carboxysome, earned its 
name and association with carbon fixation in 1973, when the CO2-fixing enzyme 
ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) co-purified with 
polyhedral bodies from the aerobic sulfur bacterium Halothiobacillus neapolitanus 
(then called Thiobacillus neapolitanus)(Shively et al. 1973). Initial evidence such as 
increase in bodies during nutrient depletion and loss of bodies upon 
refeeding/reactivation supported the idea that carboxysomes were storage bodies 
rather than the major sites of carbon fixation (Shively 1974, Bock and Heinrich 
1971). However, studies over the next 30 years showed that RuBisCO in 
carboxysomes are active and that carboxysomes also contain carbonic anhydrases to 




Crystal structures of carboxysome shell proteins model the wall as a single 
layer of interlocking hexagonal subunits with a pore in the center of each. The sheets 
of hexagonal subunits are joined at the vertexes by pentagonal subunits to complete 
the icosahedrons (Iancu et al. 2007, Kerfeld et al. 2005). The shell seems to provide 
selective permeability to metabolites while blocking the diffusion of even smaller gas 
molecules by an unknown mechanism (Dou et al. 2008). The co-localization of 
enzymes and substrates within the diffusion barrier of the carboxysome shell greatly 
increases the efficiency of carbon fixation, and carboxysomes are the main sites of 
CO2 capture in cyanobacteria. 
 
Searches for sequence homology to the major shell proteins have revealed that 
at least 189 bacterial species contain shell protein orthologs in gene clusters that 
potentially produce microcompartments (Yeates et al. 2008). Among these, 
microcompartments with functions other than CO2 capture have begun to be 
characterized. In Escherichia coli and some Salmonella enterica serovars, orthologs 
of the carboxysome shell proteins were found in operons containing genes essential 
for growth on ethanolamine (Stojiljkovic, Baumler, and Heffron 1995). Acetaldehyde 
is a toxic and volatile intermediate in this pathway and might otherwise diffuse away 
rapidly in the absence of the shell proteins. Thus, a portion of the ethanolamine 
degradation pathway occurs within an ethanolamine-utilizing microcompartment 
(Brinsmade, Paldon, and Escalante-Semerena 2005). A similar 1–2 propanediol-
utilizing (PDU) microcompartment was found in S. enterica serovar typhimurium 
(Chen, Andersson, and Roth 1994). The PDU microcompartment may shield the cell 
from the toxic intermediate propionaldehyde (Havemann, Sampson, and Bobik 2002, 
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Havemann and Bobik 2003). The discovery of an N-terminal targeting sequence for 
loading proteins into PDU microcompartments and the transgenic expression of 
functional carboxysomes containing fusion proteins in E. coli mark the first steps 
toward rationally engineering bacterial microcompartments (Bonacci et al. 2012, Fan 
et al. 2010). 
 
2.5 Aggregates with microbodies 
It is interesting that protein microcompartments are found primarily in 
bacteria rather than in eukaryotes, in the same way that it is interesting that 
bacteriophages primarily have protein coats, whereas their eukaryotic counterparts 
have membranous coats. It may be that as the complexity of a system scales, the 
opportunities for inadvertent protein aggregation also scale (a point we touch on 
later), and that the less precise organization of lipids relative to proteins is a hedge 
against such aggregates. Conversely, as suggested above, enzyme 
compartmentalization may provide opportunities for increasing concentrations to the 
point at which ordered aggregation is possible. Whatever the reason, eukaryotes 
frequently compartmentalize metabolic enzymes within membranes. We highlight 
three cases of ordered aggregates within peroxisomes as examples typical of bodies 
seen in other membrane-bound compartments such as the mitochondria (Polianskyte 





Peroxisomes are eukaryotic microbodies bound by a single lipid membrane. 
These structures, typically 100 nm to 1 µm across, compartmentalize enzymes and 
substrates at high concentrations for particular metabolic pathways to improve the 
rates of catalysis or to shield the rest of the cell from the potential damaging effects 




Figure 2-2. Examples of microbodies visualized by TEM. 
Microbodies visualized by thin-section transmission electron microscopy include: (a) 
Peroxisomes (arrow) within sunflower cotyledon mesophyll cells. Crystalline inclusion bodies are 
formed from catalase, as shown by the immunogold nanoparticle localization (black dots). Adapted 
from Tenberge and Eising (1995). (b) Aspergillus nidulans showing a Woronin body filled with a 
HEX-1 protein crystal. Adapted from Yuan et al. (2003). Abbreviations: C, crystalline inclusion 
bodies; PM, peroxisomal matrix. 
 
Most peroxisomes possess one or more enzymes for purine catabolism or 
salvage, usually xanthine oxidase and urate oxidase. These proteins are often 
clustered, even to the extent of forming amorphous and crystalline inclusions. Urate 
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oxidase is a cuproprotein that normally forms homotetrameric rings, but in some 
mammalian peroxisomes these tetramers stack into fibers, which combine into 
crystalline cores (Angermuller et al. 1987). These crystalline cores are a common 
feature of many types of peroxisomes, though their effects on the enzymatic activity 
are unknown. 
 
In plants, peroxisomes commonly specialize in β-oxidation and contain high 
concentrations of oxidases and enzymes to degrade hydrogen peroxide produced by 
the oxidases. Electron microscopy of plant peroxisomes reveals crystalline and 
amorphous inclusions likely composed of catalase, a homotetrameric enzyme that 
degrades hydrogen peroxide (Heinze et al. 2000). Biochemical studies comparing 
crystalline catalase with diffuse catalase found that the crystalline catalase had up 
to tenfold-less specific activity but greater stability under UV, pH, and temperature 
stresses (Eising et al. 1998). Although there is a clear loss of function owing to 
aggregation, the gain of structural stability in a highly oxidizing environment could 
be an example of adaptive change in catalytic potential mediated by forming larger 
aggregates. 
 
Specialized types of peroxisomes, called Woronin bodies, are found in 
filamentous fungi and staunch the flow of cytoplasm from hyphal wounds (Jedd and 
Chua 2000). The major and essential component of Woronin bodies is an aggregate 
of HEX protein oligomers, which form the eponymous hexameric crystalline cores. 
HEX proteins are related most closely in structure and sequence to eIF-5a, though 
the residues responsible for inter-subunit contacts are different, and the precise 
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enzymatic function is unknown (Yuan et al. 2003). Mutation of residues at the 
oligomerization interface abolishes both the wound-healing function and the classic 
polymerization phenotype, which shows this to be an example of a functional 
aggregate (Yuan et al. 2003). 
 
In mammals, the processed form of the β-lactamase-like protein polymerizes 
into ordered filaments hundreds of micrometers in length in the intermembrane space 
of mitochondria (Polianskyte et al. 2009). The role of these fibers within 
mitochondria and the factors that drove the evolution of fiber formation from the 
non-fiber forming bacterial ortholog are unclear. 
 
2.6 Fibers and foci 
Although micro-compartments and membranous organelles are complex and 
highly structured organizing centers of metabolism, metabolic enzymes also self-
assemble into a wide array of simpler intracellular bodies, among them fibers and 
foci. Many such bodies have been discovered; some are clearly functional, whereas 
the functions of others have yet to be established. The probability of forming 
functional aggregates arguably scales with the concentrations of the enzymes 
involved, and thus, perhaps unsurprisingly, many of these fibers and foci seem to be 
enzymes that support key metabolic processes such as carbon utilization, nitrogen 




2.6.1 Fibers of metabolic proteins: carbon utilization 
2.6.1.1 Acetyl-CoA carboxylase 
Self-assembling fibers of a single enzyme are perhaps the simplest metabolic 
bodies observed in cells. The textbook example of a functional fiber is acetyl-CoA 
carboxylase (Gregolin et al. 1966, Ahmad et al. 1978); it was the first and remains 
the best characterized of all enzymatic fibers. Most mammals encode acetyl-CoA 
carboxylase as a single multi-domain protein, nominally a homodimer, but one that 
can assemble into polymers with >50-fold greater activity (Beaty and Lane 1983a, 
Meredith and Lane 1978). In mammals, there are two isoforms of the enzyme, one 
localized to the cytoplasm and the other to the mitochondria. Both isoforms carry 
out the first and rate-limiting step of fatty acid biosynthesis by carboxylating acetyl-
CoA to malonyl-CoA. Recently, acetyl-CoA carboxylase filaments have been 
revealed in yeast (Acc1) under light microscopy, in which Acc1p-GFP assembles into 
long filaments under prolonged starvation (Shen et al. 2016, Suresh et al. 2015). In 
bacteria, the beta-carboxyltransferase subunit of acetyl-CoA carboxylase fused to 
mCherry was observed to assemble into foci (Werner et al. 2009). 
 
Although polymerization is dependent on enzyme concentration, many other 
mechanisms shift the enzymes between inactive monomers and the active polymer 
form (Beaty and Lane 1983b). Phosphorylation or de-phosphorylation will decrease 
or increase acetyl-CoA carboxylase polymerization, respectively; allosteric binding of 
citrate induces polymerization, whereas excess product (malonyl-CoA) triggers de-
polymerization. Binding of MIG12, an effector protein, to acetyl-CoA carboxylase 
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also induces its polymerization and further increases fatty acid synthesis and 
triglyceride accumulation  (Kim et al. 2010). Interestingly, MIG12 is also involved 
in stabilizing another well-known polymer: microtubules (Berti et al. 2004). 
 
2.6.1.2 β-glucosidase 
Gunning (1965) first reported fibers of β-glucosidase in electron micrographs 
of oat plastids in 1965. This enzyme is nominally a homohexamer that hydrolyzes 
β1→4 glucose bonds; it also cleaves avenacosides as an antifungal defense. Structural 
studies 40 years later revealed rings of hexamers stacked into fibers up to 2 µm in 
length (Kim et al. 2005), and biochemical analyses provided evidence that the fibers 
might be the active form of the enzyme: longer fibers were more active in hydrolyzing 
avenacosides and more resistant to inhibitors than were shorter fibers (Kim et al. 
2005). 
 
2.6.2 Fibers of metabolic proteins: nitrogen utilization 
2.6.2.1 Glutamine synthetase 
Several enzymes at the core of nitrogen metabolism also form fibers. Studies 
of E. coli glutamine synthase (Class I), which catalyzes the ATP-driven addition of 
ammonia to glutamate, found that zinc progressively induces the dodecameric rings 
of the enzyme complex to aggregate into fibers (Miller, Shelton, and Stadtman 1974). 
Mammals have an eye-specific glutamine synthetase (Class I-like) that is 
catalytically inactive but essential for proper eye development (Harding et al. 2008). 
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Like crystallins, it is one of many chance adaptations of structured enzyme 
aggregates to serve as eye proteins. In yeast, glutamine synthetase (Class II) is a 
decamer that forms foci (Narayanaswamy, Levy, et al. 2009, O'Connell et al. 2014) 
and filaments (Petrovska et al. 2014) both in vivo and in vitro under various 
conditions such as starvation or low pH. Glutamine synthetase filaments constituted 
in vitro with cobaltous ions can form highly ordered helical cables (Frey, Eisenberg, 
and Eiserling 1975) and wheat sheaf bundles (Valentine, Shapiro, and Stadtman 
1968). The formation of these assemblies in vivo were shown to have implications on 
the protein’s enzymatic activity and the ability of yeast cells survive and recover 
from severe starvation (Petrovska et al. 2014), further discussed in Section 2.7.  
 
2.6.2.2 Glutamate dehydrogenase and glutamate synthetase 
When cells are starved of glutamine, they degrade glutamate to α-
ketoglutarate and ammonia using the NAD-dependent glutamate dehydrogenase in 
mitochondria. In mammals, this enzyme normally forms homohexamers but at high 
concentrations associates into either highly ordered filaments or helical fiber bundles 
(Josephs and Borisy 1972). In quiescent yeast, glutamate dehydrogenase (Gdh2p) 
assembles into long filaments under light microscopy (Shen et al. 2016). It is unclear 
what effect polymerization has on enzyme activity (Zeiri and Reisler 1978); however, 
glutamate dehydrogenase has a host of allosteric regulators, including zinc, ADP, 
and GTP, and those that activate function also promote polymerization and decrease 
thermal aggregation (Cioni and Strambini 1989, Eisenberg and Reisler 1971, Frieden 
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1958, Olson and Anfinsen 1952, Sabbaghian, Ebrahim-Habibi, and Nemat-Gorgani 
2009).  
 
The reverse reaction—glutamate synthesis—can be carried out either by 
highly related enzymes using NADPH as a cofactor or by glutamate synthetases, 
which catalyze a transamination from glutamine to α-ketoglutarate, forming two 
molecules of glutamate. In starved yeast, the green fluorescent protein (GFP)-tagged 
glutamate synthetase forms fibers (Noree et al. 2010); similar to glutamate 
dehydrogenase, the enzyme forms homohexamers, and the fibers observed by 
fluorescence microscopy may represent fibrillar bundles of the homohexamers. 
 
2.6.3 Fibers of metabolic proteins: nucleotide biosynthesis 
2.6.3.1 Cytidine triphosphate (CTP) synthase 
Multiple groups have reported that CTP synthase forms filamentous, foci, 
and ring structures in vivo in fly (Chen et al. 2011, Liu 2010, Noree et al. 2010), 
bacteria (Ingerson-Mahar et al. 2010), budding yeast (Noree et al. 2010), fission yeast 
(Zhang, Hulme, and Liu 2014), rat (Noree et al. 2010), and human cells (Chen et al. 
2011, Carcamo et al. 2011) (Figure 2-3). In the crescent-shaped 
bacterium Caulobacter crescentus, CTP synthase forms a single rod lining the inner 
curvature of the cell. In Drosophila, CTP synthase filaments, termed cytoophidia 
(meaning “cell snake”), exist in two forms, termed microcytoophidia and 
macrocytoophidia, the latter being considerably thicker and longer than the former. 
In yeast, CTP synthase assembles into filaments as cells enter quiescence upon 
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culture growth to stationary phase. In fact, yeast cells express two CTP synthase 
isozymes, Ura7p and Ura8p, which co-localize within the same filaments but not 




Figure 2-3. CTP synthase fibers within various organisms. 
CTP synthase labeled with GFP forms filaments in fruit flies (Liu 2010) (A), budding yeast 
(Noree et al. 2010) (B), fission yeast (Zhang, Hulme, and Liu 2014) (C), and human HEK293T cells 
(Carcamo et al. 2011, Chen et al. 2011) (D). Nuclei are labeled by DNA dyes (magenta in A–C; blue 




Initial data suggest that these fibers may be formed by the self-association of 
CTP synthase and do not require energy or special machinery (such as chaperones 
or scaffolds) for formation. Filaments are seen to form upon heterologous expression 
of C. crescentus CTP synthase in E. coli, and native E. coli CTP synthase forms 
filaments both in vivo and in vitro (Ingerson-Mahar et al. 2010). That said, other 
studies now implicate IMPDH as additional components in these fibers within higher 
eukaryotes (Carcamo et al. 2011, Chang et al. 2015), although this observation has 
since been contested (Probst et al. 2013, Carcamo et al. 2014). 
 
Although the filaments show distinct intracellular locations, these apparently 
vary in different organisms. In C. crescentus, CTP synthase filaments co-localize to 
crescentin along the inner curvature of the cell and apparently help regulate the 
crescent cell shape (Ingerson-Mahar et al. 2010). In rat neurons, CTP synthase 
filaments occur in axons but not dendrites (Noree et al. 2010). Fly microcytoophidia 
associate with Golgi complexes and in some cases with microtubules (Liu 2010). In 
contrast, human and yeast CTP synthase filaments were not observed to co-localize 
with microtubules (Carcamo et al. 2011, Noree et al. 2010), and human CTP 
synthase filaments also were not observed to co-localize to Golgi complexes or 
centrosomes and were not enriched in actin or vimentin (Carcamo et al. 2011). 
 
Compounds that modulate CTP synthase protein function modulate fiber 
formation. For example, CTP synthase inhibitors such as acivicin and the glutamine 
analogs 6-diazo-5-oxo-L-norleucine (DON) and azaserine (Carcamo et al. 2011, Chen 
et al. 2011) have dramatic effects on CTP synthase filaments. Interestingly, CTP 
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synthase inhibitors produce different effects in different organisms: DON treatment 
disrupts CTP synthase filament formation in C. crescentus and also disrupts 
filaments of heterologously expressed C. crescentus CTP synthase 
in Schizosaccharomyces pombe or E. coli (Ingerson-Mahar et al. 2010). In contrast, 
DON and azaserine treatments promote filament formation in fly cells, and DON 
and acivicin treatments induce filament formation in human cells (Carcamo et al. 
2011, Chen et al. 2011). Notably, DON binding induces tertiary (Levitzki, Stallcup, 
and Koshland 1971) and quaternary (Robertson 1995) structural changes of CTP 
synthase in E. coli. As in the glutamine synthetase case mentioned above, such 
allosteric changes also alter the conformational state of neighboring subunits 
coordinately (Levitzki, Stallcup, and Koshland 1971), which is consistent with the 
hypothesis that differences in inter-subunit amino acid contacts might be exposed or 
hidden by conformational changes. This would help to explain not only the evolution 
of fiber formation but also how fiber formation is functionally related to regulatory 
logic. 
 
Filament formation also can vary broadly according to systemic conditions, 
including cell types, stages, and growth conditions. Ingerson-Mahar et al. 
(2010) reported that mCherry-CTP synthase filaments were generally shorter in 
newly formed stalked cells of C. crescentus and then elongated with the progression 
of the cell cycle. Additionally, subcellular localization was also dependent on cell 
cycle. Carcamo et al. (2011) observed the opposite in human cells, in which 
expression of filaments occurred in all phases of the cell cycle in HEp-2 cells, 
and Chen et al. (2011) found a similar ubiquity in HeLa cells. However, in other 
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human cells, the filaments varied by cell type and culture conditions. For example, 
undifferentiated, uninduced human embryonic stem cells contained CTP synthase 
rings and rods but lost them when stimulated to differentiate by retinoic acid 
(Carcamo et al. 2011). Similarly, filaments of the yeast CTP synthase Ura7p are 
induced strongly by growth to saturation or glucose depletion but disappear upon 
addition of fresh medium. Thus, CTP synthase fibers currently represent something 
of a quandary: Although widely observed, they show mixed regulatory logic across 
organisms, and their enzymatic functionality is further explored in Sections 2.7.1.2 
and 2.8.3. 
 
2.6.3.2 Inosine 5’-monophosphate dehydrogenase, types I and II 
A study in human cells that was later contested demonstrated that 
cytoplasmic filaments consisting of human CTP synthase also contained inosine 5′-
monophosphate dehydrogenase (IMPDH) (Probst et al. 2013, Carcamo et al. 2014, 
Carcamo et al. 2011). IMPDH catalyzes the NAD-dependent oxidation of inosine 
monophosphate (IMP) to xanthosine monophosphate, the first and rate-limiting step 
for the synthesis of guanosine nucleotides. The predominant isotype, IMPDH type 
II, is highly expressed in neoplastic and differentiating cells, which makes it an 
inviting target for anti-proliferation drugs such as the immunosuppressive, 
noncompetitive inhibitor mycophenolic acid (MPA) (Nagai et al. 1991, Woolfolk and 
Stadtman 1967). MPA induced IMPDH2 rings and filaments in cultured human cells, 
reduced the enzyme’s specific activity in cell lysates, and induced purified IMPDH2 
homotetramers of ~15 nm in diameter to form large, disordered aggregates in vitro 
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(Ji et al. 2006). Independent studies have observed that IMPDH2 fibers have a 
regular diameter of about 8.5 nm and consist of regularly shaped particles with a 
length of approximately 11 nm (Juda et al. 2014). Both MPA-induced rings and 
fibers in vivo and aggregation in vitro could be dispersed by the addition of GTP at 
physiological concentrations, with GTP addition restoring the activity of MPA-
inhibited IMPDH2 in cell lysates (Ji et al. 2006). These results are consistent with a 
hypothesis that MPA stabilizes inter-tetramer interactions and shifts the equilibrium 
between active IMPDH2 tetramers and inactive fibers to favor the inactive form.  
 
IMPDH type I (IMPDH1), which shares 84% amino acid identity and 
virtually indistinguishable catalytic activity with IMPDH2, was shown to form 
intracellular fibers with higher propensity than IMPDH2 (Gunter et al. 2008). 
Purified human IMPDH1 in the presence of an allosteric effector (Mg-ATP) form 
fibers by a linear stacking of two conformations of IMPDH1 octamers, in which the 
eight Mg-ATP-binding domains (CBS modules) point out perpendicular to the fiber 
axis (Labesse et al. 2013). The CBS module harbors the location of the D226N point 
mutation in human IMPDH1 responsible for retinal degeneration and IMPDH1-
based retinitis pigmentosa. Interestingly, the D226N variant has a high propensity 
to spontaneously form intracellular fibers (Thomas et al. 2012). In vitro, the purified 
D226N variant show intertwined fibers with strong interactions between adjacent 
fibers (Labesse et al. 2013). The aggregation of such fibers in the autosomal dominant 





2.6.3.3 Purine biosynthesis and purinosomes 
The enzymes of nucleotide metabolism appear to be particularly prone to 
form intracellular bodies (Shen et al. 2016). In particular, the existence of a multi-
enzyme complex consisting of all the members of the de novo purine biosynthesis 
pathway, termed the purinosome, has been postulated for some time on the basis of 
the accumulation of a variety of evidence from many experiments; this topic is 
explored in-depth in the next Chapter. The de novo purine biosynthesis pathway 
encompasses a ten-step enzymatic reaction converting phosphoribosyl pyrophosphate 
(PRPP) to inosine monophosphate (IMP). In higher eukaryotes such as mammals, 
de novo purine biosynthesis is carried out by phosphoribosyl pyrophosphate 
amidotransferase (PPAT), the trifunctional phosphoribosylglycinamide 
formyltransferase/phosphoribosylglycinamide 
synthetase/phosphoribosylaminoimidazole synthetase (GART), 
phosphoribosylformyl-glycinamidine synthase (FGAMS), the bifunctional 
phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole 
succinocarboxamide synthetase (PAICS), adenylosuccinate lyase (ADSL), and the 
bifunctional 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP 
cyclohydrolase (ATIC). The de novo purine biosynthesis pathway is upregulated 
when exogenous hypoxanthine is unavailable (Becker and Kim 1987, Yamaoka et al. 
2001). 
 
In higher eukaryotes, these ten enzymes have fused into six polypeptide 
chains, three of which possess multiple active sites, as listed above. Early hints that 
the purinosome might form included co-immunoprecipitation of trifunctional GART 
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and bifunctional PAICS from chicken liver (Caperelli et al. 1980), along with serine 
hydroxymethyl transferase and the trifunctional methylene tetrahydrofolate 
dehydrogenase (MTHFD1). These latter two enzymes form a cycle for the production 
of the labile 10-formyl tetrahydrofolate coenzymes required for steps 3 and 9 of purine 
biosynthesis. Cross-linking studies in vitro found a physical interaction between 
GART and MTHFD1, and their interaction increased GART activity (Smith et al. 
1980). Fluorescence microscopy of transiently expressed, fluorescently tagged 
proteins showed co-localization between tetrahydrofolate synthase and FGAMS or 
GART (Field, Anderson, and Stover 2011). 
 
In 2008, the Benkovic group reported the first direct observation of the 
purinosome in cells (An et al. 2008). Fluorescent protein constructs of the six 
mammalian purine biosynthesis enzymes formed intracellular punctate foci when 
transiently overexpressed in HeLa cells in purine-depleted culture medium. FGAMS-
OFP was shown to co-localize with the five other enzymes of the pathway, which 
suggested the assembly of de novo purine biosynthesis enzymes into purinosomes. 
FGAMS-GFP foci could be dissolved by exchanging purine-depleted for purine-rich 
medium, although the addition hypoxanthine, a purine derivative, to purine-depleted 
medium did not dissolve the foci. Intracellular foci of PPAT, GART, ADSL, and 
ATIC were also detected via immunofluorescence confocal microscopy of endogenous 
enzymes in many human cell types, including primary keratinocytes. The bodies 
formed and dispersed when culturing cells in purine-depleted and purine-rich 




Inhibitor studies have yielded some insights into the mechanism of purine 
enzyme foci formation, which will be expounded upon in the next Chapter. The study 
of these foci is a case study in how the methods used to query intracellular bodies 
potentially influence outcomes. These foci have been observed largely by transient 
overexpression with fluorescent protein tags. In contrast, previous stably expressed 
purine biosynthesis enzymes did not form foci (Gooljarsingh et al. 2001). 
Overexpression of proteins can result in deleterious disruption of homeostasis leading 
to aggregation (Tartaglia et al. 2007). As well, transient transfection is well-known 
to induce stress and cell death. The transiently overexpressed purine biosynthetic 
enzymes formed foci to extents that correspond to each enzyme’s predicted 
aggregation propensity (Zhao et al. 2013). Foci formation could be induced by 
general stress agents, and foci were marked by ubiquitin and heat-shock chaperones, 
which suggested that they may represent aggregated protein clusters (Zhao et al. 
2013). 
 
The formation of functional purinosomes is not necessarily inconsistent with 
the observation of aggregated purine biosynthetic enzymes. Indeed, both may be 
true, depending on the cell state and method of observation. Foci formed by purine 
enzymes appear to be quite heterogeneous, as the penetrance of fluorescent body 
formation varied broadly for each individual enzyme, ranging from 5% to 77% of the 
cells (An et al. 2008). A similar broad distribution was observed for CK2 inhibitor-
mediated effects (ranging from 15% to 95% penetrance) (An, Kyoung, et al. 2010). 
Regulatory influences can also be interpreted in terms of either functional or 
nonfunctional aggregation (or both): although microtubules and CK2 could regulate 
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purine enzyme foci, they have also been implicated in general protein aggregation 
(Muchowski and Wacker 2005, Watabe and Nakaki 2011, 2012). Nocodazole 
inhibition of purine enzyme foci formation (An, Deng, et al. 2010) is consistent with 
functional assembly requiring microtubules, but nocodazole treatment also inhibits 
inclusion body formation of aggregated huntingtin (Kaminosono et al. 2008, 
Muchowski et al. 2002), suggesting general protein aggregation mechanisms. Future 
studies will clearly be required to address the key questions of functionality of the 
purine enzyme foci, ideally leading to purification and in vitro characterization, and 
to assess the relationships, if any, between the intracellular foci formed by the 
recombinant purine biosynthetic enzymes and the endogenous forms of those 
proteins. 
 
2.6.4 Large-scale screens in various systems reveal many additional 
intracellular foci and fibers 
The frequency at which intracellular bodies have been found during the study 
of metabolism indicates either that metabolic enzymes are prone to aggregation or, 
perhaps, that all enzymes are prone to aggregation and, to date, biochemists just 
happen to have largely studied metabolic enzymes. In fact, large-scale microscopy 
screens of protein localization dynamics have revealed tens to hundreds of additional 
enzymes that form intracellular bodies (Figure 2-4). Using cell 
microarrays, Narayanaswamy, Levy, et al. (2009) surveyed large-scale trends in yeast 
(Saccharomyces cerevisiae) protein reorganization using a genome-wide GFP fusion 





Figure 2-4. Hundreds of foci- and fiber-forming proteins discovered in various 
organisms. 
Hundreds of foci- and fiber-forming proteins have been discovered in systematic protein 
localization screens; most of these intracellular bodies are still largely uncharacterized. (a,b) 
Representative foci (acetyl-coA carboxylase carboxyl transferase β-subunit)- and fiber (UDP-N-
acetylmuramate-alanine ligase)-forming mCherry fluorescent protein fusion proteins, respectively, 
from Caulobacter crescentus. Adapted from Werner et al. (2009). (c,d) Representative foci (Ade4p)- 
and fiber (Pil1p)-forming yellow fluorescent protein–fusion proteins, respectively, 
from Schizosaccharomyces pombe. Adapted from Matsuyama et al. (2006). (e,f) Representative foci 
(Gln1p)- and fiber (Asn2p)-forming GFP-fusion proteins, respectively, from Saccharomyces 
cerevisiae. Adapted from Narayanaswamy, Levy, et al. (2009). 
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GFP-tagged proteins from their native locus in the genome were grown to stationary 
phase, 180 proteins involved in intermediary metabolism and stress response were 
observed to form cytoplasmic punctate foci. The formation of many of these protein 
macrostructures was confirmed also by immunofluorescence and mass spectrometry 
of untagged proteins, with 33 proteins confirmed by both microscopy and mass 
spectrometry (Narayanaswamy, Levy, et al. 2009).  
 
A second screen of a portion of the S. cerevisiae GFP library by Noree et al. 
(2010) found 29 foci- and 9 filament-forming proteins. Of these, three distinct fibers 
were formed by metabolic proteins. One was formed by CTP synthases Ura7p and 
Ura8p. The other two fibers, composed of Psa1p and Glt1p, were novel observations. 
Psa1 is a GDP-mannose pyrophosphorylase essential for building the glycoproteins 
of the cell wall and is highly conserved across eukaryotes. The other, Glt1, is an 
NAD-dependent glutamate synthase, which, along with Gln1, forms one of the core 
ammonia incorporation pathways. CTP synthase fibers have been further extensively 
characterized and suggested to comprise inactive forms of the enzyme (Noree et al. 
2014), further discussed in Section 2.7.  
 
A third screen of the entire S. cerevisiae GFP library (which represents ~75% 
of the S. cerevisiae genome) by Shen et al. (2016) report 23 filament-forming 
proteins, confirming previous findings and declaring new filament-forming proteins, 
including asparagine synthetases Asn1p and Asn2p, glycogen debranching enzyme 
Gdb1p, glutamate dehydrogenase Gdh2p, phosphofructokinases Pfk1p and Pfk2p, 
and thioredoxin peroxidase Tsa1p. Most of the identified filament-forming proteins 
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are metabolic enzymes, a point we touch on later in Section 2.8.1. Culture 
conditions apparently affected the occurrence and length of the metabolic filaments. 
Additionally, Asn1p/Asn2p filaments were also found in the nucleus.  
 
As well, several systematic microscopy screens of protein localization have 
been performed in the fission yeast S. pombe (Ding et al. 2000, Hayashi et al. 2009, 
Matsuyama et al. 2006, Sawin and Nurse 1996). Although these screens were not 
searching specifically for new structures, they still describe many proteins appearing 
as cytoplasmic dots (e.g., CTP synthase Ura7p and Ura8, and 
phosphoribosylpyrophosphate amidotransferase Ade4p, as were seen also in S. 
cerevisiae (Narayanaswamy, Levy, et al. 2009)) or in fibrous morphologies (e.g., 
Pil1p, an essential cell wall peptidoglycan synthetase). 
 
A localization study of ~300 cytoplasmic proteins labeled with mCherry in 
the asymmetric bacterium Caulobacter crescentus identified many proteins that 
showed non-diffuse localization (Werner et al. 2009). Of these, they described 29 
proteins’ cellular distributions as discrete foci, 129 proteins as patchy/spotty, and 3 
as filament-forming. Two of the filament-forming proteins are CTP synthase and an 
associated structural protein, CreS. The third fiber is formed by UDP-N-
acetylmuramate-alanine ligase. Similar to Psa1, it is an essential enzyme for 
peptidoglycan synthesis. 
 
These large-scale screens clearly reveal a remarkably extensive assortment of 
intracellular bodies forming across diverse environmental conditions. It would appear 
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that at least some of these bodies are metabolically inducible and form reversibly, 
which strongly suggests functionality. For example, the yeast purine biosynthetic 
enzyme Ade4p-GFP formed foci in the absence of adenine, and cycling between 
punctate and diffuse phenotypes could be controlled by adenine removal and 
supplementation, respectively. Similarly, yeast glutamine synthetase (Gln1p-GFP) 
foci cycled reversibly in the absence and presence of glucose (Narayanaswamy, Levy, 
et al. 2009). Finally, there is evidence for the yeast translation initiation regulatory 
complexes eIF2 and eIF2B polymerizing into filaments during log phase growth 
(Noree et al. 2010, Campbell, Hoyle, and Ashe 2005). As this is precisely when 
translation rates are the highest in yeast, it suggests the fibers may be functional 
and regulated. However, as with the purine metabolism enzyme foci, caution must 
be used in interpreting whether the bodies form for functional roles or whether 
regulated changes in concentration or fluorescent protein tagging inadvertently led 
to intracellular aggregates. 
 
All of these large-scale localization studies use fusion proteins, and the 
properties of the tag can affect the solubility and interactions of the tagged protein. 
One recent study found that a commonly accepted proteinaceous body formed by 
Clp proteases was entirely dependent on certain fluorescent tags (Landgraf et al. 
2012). In the absence of a tag or expressed with a GFP evolved for monomeric 
expression in E. coli, Clp proteases did not form the bodies. Similarly re-tagging five 
additional proteins that were reported to form bright foci in multiple fluorescent 
protein libraries resulted in greatly reduced or entirely eliminated foci (Landgraf et 
al. 2012). The authors proposed that the dimerization of fluorescent protein tags (a 
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known property of many fluorescent proteins) cause homo-oligomeric complexes to 
assemble into an extended network to produce an intracellular body (Landgraf et al. 
2012). If this is a major cause of intracellular bodies, it predicts the set of foci forming 
proteins should be strongly enriched for oligomers. Thus, structures discovered by 
large-scale fluorescence localization screens need to be confirmed by orthogonal, 
preferably tag-free, methods to verify their biological relevance. Further evidence of 
tag-induced mis-localization is discussed in later chapters. 
 
2.7 Three potential roles for intracellular bodies 
The panoply of intracellular protein bodies also raises interesting questions 
regarding their evolution and maintenance within cells. We conclude by offering 
additional speculations on several particular aspects of how and why such bodies 
might evolve. 
 
Case studies such as CTP synthase and the purine biosynthesis enzymes raise 
many interesting questions regarding the functionality of intracellular bodies. It is 
thus useful to consider why metabolic enzymes might assemble into such large 
intracellular assemblies. In general, metabolic enzymes are notable for often forming 
large complex quaternary structures (e.g., pyruvate dehydrogenase). These massive 
intracellular assemblies may provide functional advantages to the cell, such as 
catalytic efficiency or improved regulation. Alternatively, these structures might be 
depots for the storage of functional proteins or the disposal of dysfunctional ones. 
Although numerous metabolic enzymes clearly form functional and well-
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characterized meta-assemblies, it is not yet clear for many of the most recently 
discovered intracellular bodies whether they represent functional structures, storage 
bodies, or aggregates. Distinguishing these roles remains one of the major challenges 
for understanding these structures. 
 
2.7.1 Catalytic efficiency and improved regulation 
2.7.1.1 Substrate channeling  
Classically, enzymes have been thought to organize into multi-subunit 
assemblies to improve their functionality. Quaternary structures enable the 
channeling of substrates between active sites on individual subunits, thereby 
protecting labile intermediates from side reactions in the cell or protecting the cell 
from toxic reaction intermediates. For example, the first intermediate substrate in 
de novo purine biosynthesis, 5-phosphoribosylamine, has a cellular half-life of 38 
seconds, and channeling is essential for its subsequent coupling to glycine (Schendel 
et al. 1988). Also, the addition of CO2 to aminoimidazole ribonucleotide to form 
carboxyaminoimidazole ribonucleotide (CAIR) through two enzymatic steps with N5-
CAIR as an unstable intermediate substrate may have driven the fusion of the 
enzymes responsible for these two steps in eukaryotes (Meyer et al. 1999). Finally, 
the N10-formyl-tetrahydrofolate coenzyme used in steps 3 and 9 is moderately labile, 
with a half-life of 30 minutes (Smith et al. 1980). Such observations underpin the 
search for the purinosome, which would in principle localize the de novo purine 
biosynthesis enzymes and their coenzymes within sufficient proximity to prevent the 
diffusion of unstable intermediates or substrates in a fashion similar to how the 
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peroxisome shields the cytosol from peroxide radicals generated by oxidases in fatty 
acid and purine catabolism. A related phenomenon is that of ethanolamine-utilizing 
micro-compartments, which localizes the production and degradation of toxic 
aldehydes within a protein shell. 
 
Channeling substrates between active sites in a quaternary structure or within 
a compartment can also improve metabolic efficiency greatly, even when no side 
reactions are in play. For instance, carboxysomes prevent the diffusive loss of CO2 
during carbon fixation and thereby allow unicellular organisms to achieve C4 
plantlike efficiencies. In an even grander organization of metabolic machinery, the 
cellulosome anchors enzymes involved in cellulose production via elaborate, 
interlocking multidomain protein scaffolds on the cell surface (Beguin and Lemaire 
1996). 
 
2.7.1.2 Allostery and cooperativity  
Finally, quaternary structure formation allows regulation by cooperative 
interactions and allosteric effectors. There are, of course, many such known examples 
of cooperativity in enzyme oligomers. Among these, the dodecameric glutamine 
synthetase from E. coli is one of the best understood. In addition to two covalent 
modification enzyme systems, glutamine synthetase has eight direct allosteric 
inhibitors that (individually) partially and (together) cooperatively inhibit activity 
(Eisenberg et al. 2000). The allosteric inhibitors bind active sites that are positioned 
at the interface between the subunits of the two hexameric rings, and in this way 
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binding is transduced into structural changes that can be transmitted between 
enzymes in both rings. This mode of regulation effectively integrates information 
about the metabolic state of the cell with overall enzyme activity (Woolfolk and 
Stadtman 1967), and such changes could in principle modulate the formation of 
glutamine synthetase foci and fibers in vivo. In yeast, glutamine synthetase (Gln1p) 
is composed of two similarly arranged pentameric rings that interact to form a face-
to-face homo-decamer. Moreover, the crystal structure of yeast Gln1p revealed a 
back-to-back association between two homo-decamers, a mechanism from which 
Gln1p filaments may form (He et al. 2009). Indeed, Petrovska et al. (2014) uncovered 
mutations at the decamer-decamer interface that either abrogated the ability of 
Gln1p to conditionally form filaments or constitutively form filaments regardless of 
the growth conditions. However, Gln1p mutants that constitutively formed filaments 
had strongly reduced synthetase activity (Petrovska et al. 2014), suggesting that 
while filament formation may regulate Gln1p’s enzymatic activity, it is likely not by 
increasing catalytic efficiency. How the filament formation induces enzymatic 
inactivation is unclear, although reasonable hypotheses are that the filament-
assembled Gln1p is sterically restricted from conformational changes required for 
enzymatic activity, or that the filaments block substrate access to Gln1p’s catalytic 
site. 
 
Due to our understanding of multiple well-established mechanisms that 
regulate its activity, CTP synthase serves as a candidate model for addressing 
whether regulation of enzyme activity is coupled to its fiber formation. Using 
multiple substrate-binding-site and phosphorylation site mutations, Noree et al. 
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(2014) found that allosteric activation and a phosphorylation site on the enzyme’s 
glutamine amidotransferase domain, along with sites of substrate binding and end-
product inhibition within the amidoligase (synthase) domain, modulated filament 
length. In particular, mutations in CTP synthase’s “L11 loop”, a region covering the 
GTP-induced activation site, is known to alter allosteric regulation of the enzyme. 
Mutations in this loop that inhibit access of the active site to positive allosteric 
regulators such as GTP result in Ura7p filaments longer than those observed of 
wildtype Ura7p (Noree et al. 2014). Conversely, shorter filaments were observed with 
a loop mutation that encourages GTP interaction (Noree et al. 2014). Interesting, 
both types of mutations increased the frequency of filament formation, and the 
reasons for this are unclear (Noree et al. 2014). However, these observations suggest 
that regulation of the enzyme’s activity is tightly coupled to the control of filament 
formation and/or filament length (Noree et al. 2014). Similar to Gln1p filaments, 
CTP synthase filaments are also suggested to comprise of inactive enzymes (Barry 
et al. 2014, Aughey et al. 2014, Noree et al. 2014). While filament formation may be 
coupled to its enzymatic activity, it does not seem to be for enhancing catalytic 
efficiency.  
 
2.7.2 Storage depots 
It has also been hypothesized that proteins may assemble into macromolecular 
depots, in which unused components can be held transiently in localized bodies before 
its eventual re-activation and release back into the cellular pool. The advantage of 
such depots is that proteins need not be resynthesized but are instead retained for 
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potential future use, especially in conditions in which rapid re-deployment may be 
required. For example, in the stationary (quiescent) phase, yeast cells have a 
remarkable ability to weather extreme stress conditions but can rapidly re-enter the 
cell cycle (Gray et al. 2004). Many changes accompany the transition into stationary 
phase; for example, exhibit decreased metabolic rates and increased size and density 
and in general cease proliferating. The cell walls increase in thickness to provide 
osmo- and thermo-tolerance, and the cells accumulate intracellular carbohydrates, 
including glycogen and trehalose, which may serve to help protect the cells against 
a variety of stresses (Gray et al. 2004). Although rates of transcription and 
translation are decreased dramatically in quiescent cells as compared with 
exponentially growing cells (Choder 1991, Fuge, Braun, and Werner-Washburne 
1994), the quiescent cells are able to rapidly restart growth when nutrients become 
available. Quiescent cells have been shown to maintain available pools of important 
cellular components in forms that can be mobilized quickly, including cytoplasmic 
processing bodies containing mRNAs that can be translated upon restarting growth 
(Brengues, Teixeira, and Parker 2005) and actin bodies—localized accumulations of 
actin that can reassemble into actin fibers and patches as necessary when cellular 
growth restarts (Sagot et al. 2006). Overall, quiescent cells appear to be rich with 
dynamic depots that are important for re-entry into the mitotic cell cycle. Such a 
trend is consistent with the tendency for many cellular proteins to be organized–
both spatially and functionally–in a manner consistent with the needs of the cell. 
 
 In particular, the aforementioned formation of Gln1p filaments in yeast were 
shown to be essential for re-entry into the cell cycle after recovery from severe 
 
 62 
starvation (0.1 M phosphate buffer). Gln1p filaments were shown to dissolve rapidly 
when yeast cells re-enter the cell cycle, and the disassembled enzyme complexes were 
presumably functional, arguing that Gln1p filaments serve as crucial storage depots 
during starvation (Petrovska et al. 2014).  
 
2.7.3 Aggregation of dysfunctional and/or misfolded proteins 
In contrast to the above examples of intracellular bodies with active 
functional roles or storage of functional potential, a third major category of 
intracellular bodies is now well established: those composed of aggregated and 
possibly dysfunctional unfolded proteins. Such bodies often are the product of active 
cellular processes for collecting, sequestering, and disposing of the aggregates 
(Tyedmers, Mogk, and Bukau 2010) but also can form when high levels of expression 
trigger self-association and aggregation (Wickner 1994). Aggregated proteins are 
commonly sequestered, often via active transport along the cytoskeleton, to specific 
cellular sites such as the aggresome (Johnston, Ward, and Kopito 1998), IPOD, and 
JUNQ (Kaganovich, Kopito, and Frydman 2008). 
 
The best-characterized examples of protein aggregates and intracellular 
aggregation bodies include amyloid fibers and inclusion bodies. Amyloid fibers, in 
particular, are linked to a range of human diseases, including Alzheimer’s, 
Parkinson’s, and Huntington’s (Ross and Poirier 2004), but they also occur broadly 
across proteins and organisms (Halfmann et al. 2012, Goldschmidt et al. 2010). The 
toxicity of protein aggregates is generally attributed not only to the depletion of 
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functional machinery (Stefani and Dobson 2003) but also to the creation of pores 
inside cell membranes by small oligomers (Ahmed et al. 2010). At the early stages 
of aggregation, small oligomers of amyloid aggregates have structural similarities to 
pore-forming bacterial toxins and eukaryotic pore proteins (Hirakura and Kagan 
2001), and their insertion into membranes leads to ion loss and cell death (Kourie et 
al. 2002). Both yeast and human prions constitute a continuous spectrum of 
aggregation with multiple morphologies (Edskes et al. 2009, Legname et al. 2006). 
 
In contrast to bodies formed by aggregates of dysfunctional proteins, some 
bodies may be formed by aggregates of functional proteins. For instance, recent 
evidence suggests RNA granules are formed by aggregation of partially unfolded 
RNA-binding proteins whose low complexity sequences form hydrogels of amyloid 
aggregates. However, the proteins retain their RNA-binding capacity, and unlike 
other amyloid aggregates these show highly dynamic assembly and disassembly rates 
and can incorporate heterogeneous sequences (Kato et al. 2012). These RNA granules 
still serve various biological functions despite being formed by amyloid aggregates, 
which are historically thought to be pathological and often associated with cell death 
in neurodegenerative diseases. 
 
2.8 Speculations and conclusions 
Similar to the large-scale screens of protein localization, microscopy screens 
have also identified numerous new yeast prions (Alberti et al. 2009). Whether 
assembling bodies for functional reasons, perhaps in response to metabolic cues, or 
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simply aggregating pathologically, a much larger set of proteins than is broadly 
appreciated may assemble into bodies or aggregate in vivo, perhaps whenever their 
abundances exceed tolerated limits (Tartaglia et al. 2007). The breadth of these 
phenomena raises the interesting possibility that all ordered proteins may exhibit 
some level of self-aggregation or self-assembly.  
 
2.8.1 Are metabolic enzymes intrinsically more likely to self-assemble? 
Because metabolic enzymes often exhibit complex quaternary structures and 
inter-subunit allostery for the purpose of regulation, such quaternary structures 
might be intrinsically more susceptible to forming intracellular foci and fibers simply 
as a result of a symmetrical arrangement of enzymes, which would replicate any 
favorable inter-subunit interactions around the structure’s axes of symmetry (Figure 
2-5). For example, stacked E. coli glutamine synthase dodecamers (dimers of 
hexamers) present six identical interfaces, one between each pair of the six repeated 
monomers around the dodecamer-dodecamer interface. Any favorable interaction at 
one such interface is therefore copied six times around the rings, making—via 
avidity—for a robust overall interface. Such a mechanism of fiber formation is 
therefore intrinsically more likely for proteins with complex quaternary structures 
typical of those found among metabolic enzymes. Figure 2-6 shows a gallery of 





Figure 2-5. Inter-subunit interactions that favor ordered structure assembly 
Proteins that assemble into symmetric quaternary structures should in principle have a higher 
propensity to form fibers, because effectors, whether allosteric, covalent, or mutational, that enhance 
binding between the oligomeric faces may be multiplied around the axis of symmetry, leading to 
enhanced fiber stability. The types of effectors and their contribution to fiber stability or 






Figure 2-6. A sampling of metabolic enzymes that self-assemble into fibers. 
The quaternary structure of each enzyme is illustrated schematically (top row), following 90° 
rotation (middle row), and imaged in fiber form by electron microscopy (bottom row). (a) Acetyl-CoA 
carboxylase: crystal structure of Streptomyces coelicolor acetyl-CoA carboxylase β-subunit, PDB ID: 
1XO6 (Diacovich et al. 2004) and electron micrograph of rat liver acetyl-CoA carboxylase (Lehninger, 
Nelson, and Cox 2005). (b) β-glucosidase: crystal structure of wheat β-glucosidase, PDB ID: 2DGA 
(Sue et al. 2006), and electron micrograph of oat β-glucosidase (Kim et al. 2005). (c) Glutamine 
synthetase: crystal structure of Escherichia coli glutamine synthetase, PDB ID: 1FY (HS and D 
2001), and electron micrograph of E. coli glutamine synthetase (Frey, Eisenberg, and Eiserling 1975). 
(d) Glutamate dehydrogenase: crystal structure of Clostridium symbiosum glutamate dehydrogenase, 
PDB ID: 1BGV (Stillman et al. 1993), and electron micrograph of cow liver glutamate dehydrogenase 
(Josephs and Borisy 1972). Scale not provided. (e) CTP synthase: human CTP synthase 2, PDB ID: 
3IHL (M. Moche et al., unpublished data), and electron micrograph of Drosophila CTP synthase (Liu 
2010). (f) Inosine monophosphate dehydrogenase: crystal structure of human type II inosine 
monophosphate dehydrogenase, PDB ID: 1NF7 (D. Risal, M.D. Strickler, B.M. Goldstein, 
unpublished data), and electron micrograph of human type II inosine monophosphate dehydrogenase 
(Ingerson-Mahar et al. 2010). (g) Human sickle-cell mutant hemoglobin: crystal structure, PDB ID: 
2HBS (Harrington, Adachi, and Royer 1997), and electron micrograph human sickle-cell mutant 




Given that metabolic enzymes often are also highly expressed and prone to 
allosteric regulation of alternate conformations, they would seem to be likely cellular 
candidates for self-assembly into higher-order structures. The resulting fibers might 
provide regulatory functionality—e.g., fine-tuning of enzymatic output by 
integrating allosteric interactions across the polymeric interfaces. Such appears to be 
the case for glutamine synthase, at least on the scale of binding of two 
homopentameric or hexameric rings (Eisenberg et al. 2000). Such fibers or assemblies 
might also provide stability or rigidity, especially with regards to the formation of 
metabolic enzymes into more extensive structures such as crystals, which we might 
expect to serve as self-chaperoning structures, decreasing the likelihood for 
component proteins to unfold and form aggregates. Indeed, lens crystallins are 
derived frequently from metabolic enzymes (Piatigorsky 1993). Similarly, the 
crystalline cores of peroxisomes as well as mitochondrial glutamate dehydrogenase 
fibers are cases in which homo-oligomeric enzymes are highly concentrated in 
stressful environments. 
 
2.8.2 Protein aggregation as an evolutionary compromise 
As we have discussed, the formation of intracellular protein aggregates is 
widespread, and such aggregates can be functional. This seems to be a phenomenon 
that is not highly selected against and that actually may be beneficial. Although, 
phylogenetic analyses of multiple proteins suggest that a negative correlation exists 
between the rate of sequence change and the level of expression (Drummond and 
Wilke 2008, 2009), which has been interpreted to mean that mistranslation of a 
highly expressed protein is more likely to lead to dysfunctional aggregation than the 
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mistranslation of scarcer proteins. Thus, despite the widespread existence of protein 
aggregates, the entire proteome is constantly under selection to avoid aggregation. 
The resolution of this conundrum is seemingly that aggregates are largely 
unavoidable and that functional organization around aggregates is an evolutionary 
compromise. 
 
This begs the question of why aggregates are unavoidable, given that 
evolutionary optimization often grinds genotypes and phenotypes to a very fine 
degree. The answer must lie in the realm of physical principles that not even 
evolution can refine, and as described below, sickle-cell hemoglobin remains one of 
the most illustrative examples. A single mutation that occurred independently 
several times within a relatively short span of evolutionary time (Wainscoat et al. 
1983) leads to polymer formation, which confers the beneficial consequence of partial 
protection against malaria for carriers of this mutation. We would argue that such 
mutations are largely unavoidable, especially in oligomeric proteins that by definition 
have the opportunity to form multiple, geometrically repeated contact points. 
 
Because oligomers often are allosterically regulated, and thus by definition 
assume multiple conformations, there may be unique opportunities for the formation 
of new mutational contact points. In many cases, new aggregates will be deleterious, 
as with the previously mentioned proteins associated with Alzheimer’s and other 
prion-based diseases, and evolution will eventually constrain the sequence of the 
protein in a concentration-dependent manner. In some cases, the aggregates will be 
neutral, and quaternary structures will form that have the opportunity to eventually 
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benefit the cell—possibly through the adoption of a new regulatory functionality, as 
in the case of acetyl-CoA carboxylase, and likely possible for the cases of IMPDH 
and CTP synthase. 
 
2.8.3 A case study in ambiguity: are CTP synthase fibers cytoskeletal 
elements or bacterial sickle-cell disease? 
The evolutionary conservation of CTP synthase filaments suggests that 
filament assembly of CTP synthase may provide a biologically useful purpose for 
cells, such as enhancing enzymatic regulation or even forming new cytoskeletal 
elements. Experimental evidence now suggests that these filaments consist of inactive 
enzymes and may serve a regulatory role (Noree et al. 2014, Aughey et al. 2014, 
Barry et al. 2014). Further functional evidence for CTP synthase filaments includes 
the observation that they help determine the C. crescentus cell curvature. However, 
for other model organisms in which CTP synthase filaments are found do not exhibit 
curved cell structures, their functional roles are limited to potential enzymatic 
activity regulation. Notably, filament formation and enzymatic roles are at least 
partially separable; for example, Ingerson-Mahar et al. (2010) separated the filament-
forming properties of CTP synthase from one of its two enzymatic activities by 
showing that catalytically inactive synthetase domain mutants retained the ability 
to form filaments in C. crescentus. Similarly, mutation of the active-site cysteine of 
the Ura7p glutamine amidotransferase domain known to eliminate enzyme activity 




The induction of cell straightening by CTP synthase mutants in C. crescentus 
is an interesting comparison to that of sickled red blood cells harboring mutant 
hemoglobin (Figure 2-7). Sickle cell hemoglobin possess a mutation that exposes a 
hydrophobic amino acid, causing preferential interaction with other hemoglobin 
molecules rather than association with the cellular environment. This preferential 
interaction of the hemoglobin molecules with each other drives its polymerization 
into fibers, which over time grow in size. The long crystallized aggregates are 
responsible for the rigidity and deformation of sickled red blood cells (Cerami and 
Peterson 1975). Under electron microscopy, the fibers of CTP synthase lining the 







Figure 2-7. Analogous effects on cell morphology by CTP synthase and sickle-cell 
hemoglobin. 
An illustration of the analogous effects on cell morphology by cytidine triphosphate (CTP) 
synthase and sickle-cell mutant hemoglobin (HbS). (a) Bright field images of Caulobacter 
crescentus cells depleted of CTP synthase show severe bending, some to the point of circularization. 
(b) Cells overexpressing CTP synthase are straightened markedly. (c) Transmission electron 
micrograph of a C. crescentus cell with CTP synthase fibers (arrows) along the cell wall, altering cell 
morphology. Panels a–c adapted from Ingerson-Mahar et al. (2010). (d) Analogous images of red 
blood cells showing their normal, round morphology when oxygenated, and (e) their highly 
straightened morphology when the deoxygenated HbS forms into fibers. Adapted from Kaul et al. 
(1983). (f) Transmission electron micrograph showing HbS fibers (arrows) along the cell border, 
altering cell morphology. Adapted from Dobler and Bertles (1968). 
 
2.8.4 High prevalence of GAT domains in assembled structures 
Glutamine amidotransferases (GATs) catalyze the hydrolysis of glutamine to 
glutamate and ammonia (glutaminase reaction), and the transfer of ammonia from 
a glutamine molecule to an acceptor substrate (synthase reaction), creating a new 
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carbon-nitrogen group on the substrate. GATs are grouped into Class-I (triad) and 
Class-II/N-terminal nucleophile superfamilies. Class-I GAT domains are defined by 
a conserved catalytic triad consisting of cysteine, histidine, and glutamate, and 
include CTP synthase. Its glutaminase domain commonly adopts an α-β-α 
structure fold. Class-II GAT domains contain an active site cysteine present at the 
N-terminal extremity of the enzyme, whose structure mainly consists of a sandwich 
of anti-parallel β sheets surrounded by two layers of α helices (α-β-β-α). Class-II 
GATs include previously mentioned enzymes phosphoribosylpyrophosphate 
amidotransferase (Ade4) and glutamate synthase (Glt1).  
 
We noticed a high prevalence of either GAT domain superfamilies within the 
subset of cytoplasmic proteins that formed discrete structures upon culturing into 
late stationary phase. 12 of the 15 tested GAT domain-containing proteins were able 
to form structures (Figure 2-8, hypergeometric test cumulative p<3E-6). Similarly, 
Shen et al. (2016) also found that many filament-forming proteins shared either GAT 
domain superfamilies. This domain may serve as an attractive starting point for 
understanding a potential unifying molecular mechanism of fiber or foci formation. 







Figure 2-8. Proteins with GAT domain preferentially form structures 
 Top: Yeast GFP-tagged proteins containing glutamine amidotranferase (GAT) domains form 
fibers and foci after 5 days in late stationary phase. A fiber-former that is not shown here is GLT1 
(Noree et al. 2010). 12 out of the 15 GAT domain-containing cytoplasmic ORFs show ability to form 
foci and/or fibers. Of the 3 that did not form foci, 2 were not expressed at levels in which subcellular 
localization was evident (CPA1 and DUG3) compared to the background strain without GFP 
(BY4741) and 1 is subjectively ambiguous (ARO4) as to whether structures were forming. Bottom: 
GAT ORF enrichment within foci/fiber former’s hypergeometric cumulative p<3E-6. Genes that 
contain GAT domains are listed. Blue gene list contains positive foci/fiber formers, and brown gene 
list contains ambiguous or negative for foci/fiber formers. Red gene list was not tested due to lack of 
availability in our GFP library or to the protein subcellular localization not scored as cytoplasmic. 
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3 Chapter 3: Purine biosynthesis, purinosomes, and punctate 
foci formed by purine biosynthesis enzymes3 
3.1 Abstract 
It has been hypothesized that components of enzymatic pathways might 
organize into intracellular assemblies to improve their catalytic efficiency or lead to 
coordinate regulation. Accordingly, de novo purine biosynthesis enzymes may form 
a multi-enzyme complex termed the purinosome in the absence of purines. The search 
for direct in vivo evidence of the purinosome culminated in the discovery of 
intracellular punctate bodies formed in part by purine biosynthesis enzymes. We 
investigated the mechanism by which human purine biosynthetic enzymes might be 
organized, especially under differing cellular conditions. Our discoveries support a 
model where these bodies behave in a manner unlike that expected for functional 
purinosomes and instead have numerous features one might expect of simple protein 
aggregates or stress-induced bodies. We demonstrate that the intracellular bodies 
formed by transiently transfected, fluorescently tagged human purine biosynthesis 
proteins are best explained as protein aggregation. 
                                      
Parts of Chapter 3 have been previously published in:  
(1) Zhao, A., M. Tsechansky, J. Swaminathan, L. Cook, A. D. Ellington, and E. M. 
Marcotte. 2013. PLoS One 8 (2):e56203. doi: 10.1371/journal.pone.0056203. 
(2) Zhao, A., M. Tsechansky, A. D. Ellington, and E. M. Marcotte. 2014. Molecular 
BioSystems 10 (3):369-374. doi: 10.1039/C3MB70397E. 






The cytoplasm of living cells is exquisitely organized and dynamic. As 
previously mentioned, enzymes have previously been found to organize into 
intracellular assemblies that may improve their catalytic efficiency or lead to 
coordinate regulation. For example, the trypanosome glycolytic pathway is organized 
into a glycosome. Similarly, many such cellular bodies occur naturally, functioning 
in degradation or storage (e.g., P-bodies (Brengues, Teixeira, and Parker 2005) or 
actin bodies (Sagot et al. 2006)). While such functional bodies continue to be found, 
it is also the case that overexpression of proteins in cells can lead to aggregation, 
(Johnston, Ward, and Kopito 1998, Alberti et al. 2009), such as the formation of 
inclusion bodies. Proteins have the inherent capability to misfold, escape cellular 
clearance mechanisms, and form intractable aggregates which are frequently 
associated with neurological diseases. 
 
As I mentioned in the previous chapter, while measuring the localization of 
green fluorescent protein (GFP)-tagged proteins with the yeast cell chip, we 
identified a surprisingly large number of intracellular punctate foci or other 
supramolecular structures (referred here throughout and in other literature as foci, 
puncta, puncti, punctate foci, bodies, clusters) that accumulated during various 
environmental growth conditions including nutrient starvation (Narayanaswamy, 
Levy, et al. 2009). This led us to further speculate whether such bodies were 
                                      
The work in Chapter 3 was supported by grants from the United States National Institute 
of Health, National Science Foundation, and the Welch Foundation (F1515), and a Packard 
Foundation Fellowship to Edward M. Marcotte. 
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representative of endogenous, functional assemblies, or accidental or pathological 
aggregates. 
 
Among >100 proteins forming such bodies, we observed that the de 
novo purine biosynthetic enzyme phosphoribosyl pyrophosphate amidotransferase 
(encoded by the yeast gene ADE4, homolog of the human enzyme PPAT) reversibly 
formed intracellular bodies in the presence and absence of adenine (Narayanaswamy, 
Levy, et al. 2009). We initially thought that such bodies might be depots for 
functional enzymes, and the observation of intracellular bodies associated both with 
the yeast Ade4 and the human PPAT enzyme suggested the possibility of a 
functional purine-biosynthetic intracellular body conserved between yeast and 
humans. In particular, Benkovic and co-workers have identified a cellular body 
(composed in part of the PPAT enzyme) that they called the purinosome (An et al. 
2008), forming in human cell culture in the absence of purines, and whose assembly 
has been shown to be assisted by microtubules and perturbed by casein kinase II 
inhibitors (An, Kyoung, et al. 2010, An, Deng, et al. 2010) and which may be under 
GPCR control (Verrier et al. 2011). 
 
However, the possibility remained that the manipulation of the gene (via 
fusion to GFP) or its expression (via transfection and/or starvation) had led to 
aggregate formation. Therefore, we sought to establish whether the observed 
punctate bodies were formed by transiently expressing the recombinant enzymes in 
cultured cells. We characterized punctate formation in greater depth and devised 
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explicit tests to determine whether the bodies may have arisen due to non-native 
protein expression, stress, or aggregation.  
 
My contributions to the work described in this Chapter include designing and 
conducting experiments and interpreting data with input from Mark Tsechansky. 
Lindsey Cook conducted experiments under my guidance, and Jagannath 
Swaminathan constructed a number of the expression clones.  
 
3.2.1 Purine biosynthesis pathway enzymes 
Purines are ubiquitous and essential components of DNA and RNA, and their 
derivatives participate in numerous biological processes. Adenine and guanine 
nucleotides are derived from the compound inosine monophosphate (IMP), which is 
synthesized de novo from phosphoribosyl pyrophosphate (PRPP) through a highly 
conserved multi-step de novo purine biosynthesis pathway. In higher eukaryotes 
(such as humans), the pathway consists of six enzymes catalyzing ten sequential 
reactions converting PRPP to IMP (Table 3-1). De novo purine biosynthesis 
activity is up-regulated when the cellular demand for purines exceeds that supplied 
by the purine salvage pathway which utilizes purines taken up from the cellular 
environment, consisting of a single-step conversion of hypoxanthine to IMP catalyzed 
by hypoxanthine phosphoribosyltransferase (HPRT). Conversely, de 
novo biosynthesis is down-regulated when exogenous purine, i.e. hypoxanthine, is 





Step(s) Gene Description 
1 PPAT Phosphoribosyl pyrophosphate amidotransferase 
2,3,5 GART Trifunctional phosphoribosylglycinamide formyltransferase/ 
phosphoribosylglycinamide synthetase/phosphoribosylaminoimidazole 
synthetase 
4 FGAMS Phosphoribosylformylglycinamidine synthase 
6,7 PAICS Bifunctional phosphoribosylaminoimidazole 
carboxylase/phosphoribosylaminoimidazole succinocarboxamide 
synthetase 
8 ADSL Adenylosuccinate lyase 
9,10 ATIC Bifunctional 5-aminoimidazole-4-carboxamide ribonucleotide 
formyltransferase/IMP cyclohydrolase 
Table 3-1. Six human enzymes catalyze the ten-step conversion of phosphoribosyl 
pyrophosphate to inosine monophosphate. 
 
3.2.2 Circumstantial evidence for the theoretical purinosome 
The existence of a multienzyme complex consisting of all the members of the 
de novo purine biosynthesis pathway, termed the “purinosome”, has been postulated 
for some time on the basis of the accumulation of a variety of circumstantial 
evidence. Some metabolic pathway enzymes are known to organize into multi-enzyme 
complexes for reasons of catalytic efficiency, metabolite channeling, and other 
advantages of compartmentalization. Though in the last several decades there has 
been growing research on multi-enzyme complexes with beneficial roles in the cell, 
there has been little evidence of anticipated protein-protein interactions that would 
enable substrate channeling and regulation of the metabolic flux through the de novo 




The hypothesis that these purine biosynthesis enzymes organize into a multi-
enzyme complex has long been attractive based at least in part on the chemical 
instability of 5-phosphoribosylamine, the first intermediate substrate in the pathway, 
which suggests an essential direct transfer between PPAT and GART (Schendel et 
al. 1988). Furthermore, the consolidation of several individual enzymatic functions 
onto single bifunctional or trifunctional polypeptide chains has been observed in 
many organisms (Henikoff et al. 1986, Aimi et al. 1990), which suggests that stable 
physical interactions between these enzymes may exist even in organisms which do 
not consolidate these enzymes on a single polypeptide chain (Marcotte et al. 
1999). Perhaps the most interesting of these is the trifunctional protein GART, 
which catalyzes the second, third, and fifth enzymatic steps in the pathway. The 
joining of the non-sequential steps into a single trifunctional enzyme in humans also 
suggests that this polypeptide may be further, non-covalently juxtaposed with the 
enzyme for step 4. 
 
3.2.3 Early experimental difficulties in demonstrating the theoretical 
purinosome 
Driven by compelling circumstantial evidence for the purinosome, early 
experiments aimed at isolating the intact multi-enzyme complex found few 
interacting pairs. Affinity purification of mammalian GART resulted in near 
homogeneous protein (Caperelli 1985), although a cruder purification of avian GART 
resulted in co-purification of PAICS and folate coenzymes (Caperelli et al. 1980). 
Pairs of purine biosynthesis pathway members (including PPAT and GART, and 
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ATIC and GART) could be enriched by partial co-fractionation under some 
conditions, yet no biophysical support was found for a larger multi-enzyme complex 
or a fully intact purinosome (McCairns et al. 1983, Rowe et al. 1978). Follow-up 
attempts failed to detect the anticipated protein-protein interaction between PPAT 
and GART previously suggested by kinetic studies (Rudolph and Stubbe 1995). 
While biochemical experiments to isolate an intact purinosome were largely 
unsuccessful, trials with detection in living cells also failed: transfected recombinant 
GART was not found to be localized to any cellular architecture that might serve as 
a structural scaffold to assemble a multi-enzyme complex (Gooljarsingh et al. 2001). 
Despite experimental difficulties to demonstrate the purinosome, a complex 
representing the purinosome may still physically exist, and it may form only 
transiently or in a condition-specific manner.  
 
3.2.4 Discovery of transiently expressed purine biosynthetic enzyme 
bodies 
In 2008, the Benkovic group reported the first direct observation of purine 
enzyme foci in human cells, suggesting that these foci were purinosomes (An et al. 
2008). Fluorescent protein constructs of the six mammalian purine biosynthesis 
enzymes formed intracellular punctate bodies when transiently expressed in HeLa 
cells in purine-depleted culture medium. FGAMS-OFP foci was shown to co-localize 
with foci formed by the five other enzymes of the pathway, supporting that these 
foci contained all direct participants of the de novo purine biosynthesis pathway and 
thus they encompassed purinosomes. These so-called “purinosome clusters” 
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apparently formed in purine-depleted medium and disassembled in purine-rich 
medium, a potentially strong indication of function.  
 
Follow-up studies perturbing these foci have yielded some insights into the 
mechanism of purine enzyme foci formation. Addition of the microtubule-disrupting 
agent nocodazole reduced foci formation and decreased overall cellular purine 
synthesis (An, Deng, et al. 2010), which suggests that the formation of these foci 
may require cytoskeletally directed active transport. Casein kinase 2 (CK2) 
inhibitors 4,5,6,7-tetrabromo-1Hbenzimidazole and 2-dimethylamino-4,5,6,7-
tetrabromo-1H-benzimidazole induced foci formation by FGAMS-GFP, GART-
GFP, or PPAT-GFP, whereas the subsequent addition of a different CK2 inhibitor, 
4,5,6,7- tetrabromobenzotriazole, appeared to reverse or suppress foci formation. In 
addition, although CK2 inhibitors affected FGAMS-GFP, GART-GFP, and PPAT-
GFP foci formation, similar effects were not seen on PAICS-GFP, ADSL-GFP, and 
GFP-ATIC unless each was co-transfected with one of the former three proteins 
tagged with orange fluorescent protein (An, Kyoung, et al. 2010). These results 
suggest a possible, but as yet unclear, role for CK2 in purinosome regulation. One 
possibility is that phosphorylation by CK2 disperses assemblies, as seen for acetyl-




3.2.5 However, purine biosynthesis enzyme bodies do not have to be 
purinosomes 
As purinosomes are structures proposed to enhance purine biosynthesis, the 
foci should exhibit abundant metabolic flux. It has been shown that flux through the 
de novo purine biosynthesis pathway is suppressed when foci assembly is disrupted 
by nocodazole. While this correlation supports a role for microtubules in establishing 
purine enzyme foci in live cells (An, Deng, et al. 2010), these observations may also 
arise from an alternative explanation, namely that given that nocodazole is a cell 
cycle arresting agent, the combination of nutrient-poor medium and arrested cell 
cycle might also be expected to greatly impede metabolic flux. Such experiments 
illustrate the intrinsic difficulties in distinguishing flux contributed by the bodies and 
flux contributed by the free, un-localized pool of the same enzymes. Experiments 
have so far monitored the complete cellular complement of purine biosynthetic 
enzymes, not explicitly flux through the bodies (An, Deng, et al. 2010, Zhao et al. 
2015); to date, no experiments have demonstrated that the foci themselves provide 
any metabolic flux. Thus, further kinetic experiments are required before purine 
enzyme foci meet the standard of proof associated with other well-characterized 
metabolic enhancing structures like acetyl-CoA carboxylase polymers (Beaty and 
Lane 1983b, a, Meredith and Lane 1978, Clarke and Clarke 1982) or quaternary 
structures verified for substrate channeling, such as for tryptophan synthase (Pan, 




3.3 Characteristics of purine enzyme foci 
Earlier in this Chapter, I introduced the compelling reasons behind the idea 
of a multi-enzyme complex consisting of all the members of the de novo purine 
biosynthesis pathway, termed the “purinosome.” Although it has never been directly 
observed nor fully supported on the basis of the accumulation of a variety of 
biochemical evidence from many experiments, it has been established that the 
transient expression of recombinant tagged purine biosynthetic enzymes form 
punctate foci visible by conventional microscopy, referred to here as “purine 
biosynthetic enzyme foci”, “purine enzyme foci”, “punctate foci”, “foci”, “puncta”, 
“bodies” and in other literature as “clusters”, “purinosomes”, or “purinosome 
bodies.” I addressed some of the key findings supporting the interpretation of the 
foci formed by purine enzymes encompassing actual purinosomes, yet I also urged 
caution for this interpretation due to insufficient critical evaluation of other 
explanations of the same data. Overexpression of proteins above their native levels 
and/or protein-tagging has been shown to result in their aggregation (Cromwell, 
Hilario, and Jacobson 2006, Klein and Dhurjati 1995, Mayer and Buchner 2004, 
Yokota, Kamijo, and Oda 2000, Zhang et al. 2004, Landgraf et al. 2012), and there 
is no a priori reason to believe that purine biosynthetic enzymes are somehow 
different from enzymes as a whole. Thus, the possibility that purine enzyme foci are 
no different than aggregated protein bodies should be explored. 
 
 In the following sections, I will examine the likely possibility that foci formed 
by purine biosynthesis enzymes are protein aggregates by addressing many 
characteristics of such bodies, including their morphological similarity to known 
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protein aggregates, their non-specific induction patterns, and their association with 
other proteins known to associate with protein aggregates.  
 
3.3.1 Purine enzyme foci formation in the context of purine dependency 
While there is supporting evidence for the hypothesis that purine enzyme foci 
form in a purine-dependent and reversible manner (An et al. 2008), it is possible that 
these effects are not solely due to the presence or absence of purines. For example, 
while it has been reported that foci form when cells are cultured in purine-depleted 
medium, the specific growth medium employed for these experiments actually 
significantly differed from the purine-rich control medium in ways that went beyond 
the mere presence or absence of purines. The purine-depleted medium was generated 
by serum dialysis with a 25,000 Da pore size, which would have removed a variety 
of compounds other than purines (which are only ~100–500 Da); additionally, the 
base media were different between the two conditions (MEM for “purine-rich” and 
RPMI for “purine-depleted”), and the serum supplementation was doubled for the 
“purine-rich” medium (An et al. 2008). These non-conservative changes clearly alters 
many additional components beyond purines and confounds the argument of purine-
dependency in those observations. Notably, altering only purine levels did not affect 
foci formation: purine enzyme foci were unaffected after specifically adding an 
exogenous purine source (hypoxanthine) back to “purine-depleted” medium (An et 
al. 2008), or after specifically adding a purine antagonist (azaserine) (An et al. 
2008). These contrary observations suggest that the bodies may not form in response 





 We studied the mechanism by which transfected genes encoding human 
purine biosynthetic enzymes might be organized into cellular aggregates, especially 
under different nutrient conditions. HeLa and HEK293 cells transiently expressing 
GFP- or RFP-tagged purine biosynthetic enzymes were cultured in purine-poor 
media. Media that was identical to that in An et al. (2008) was reproduced, but to 
ensure that any observed outcomes could be attributed more specifically to purine 
depletion, I formulated more optimized media in which our base medium used in 
both conditions was DMEM supplemented with 10% FBS, in which purine depletion 
was carried out with a more stringent 1,000 Da pore size dialysis. Punctate foci were 
observed, resembling those seen by An et al. (2008). While variable penetrance of 
different purine biosynthetic enzymes was confirmed, we were surprised to find that 
this penetrance was independent of the presence or absence of purines in the growth 





Figure 3-1. The formation of intracellular foci by transfected purine biosynthetic 
enzymes is not strongly influenced by purine availability 
(A) The frequency with which intracellular bodies appeared across the population of 
transfected cells varied for individual de novo purine biosynthetic enzymes, and did not depend upon 
the purine content of the cell growth medium, shown here for HEK293 cells cultured using the 
optimized medium formulations as described in the Methods. Unless otherwise specified, for HEK293 
cells assays in this and later figures within this Chapter, 200 ng of DNA were transfected for each 
construct. Bars in all experiments represent the average and +/- 1 s.d. from at least 3 replicates, 
counting n = 769, 742, 755, 665, 1225, and 1016 cells, respectively. See Methods for abbreviations of 
protein names. (B) This trend was similar for HeLa cells cultured in purine-rich medium versus 
purine-depleted medium, formulated as described previously (An et al. 2008). Unless otherwise 
specified, for HeLa cell assays in this and later figures, 1.6 µg of DNA were transfected for each 
construct. Bars in all experiments represent the average and +/- 1 s.d. from at least 3 replicates, here 




3.3.2 Heterogeneity of foci morphologies and varying prevalence 
Published purine enzyme bodies have varied widely in their morphologies, 
ranging from pinpoint foci to oil droplet-like, and methods have not been developed 
yet either to classify these bodies or to distinguish them from bodies of any different 
nature (i.e. aggregates) based on morphology (Figure 3-2). In my own studies, I 
have observed a dynamic spectrum of morphologies, as well as both increases and 
decreases in the numbers of foci per cell even over the course of unperturbed growth. 
For my experiments, I did not apply any selective counting of purine enzyme foci; 
all cells exhibiting visible foci were chosen for analysis. 
 
There is also large heterogeneity observed in the penetrance of foci formation. 
The penetrance of body formation following transient transfection varies widely 
across enzymes, with individual enzyme foci formation rates ranging from 5% to 77% 
of the transfected cells (Zhao et al. 2013, An et al. 2008). This heterogeneity, 
persisting even in cell populations treated with pharmacophores that promote the 
formation of purine enzyme foci (15 to 95% penetrance of assembly) (An, Kyoung, 
et al. 2010), is inconsistent with the hypothesis that each foci contains all members 






Figure 3-2. Purine enzyme foci display a spectrum of morphologies similar to those of 
canonical protein aggregates. 
(A–F) Purine enzyme foci in HeLa cells. (A’–F’) Various disease-associated protein 
aggregates in indicated cell lines. These representative (but not exhaustive) morphologies can be 
roughly classified into categories: pinpoint foci of (A) TrifGART-GFP (An et al. 2008) and (A’) α-
synuclein in oligodendroglial cells (Riedel et al. 2010), Droplet-like clusters of (B) FGAMS-GFP (An 
et al. 2008) and (B’) mutant glial fibrillary acidic protein (GFAP)-CFP in astrocytes (Mignot et al. 
2007). Bulk clumps of (C) FGAMS-OFP (Field, Anderson, and Stover 2011) and (C’) GFP-tagged 
huntingtin fragment in HeLa cells (Bjorkoy et al. 2005). Spherical puncta of (D) FGAMS-OFP (An, 
Kyoung, et al. 2010) and (D’) GFAP-GFP in astrocytes (Mignot et al. 2007). Sparse pinpoint foci 
formed by (E) FGAMS-GFP (An, Deng, et al. 2010) and (E’) a fragment of p62 protein, a common 
component of disease-associated protein aggregates (Kuusisto, Salminen, and Alafuzoff 2001, 2002, 
Zatloukal et al. 2002, Nagaoka et al. 2004) tagged to GFP in NIH3T3 fibroblasts (although the 
authors classify this subtler morphology as diffuse (Bjorkoy et al. 2005)). Large oil-droplet-like bodies 
of (F) hTrifGART-OFP in HeLa cells (Field, Anderson, and Stover 2011) and (F’) α-synuclein-EGFP 
into H4 neuroglioma cells (McLean, Kawamata, and Hyman 2001).  
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3.3.3 Low rates of co-localization among purine biosynthetic enzymes 
A key finding in support of the foci encompassing the functional multi-enzyme 
purinosome complex is the co-localization of FGAMS-OFP with each of the five 
other enzymes in the pathway (An et al. 2008). To reproduce these results, I revisited 
the possible co-localization of pairs of fusion purine biosynthetic enzymes by co-
transfecting FGAMS-EGFP with PPAT-RFP, PAICS-RFP, or ADSL-RFP, and also 
tested PPAT-EGFP with PAICS-RFP or with ADSL-RFP. Only ~1% on average of 
co-transfected cells showed co-localization of different purine biosynthetic enzymes 
to the same puncta (Figure 3-3, Table 3-2, Table 3-3). Increasing the total 
dosage of DNA transfected did not alter the rate of co-localization, nor did varying 
growth in purine-rich or purine-depleted media. More generally, co-transfection 
tended to suppress puncta formation, or individual enzymes aggregated separately 
(Table 3-2, Table 3-3).  
 
We also attempted to co-localize endogenous purine biosynthetic enzymes 
with protein puncta by use of immunofluorescence with antibodies against 
endogenous PPAT, PAICS, and GART. However, we did not find commercial 
antibodies satisfactory for immunofluorescence imaging, as all showed speckling in 
immunofluorescent experiments, regardless of purine availability (for an example, see 
Figure A-1 in Appendix A), and no co-localization with transfected recombinant 
proteins, arguing that the speckles are immunofluorescence artifacts. Similarly, An 
et al. (2008) also reported puncta, or clustering, with immunofluorescence regardless 
of cell growth conditions. Baresova et al. (2012) observed punctate structures using 
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immunofluorescent against purine biosynthesis enzymes, although it is difficult to 
determine whether those structures are immunofluorescent artifacts or representative 
of the actual targeted proteins. 
 
 
Figure 3-3. Purine biosynthesis enzymes commonly do not co-localize to the same foci. 
The top row shows an example of partial but minimal co-localization of FGAMS-EGFP and 
PAICS-RFP foci. The middle row shows an example of non-co-localizing FGAMS-EGFP and ADSL-
RFP foci. The bottom row shows an example of a more typical case, non-co-localization due to the 






Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-loc. Co-localizing foci
6/3/2011 0.8/0.8 343 (99%) 1 (0.3%) 2 (0.6%) 0 (0%) 0 (0%)
6/6/2011 0.8/0.8 592 (99%) 2 (0.3%) 1 (0.2%) 1 (0.2%) 2 (0.3%)
6/20/2011 0.8/0.8 325 (98%) 6 (1.8%) 1 (0.3%) 0 (0%) 1 (0.3%)
6/3/2011 1.6/1.6 425 (100%) 1 (0.2%) 0 (0%) 0 (0%) 1 (0.2%)
6/6/2011 1.6/1.6 686 (99%) 3 (0.4%) 5 (0.7%) 1 (0.1%) 0 (0%)
6/20/2011 1.6/1.6 291 (96%) 5 (1.7%) 3 (1.0%) 2 (0.7%) 1 (0.3%)
PPAT-EGFP and ADSL-RFP
Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-loc. Co-localizing foci
6/3/2011 0.8/0.8 371 (97%) 1 (0.3%) 6 (1.6%) 0 (0%) 4 (1%)
6/6/2011 0.8/0.8 770 (97%) 1 (0.1%) 15 (1.9%) 1 (0.1%) 4 (0.5%)
6/20/2011 0.8/0.8 324 (96%) 4 (1.2%) 7 (2.1%) 1 (0.30) 1 (0.3%)
6/3/2011 1.6/1.6 382 (96%) 0 (0%) 15 (3.8%) 0 (0%) 1 (0.3%)
6/6/2011 1.6/1.6 808 (97%) 1 (0.1%) 14 (1.7%) 2 (0.2%) 7 (0.8%)
6/20/2011 1.6/1.6 360 (95%) 1 (0.3%) 11 (2.9%) 1 (0.26) 5 (1.3%)
FGAMS-EGFP and PPAT-RFP 
Experiment DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-loc. Co-localizing foci
6/3/2011 0.8/0.8 215 (97%) 0 (0%) 2 (0.9%) 0 (0%) 5 (2.3%)
6/6/2011 0.8/0.8 611 (96%) 3 (0.5%) 10 (1.6%) 1 (0.2%) 13 (2.0%)
6/20/2011 0.8/0.8 386 (93%) 5 (1.2%) 4 (1.0%) 0 (0%) 18 (4.4%)
6/3/2011 1.6/1.6 241 (97%) 0 (0%) 2 (0.8%) 0 (0%) 5 (2.0%)
6/6/2011 1.6/1.6 574 (97%) 0 (0%) 2 (0.3%) 0 (0%) 13 (2.2%)
6/20/2011 1.6/1.6 354 (95%) 5 (1.3%) 6 (1.6%) 0 (0%) 8 (2.1%)
Table 3-2. Minimal co-localization of purine biosynthetic enzyme pairs into foci in “purine-depleted” medium. 
Differential expression localization quantified for different purine biosynthetic enzyme pairs, reporting counts and percentages of 
successfully co-transected HeLa cells as a function of protein localization. Cells were grown in RPMI + 5% 25kDa dialyzed FBS. 
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FGAMS-EGFP and ADSL-RFP 
Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-loc. Co-localizing foci
5/18/2011 1.6/1.6 174 (93%) 6 (3.2%) 5 (2.7%) 0 (0%) 2 (1.1%)
5/19/2011 0.8/0.8 108 (95%) 3 (2.6%) 0 (0%) 0 (0%) 3 (2.6%)
5/20/2011 0.8/0.8 124 (89%) 8 (5.8%) 4 (2.9%) 1 (0.7%) 2 (1.4%)
    
FGAMS-EGFP and PAICS-RFP 
Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-loc. Co-localizing foci
5/18/2011 1.6/1.6 137 (94%) 7 (4.8%) 0 (0%) 0 (0%) 1 (0.7%)
5/19/2011 0.8/0.8 148 (98%) 1 (0.7%) 2 (1.3%) 0 (0%) 0 (0%)
5/20/2011 0.8/0.8 148 (94%) 5 (3.2%) 4 (2.5%) 0 (0%) 0 (0%)
Table 3-3. Minimal co-localization of purine biosynthetic enzyme pairs into foci in “purine-rich” medium. 
Differential expression localization quantified for different purine biosynthetic enzyme pairs, reporting counts and percentages of 




3.3.4 Time-lapse dynamics of foci formation and dissolution 
Unperturbed time course of live cells transfected with purine biosynthetic 
enzyme constructs show variable dynamic range. Foci were observed to 
spontaneously appear and disappear within 1-2 hours (Figure 3-4). Replacing the 
culture medium seemed to induce foci formation, however this induction was 
apparently regardless of whether “purine-rich” or “purine-depleted” medium was 
newly introduced. This observation challenges the previous report that the cycling 
of foci formation and dissolution was dependent on the purine content in the media 
in the newly introduced media, and instead suggests that a gentle process of replacing 
media might impose short-lived mechanical or osmotic stress on the cells which 
results in the temporary aggregation of proteins. 
 
 
Figure 3-4: FGAMS-EGFP foci form after purine-independent medium replacement 
and disappear with adaption to the medium. 
HeLa cells grown in “purine-rich” medium with FGAMS-EGFP foci may dissolve foci after 
normal culture condition incubation without perturbation (2 hour incubation, A to B). However, 
upon media replacement with identical “purine-rich” media induces foci to reappear within 30 minutes 




3.3.5 Foci formation rate correlates with transfected DNA quantity 
For single enzyme transfections, we observed a positive correlation between 
foci formation rate and amount of transfected DNA (Figure 3-5). This observation 
is consistent with the known phenomenon that higher protein production result in 




Figure 3-5. Formation of PAICS-RFP bodies in HEK293T cells scaled with DNA 
transfected. 
Among successfully transfected cells, the fraction of the cell population exhibiting PAICS-
RFP puncta correlated strongly with the quantity of plasmid DNA transfected. Bars indicate average 
+/- 1 s. d. across at least 3 replicates, n = 498, 627, and 591 cells, respectively. 
 
3.4 Mounting evidence for protein aggregation 
In the previous section, I speculated that the formation of the punctate foci 
by purine biosynthesis enzymes might be due to factors other than purine starvation. 
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Previously, the formation of protein puncta in yeast (Narayanaswamy, Levy, et al. 
2009) was correlated with protein aggregation potentials measured by TANGO 
scores (Fernandez-Escamilla et al. 2004), and many metabolic proteins that formed 
punctate foci seemed to be insoluble aggregates (O'Connell et al. 2014). This 
suggested the possibility that the recombinant human proteins might be aggregating. 
Indeed, the fraction of cells in which individual purine biosynthetic enzymes formed 
detectable punctate bodies correlated well with the predicted aggregation potentials 
of the enzymes (Figure 3-6). As well, the bodies exhibit overlapping co-localization 
with a recombinant fusion protein known to mark aggregates and aggresomes 




Figure 3-6. Correlation between purine biosynthesis enzyme foci formation rates and 
their respective TANGO score 
The frequency with which transfected cells exhibited punctate foci (shown here for values 
reported in An et al. (2008)) correlated strongly with each protein’s predicted aggregation potential 
(Fernandez-Escamilla et al. 2004). For comparison, the unrelated enzyme GAPDH has a TANGO 





Figure 3-7. Bodies partially overlap with chimera protein aggregate. 
Partial co-localization of (A) gp-250 (also known as GFP-250) with (B) FGAMS-OFP, co-
transfected in the same cell (French et al. 2013). The overlay in (C) shows the merge of panel A in 
green and panel B in red (Pearson's coefficient of 0.4 and overlap coefficient of 0.41) with regions of 
co-localized expression extracted and plotted in (D) for clarity. Notably, overexpression of the GFP-
chimera, gp-250, has been reported to form insoluble aggregates that are delivered to aggresomes 
(Garcia-Mata et al. 1999, Garcia-Mata, Gao, and Sztul 2002). Adapted from French et al. (2013). 
 
If the proximal cause of the formation of punctate foci was aggregation, then 
it seemed likely that: (a) cells may experience differential survivability due to 
inability to cope with such structures, (b) such structures could be induced by 
cellular stress, and (c) such structures would contain proteins normally associated 
with aggregates, such as chaperones and ubiquitin.  
 
3.4.1 Fate of cells with and without purine biosynthetic enzyme foci 
During time-lapse microscopy experiments of transfected cells, I observed 
variation both in punctate body dynamics as well as in cell survival (Figure 3-8, 
Figure 3-9). Microscopy analysis of individual transfected cells over the course of 
1-2 hours revealed that transfected cells without punctate bodies exhibited 
significantly higher survival rates than cells marked by punctate bodies (Figure 
3-9). This difference in survival rate was largely independent of purine availability, 
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and persisted even when the cell growth medium was exchanged from purine-
depleted to purine-rich. The observation that cells marked by punctate bodies died 
at greater rates than transfected cells lacking such aggregates suggested that these 
cells likely experienced greater levels of stress, although lacking in an established 
mechanism and known molecular signals, it is not clear from these data if the 
punctate bodies were a cause or consequence of that stress.  
 
 
Figure 3-8. Time course imaging reveals that punctate foci are dynamic. 
Shown here for HeLa cells transfected with PAICS-RFP grown in purine-depleted medium 
in two replicate 4 hour time series. Panels (A) and (D) show the time zero condition; panels (B) and 
(E) show the same cells as in (A) and (D), respectively, following two hours of growth in the same 
medium; panels (C) and (F) show the same cells following two hours of growth after exchanging the 
growth medium to purine-rich. Cells marked by * display formation of punctate foci over the time 
series, while cells marked by p display variable dynamics of punctate foci. The # sign marks cells 
with punctate bodies that die over the course of the series; the cell marked by d dies in the absence 
of punctate bodies. Cell death was determined by marked cell shrinkage and membrane blebbing, 
detected by differential interference contrast (DIC) microscopy, as in panel (C-DIC), accompanied 
by markedly increased cellular fluorescence, easily distinguishable from flat healthy cells and mitotic 
cells (one is marked by m in panels (C) and (C-DIC)). Notably, punctate bodies are detectable in 
both purine-poor and rich media, with some forming even after the shift into purine-rich medium, as 




Figure 3-9. Transfected cells exhibiting purine enzyme foci die at a greater rate than 
transfected cells lacking foci. 
Shown here are HeLa cells two hours after either no treatment or after exchanging the growth 
medium from purine-depleted to purine-rich. All comparisons between cells with and without 
intracellular foci are statistically significant (p-values ranging from 10-4 to <10-16). Cell death was 
measured as marked cell shrinkage and membrane blebbing accompanied by markedly increased 
cellular fluorescence during time lapse fluorescence microscopy (e.g., as for the example cells in Figure 
3-8). 
 
3.4.2 Oxidative induction of purine biosynthetic enzyme foci formation 
Oxidative stress may induce aberrant disulfide bond formation that can result 
in improper protein folding, and has also been found to impair proteasome function 
(Goswami et al. 2006). Application of oxidative stimuli has been shown to promote 
the aggregation of various disease-associated proteins (Hashimoto et al. 1999, 
Goswami et al. 2006). Similarly, I found that hydrogen peroxide can induce the 
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formation of purine biosynthesis enzyme bodies irrespective of the presence or 
absence of purines in the medium (Figure 3-10). Likewise, menadione-induced 
oxidative stress also led to an increase of foci formation. Pyruvate is known to protect 
against oxidative stress through direct scavenging of reactive oxygen species, and 
has previous been shown to prevent oxidation-induced protein aggregation (Aouffen 
et al. 2004). Cells grown in the presence of pyruvate have lower penetrance of purine 
enzyme foci formation (Figure 3-11), suggesting that oxidative stress at least 
partially underlie the basal formation of purine enzyme foci.  
 
 
Figure 3-10. Hydrogen peroxide strongly induced purine biosynthetic enzyme foci 
regardless of hypoxanthine. 
Base medium is DMEM supplemented with 10% FBS. As indicated, medium was also 
supplemented with 1 mM hydrogen peroxide (H2O2) and/or 35 µM hypoxanthine (Hx) as described 
in Methods. For HEK293 cells transfected with, n = 4419, 2652, 3088, 3182 cells per bar. For HEK293 
cells transfected with PAICS-RFP, n = 2970, 1944, 1880, 1760. For HEK293T cells transfected with 
PPAT-EGFP, n = 4537, 2267, 2411, 2947. For HEK293T cells transfected with PAICS-RFP, n = 
4612, 3660, 4211, 3760. Bars indicate average +/- 1 s. d. across at least 3 replicates. 
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                PAICS-RFP
Figure 3-11. Pyruvate reduces the formation of PAICS-RFP bodies 
HEK293T cells cultured in DMEM without sodium pyruvate (NaPyr) show nearly double 
the rate of PAICS-RFP foci formation compared to cells cultured in DMEM with 110mg/L sodium 
pyruvate. n = 314 and 785 cells. –NaPyr bar represents average +/- 1 s.d. across 2 replicates, +NaPyr 
bar represents average +/- 1 s.d. across 4 replicates. 
 
3.4.3 Abundance of proteostasis chaperones in purine biosynthetic 
enzyme foci 
The punctate foci appeared to be universally associated with the chaperone 
HSP70, as measured by co-transfection with a plasmid expressing fluorescently-
tagged HSP70 (Figure 3-12A-I). Similarly, I observed the chaperone HSP90 to co-
localize to punctate foci (Figure 3-12J-L). I verified via immunofluorescence that 
this was not an overexpression artifact, showing that endogenous HSP70 localized 
with the foci (Figure 3-13A-C). As heat shock proteins are highly multifunctional 
and interact with many proteins in the cell, I further tested whether purine enzyme 
foci might be aggregates by assaying for their association with ubiquitin. Using 
immunofluorescence, I observed the co-localization of endogenous ubiquitin to the 
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foci (Figure 3-13D-F). In contrast, control experiments employing only secondary 
antibody or primary antibody targeting the unrelated enzymes GAPDH or glutamine 
synthetase showed no such co-localization with the foci (Figure 3-13G-O). 
 
Beyond HSP70 and HSP90 co-localization to purine enzyme foci which have 
been independently reproduced (French et al. 2013), a multitude of additional other 
proteins not previously implicated in purine biosynthesis have been localized to 
purine enzyme foci, including Bag2 (binds to ATPase domain of Hsp70 and inhibit 
its chaperone activity), Bag5 (inhibits ubiquitination of target proteins), Stip1/Hop 
(adaptor protein that binds both HSP70 and HSP90), p23 (a lesser-understood 
HSP90 cochaperone), DnaJ-C7 (Hsp40; crucial partners for HSP70 cochaperones), 
and DnaJ-A1 (Hsp40) (French et al. 2013, Zhao et al. 2013). Many of these proteins 
are commonly associated with deleterious protein aggregates and global regulation 
of protein quality control (Broadley and Hartl 2009, Ren et al. 2009, Chai et al. 1999, 
Uryu et al. 2006, Jana et al. 2000, Schmidt et al. 2002, McLean et al. 2002, Kalia et 
al. 2011, Shinder et al. 2001, Muchowski and Wacker 2005, Dai et al. 2005, Kalia et 
al. 2004, Freeman, Toft, and Morimoto 1996). The relatively high rate of co-
localization between an individual purine biosynthesis enzyme and HSP70 compared 
to that among pairs of purine biosynthesis enzymes gives rise to the hypothesis that 
the purine enzyme foci are non-specific aggregates rather than the long sought-after 
functional metabolic purinosome complex (Table 3-4). If the foci are aggregates, 





Figure 3-12. Co-expressed HSP70 and HSP90 chaperones marked purine biosynthesis 
enzyme bodies. 
Intracellular bodies formed by (A) PPAT-EGFP, (D) FGAMS-EGFP and (G) PAICS-RFP 
co-localized with co-transfected (B,E) HSP70-RFP or (H) HSP70-GFP, shown here in HeLa cells. 
(C, F and I) show merged images. (J-L) Intracellular bodies were also often observed to co-localize 




Figure 3-13. Endogenous markers of aggregated proteins associated with intracellular 
foci of transfected purine biosynthetic enzymes. 
(A-C) Endogenous HSP70 and (D-F) ubiquitin co-localized with bodies formed in cells 
transfected with FGAMS-EGFP, as assayed using immunofluorescence. Immunofluorescence against 
endogenous glutamine synthetase (G-I) or GAPDH (J-L), which are not markers for protein 
aggregation, confirmed that these proteins did not co-localize with the bodies. (M-O) Additional 
control experiments employing only the secondary antibodies (tested for both secondary antibodies 
and shown here for Alexa Fluor 594-conjugated goat anti-rabbit) exhibited no positive signal and, 
with the experiments in panels (G-L), ruled out the possibility of non-specific antibody-mediated 
localization to the bodies. 
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FGAMS-EGFP and HSP70-RFP  
Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-localized Co-localizing foci
6/30/2011 0.8/0.8 385 (94%) 0 (0%) 2 (0.5%) 0 (0%) 21 (5.1%)
6/30/2011 1.6/1.6 349 (90%) 2 (0.5%) 7 (1.8%) 0 (0%) 28 (7.3%)
      
PPAT-EGFP and HSP70-RFP 
Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-localized Co-localizing foci
6/30/2011 0.8/0.8 393 (96%) 0 (0%) 12 (2.9%) 0 (0%) 4 (1%)
      
FGAMS-EGFP and HSP70 (Native, IF) 
Experiment  DNA (ug) Both diffuse P1 foci P2 diffuse P1 diffuse P2 foci Both foci NOT co-localized Co-localizing foci
7/6/2011 1.6 FGAMS 200 (61%) 7 (2.1%) 33 (10%) 1 (0.3%) 85 (26%)
7/6/2011 1.6 FGAMS 223 (69%) 4 (1.2%) 14 (4.4%) 0 (0%) 80 (25%)
7/6/2011 1.6 FGAMS 199 (62%) 7 (2.2%) 24 (7.5%) 0 (0%) 89 (28%)
Table 3-4. Purine biosynthesis foci are enriched for HSP70. 
Co-transfection of FGAMS and HSP70 as well as staining endogenous HSP70 in FGAMS-EGFP transfected HeLa cells show high rates 
of co-localizing puncta, reporting counts and percentages of successfully co-transected (or for the immunofluorescence labelling (IF), transfected) 
HeLa cells as a function of protein localization. Cells were grown in RPMI + 5% 25kDa dialyzed FBS.  
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3.4.4 Proteostasis machinery perturbation affects foci formation 
Association with HSP70 and HSP90 did not appear to be accidental; short-
term treatment of cells with the HSP90 chaperone inhibitor geldanamycin increased 
accumulation of the punctate foci (Figure 3-14A). However, longer term treatment 
with low doses of geldanamycin is known to induce HSP70 chaperone production via 
hormesis (McLean et al. 2004), and accordingly longer term treatment with 
geldanamycin not only inhibited the formation of these foci, but also prevented their 
basal formation (Figure 3-14C) as well as their induced formation by hydrogen 
peroxide (Figure 3-14B).  
 
The association of purine biosynthetic enzyme foci with ubiquitin as measured 
by immunofluorescence also suggested the possible involvement of the ubiquitin-
proteasome proteolytic pathway. Consistent with this involvement, I observed strong 
induction of foci formation by treatment with the proteasome inhibitor MG-132 
(Figure 3-15). The induction of foci by blocking protein degradation suggests that 
they form in cases of excess protein buildup or compromised protein homeostasis, 
conditions which can lead to intracellular aggregation of proteins.  
 
MG-132 is known to induce restructuring of the distributed vimentin network 
into a perinuclear cage surrounding the aggresome, a large inclusion body composed 
of aggregated ubiquinated proteins (Johnston, Ward, and Kopito 1998) (Figure 
3-16A). Should the punctate foci represent large protein aggregates, they would 




Figure 3-14. Chaperone activity modulated the formation of intracellular foci 
comprised of purine biosynthetic enzymes 
(A) Short-term treatment with the HSP90 chaperone inhibitor geldanamycin induced puncta 
formation in a concentration-dependent manner, shown here for PPAT-EGFP in HEK293T cells. 
Bars indicate average +/- 1 s. d. across 3 replicates, n = 680, 351, 565, 601, and 616 total cells, 
respectively. (B) Low-dosage geldanamycin pre-treatment—known to induce HSP70 
activity (McLean et al. 2004)—suppressed oxidatively-induced puncta formation, shown here for 
PPAT-EGFP in HEK293T cells. Bars indicate average +/- 1 s. d. across 3 replicates, n = 555, 500, 
608, and 601 total cells, respectively. Geldanamycin pre-treatment yielded similar foci-inhibitory 
results tested in the absence of hydrogen peroxide for FGAMS-EGFP in HEK293T cells (C), although 
a high concentration of geldanamycin (GA) abolished the foci-inhibitory affect; bars indicate average 




Figure 3-15. Proteasome inhibition induce PPAT-EGFP foci in a time-dependent 
manner.  
HeLa cells treated with 20 µM MG-132 for 1.5, 2.5, 5, and 8 hours showed increasing cells 
populations with foci. Carrier-only control (DMSO) for 8 hours showed only minimal penetrance, 
consistent with no treatment (see Figure 3-1). Bars indicate average +/- 1 s. d. across 3 replicates, 
n = 625, 793, 1024, 466, and 397 cells, respectively. 
 
 
Foci induced with MG-132 were usually accompanied by a single dominant 
perinuclear purine enzyme body surrounded by vimentin (Figure 3-16B), and 
smaller bodies were occasionally juxtaposed to vimentin filaments (Figure 3-16C). 
Thus, collectively, these data indicate that purine enzyme foci associated strongly 
with known markers of aggregation, and that their formation is modulated in a 
manner consistent with aggregation (Howard et al. 2007, Sampathu et al. 2003, Kim 




Figure 3-16. Proteasome inhibition induces aggresome-localization of purine enzyme 
foci. 
(A) The intermediate filament vimentin   (left, untreated) collapses into a perinuclear ring 
surrounding the aggresome upon treatment with MG-132 (right, 20 µM for 8 hours). (B) MG-132-
induced PPAT-EGFP foci are predominated by a single large body at the site of the aggresome, 
encased by vimentin. (C) Smaller foci (left) distributed across the cytoplasm are frequently associated 
with vimentin filaments (right) extending from the aggresome; examples are marked by arrows 
(overlay, bottom) (20 µM MG-132 for 5 hours). For all panels, red: anti-vimentin antibody; green: 
PPAT-EGFP; blue: nucleus stained with Hoechst.  
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3.5 Undirected investigation of protein interactions suggests sequential 
enzyme pairing 
The repertoire of current studies on purine biosynthesis enzyme interactions 
rely heavily on fluorescence microscopy of transfected recombinant tagged 
constructs, which are known to influence expression behavior of foci (Landgraf et al. 
2012). To access the existence of the putative purinosome as a true native multi-
enzyme complex, we used undirected, unbiased method orthogonal to fluorescence 
microscopy including (1) a high-scale proteomic-level mass spectroscopy profiling of 
the proteome to search for native protein complexes, and (2) mass spectroscopy 
coupled with immunoprecipitation (IPMS) of FGAMS-EGFP to identify associated 
endogenous proteins. The high-scale protein complex search described in Section 
3.5.1 was done in collaboration with Pierre Havugimana and Cuihong Wan from 
Andrew Emili’s lab at the University of Toronto, who carried out all the fractionation 
experiments, and with Blake Borgeson, who optimized the computation pipeline for 
data processing and map assembly. The IPMS experiments described in Section 
3.5.2 were done in collaboration with Daniel Boutz, who collected and analyzed the 
data from the experiments that I designed and conducted. We find no strong evidence 
for a native purinosome and no consistent associations of endogenous proteins to 
FGAMS-EGFP. 
 
We devised a method of identifying conserved protein complexes in an 
untargeted manner by combining scaled-up biochemical fractionation with mass 
spectroscopy profiling (Havugimana et al. 2012). To assemble candidate protein 
complexes, we employed multiple separation techniques to resolve proteins followed 
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by computational filtering and clustering methods. Using this methodology, we not 
only recapitulated many previously reported complexes (Figure 3-17) but also 
inferred hundreds of new putative complexes, including a partial purinosome (Figure 
3-18).  
 
3.5.1 Endogenous enzymes may associate in pairs but not in full complex 
Purine enzyme foci average 560 nm (ranging 200-900 nm) (French et al. 2013). 
One might expect that such large structures, even if partially disassociated, might 
still retain protein-protein interaction with other foci constituents. Some of the 
largest known protein complexes such as the human proteasome and 80S ribosome 
which are no larger than 50 nm (Jones et al. 2014, da Fonseca and Morris 2008) are 
robustly recapitulated in our biochemical fractionations (Figure 3-18A). Five of 
the six enzymes of the de novo purine biosynthesis pathway were predicted as a 
complex via our mapping pipeline (Figure 3-18B). However, the elution profiles of 
the pathway proteins indicated a pattern of protein “pairing”, or the possibility of 
multiple sub-complexes, as opposed to a single complex consisting of at least all six 
enzymes (Figure 3-19). The pattern of mutually exclusive pairwise associations at 
each sequential step is consistent with the idea that the purine biosynthesis enzymes 
associate to exchange unstable intermediates and may facilitate metabolic 
channeling, and is inconsistent with the idea that the pathway coalesces into a single 




Figure 3-17. All inferred conserved animal complexes from large scale fractionations. 
Each cluster represents a conserved animal complex inferred from co-elution data, with nodes 
presenting proteins connected by weighted edges presenting strength of association. Curated human 
interactions from CORUM (Ruepp et al. 2010) are shown colored: red associations were given as 
training set, and green associations were not given as training set (thus served as validation of our 





Figure 3-18. Recapitulated known proteasome complex and inferred novel purine 
biosynthesis complex. 
(A) Complex discovery method recapitulated the proteasome, with proteins shown as circular 
nodes connected by weighted edges presenting the calculated probability of association. Some known 
interactions from CORUM associations (red edges) were used to train the clustering algorithm. (B) 
5 of the 6 human purine biosynthetic pathway enzymes clustered into a single module representing a 




Figure 3-19. Elution profile for purine biosynthesis pathway enzymes. 
(A) Actual elution profiles for dual heparin-ionic exchange fractionation of partial cellular 
extracts from HEK293 and HeLa S3 cells. The six human purine biosynthesis pathway enzymes 
appear in different fractions plotted along the x-axis. Each enzyme’s normalized mass spectral counts 
are plotted along the y-axis. Peak height is relative to the maximum count observed for each particular 
individual protein. (B) Cartoon representation of the elution profiles highlighting mutually exclusive 
putative interactions at each step of the sequential pathway. The chemical reaction steps are carried 
out by the enzymes in the following order: PPAT  GART  FGAMS  GART  PAICS  
ADSL  ATIC. Methods used are those described in Wan et al. (2015). 
 
3.5.2 No evidence of complex by IPMS of FGAMS-EGFP  
Immunoprecipitation of FGAMS-EGFP subject to mass spectroscopy 
identification of co-precipitated proteins (IPMS) revealed a lack of high-confidence 
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interacting proteins (Figure 3-20) which would have formed the purinosome 
complex. The notion that FGAMS-EGFP foci are homogenous is consistent with the 
fact that protein aggregates are highly homogenous (Rinas and Bailey 1992). A large 
fraction (>60%) of the immunoprecipitated FGAMS-EGFP should be derived from 
the diffuse expression state, suggesting that even the diffuse protein does not strongly 
associate with any interacting partner proteins. Consistent with this observation, 
independent IPMS of transfected FGAMS-MYC also failed to identify strong 
associations with other enzymes, including the purine biosynthetic pathway enzymes 











Figure 3-20. IPMS of FGAMS-EGFP show no strongly enriched interacting proteins. 
Immunoprecipitated FGAMS-EGFP from HeLa cells grown in RPMI + 10% dialyzed FBS 
was subject to mass spectroscopy identification. Immunoprecipitated GFP from cells grown in 
identical condition was used as control. (A) Combined Z-scores with most significant protein IDs 
being: 18.35 FGAMS-EGFP and 7.15 transketolase, the latter presumably a contaminant. The 
significant Z-score for antibody (-30.23) resulted from detection of abundant antibody used in the IP. 
(B) Fold-change enrichments suggest FGAMS-EGFP does not strongly associate with other proteins. 
Protein IDs with highest fold-change are 97.49 FGAMS-EGFP and 23.7 dynein, the latter presumably 
a contaminant. All values were calculated from PSMs (see Methods) from 3 experiments. 
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3.6 Discussion and Remarks 
Multi-enzyme complexes often engage in various forms of substrate 
channeling, in which sequential pathway enzymes “hand off” intermediate metabolic 
products amongst each other rather than release them into bulk solution. The 
advantages of such complexes include improved efficiency and optimized usage of 
short-lived intermediates. 
 
One such possible complex involves the enzymes for de novo purine 
biosynthesis. Termed the “purinosome,” the complex's existence has long been 
suggested by circumstantial evidence. The search for direct in vivo evidence of the 
purinosome culminated in the discovery of intracellular punctate foci formed in part 
by purine biosynthesis enzymes. An et al. (2008) argued, based in part upon the 
now-debated evidence for purine dependency, that these were functional complexes. 
However, the new discoveries described in this dissertation support a model where 
these foci behave in a manner unlike that expected for functional purinosomes and 
instead have numerous features one might expect of simple protein aggregates or 
stress bodies. Specifically, the transiently overexpressed purine biosynthetic enzymes 
form intracellular bodies at frequencies that correspond to each enzyme’s predicted 
aggregation propensity. The resultant bodies are marked by ubiquitin and heat-shock 
chaperones, and they were inducible using a number of nonspecific cellular insults. 
 
 In this discussion section, I will address issues with current literature that 
models purine enzyme foci as metabolically active associations (purinosomes), and 
demonstrate that the same experiments do not disentangle the bodies from possibly 
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being general protein aggregation. Then I will address the issues that emerge with 
characterizing the bodies with evidence obtained with a single method. 
 
3.6.1 Conciliating seemingly contradictory observations 
Reports of seemingly contradicting observations of purine biosynthetic 
enzyme foci by different groups or in differently designed experiments calls a need 
to reconcile the apparent contradictions.  
 
3.6.1.1 “Purine-dependency” experiments were not purine-specific 
experiments 
Functionality of cellular bodies is strongly suggested when they are 
metabolically inducible and form reversibly. Based in part upon evidence for purine 
dependent formation and dissolution of purine enzyme foci, they were argued to be 
functional complexes. However, as stated above, the medium used to observe 
purinosomes by An et al. lacked bulk nutrients up to 50X larger than purines, and 
was supplemented with only half of the serum concentration compared to that for 
purine-rich medium (An et al. 2008). Unsurprisingly, a switch to this nutrient-
depleted medium may be stressful for some cells (e.g., it was reported that HTB-125 
cells did not survive in this “purine-depleted” medium (An et al. 2008)). It is 
therefore possible that this stress contributed to the visible aggregation of 
recombinant purine enzyme constructs.  
 
 117 
Although HeLa cells seem to fare better than HTB-125 cells in “purine-
depleted” medium (An et al. 2008), claims that “purine-depleted” medium promotes 
assembly of puncta while “purine-rich” medium promotes disassembly are not 
supported by more quantitative measurements of puncta penetrance across HeLa 
cells. In experiments replicated exactly or replicated with optimized media 
formulations, I did not see differences in puncta penetrance between different growth 
conditions. While the foci formation rate for HeLa cells grown in “purine-rich” 
medium was not reported in An et al., their HeLa cells grown in “purine-depleted” 
medium showed foci rates similar to those I report. In particular, puncta penetrance 
in four out of the six pathway enzymes is agreeably very low (~5-8%), and the 
opposite of might be predicted if they were functional entities, given that the de novo 
purine biosynthesis pathway is also active and detectable in “purine-rich” 
mammalian cell culture (Yamaoka et al. 1997, Yamaoka et al. 2001). 
 
Interestingly, in my own work and in other independent labs, no differences 
in foci rates between cells grown in the two media are observed (personal 
communication with Dr. Michael Rosen, UTSW; personal communication with Dr. 
Donald Anderson, UTSW), although one group saw increased foci rates only when 
the “purine-depleted” medium was further filtered with charcoal (Field, Anderson, 
and Stover 2011), a method that powerfully and non-specifically depletes organic 
compounds. These discrepancies may have risen from unintentional differences in cell 
line sub-culturing practices or imaging techniques used by different groups. For 
example, immediately prior to live imaging, one group washed the cells for several 
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times in variously supplemented buffered saline solutions (An et al. 2008) for which 
both reasons and implications are unclear.  
 
3.6.1.2 “Purine-dependency” claim is not supported by purine-specific 
experiments. 
While there is no convincing published evidence that levels of purines in the 
medium alone affect foci formation, it has been shown that levels of purines in the 
medium do not affect the foci formation. Specifically, the observation that purine 
enzyme foci remained robust after specifically adding an exogenous purine source, 
hypoxanthine, back to “purine-depleted” medium (An et al. 2008) strongly argues 
that foci formation is not controlled solely by purine levels in the growth medium. 
In this regard, azaserine (a purine antagonist) also has no effect on the formation of 
purine biosynthesis enzyme foci (An et al. 2008). The lack of purine-specific 
dependencies is inconsistent with the hypothesis that the inducible foci represent 
true purinosomes or functional purine biosynthesis enzymes. 
 
3.6.1.3 Purine-independent foci cycling 
Furthermore, An et al. (2008) showed cycling of foci assembly and 
disassembly by exchanging the “purine-rich” for “purine-depleted” media and vice-
versa; however, no control was performed. Figure 3-4 showed cycling could also be 
achieved by simply removing and replacing with the same medium, arguing that the 
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induction and disappearance of bodies may be due to the shock and adaptation to 
the brief mechanical or oxidative stress associated with media swap.  
 
3.6.1.4 Heat shock chaperone perturbation  
The association of heat shock chaperones (particularly of HSP70) with purine 
enzyme foci has been independently established (Zhao et al. 2013, French et al. 2013), 
although there are opposing views on the nature of this association. As shown earlier 
in this manuscript in support of purine enzyme foci as aggregated proteins, HSP70 
induction by geldanamcyin reduces foci prevalence, even in the presence of foci 
induction by peroxide. This observation supports the bodies as aggregating proteins 
which may be chaperoned into their solubilized with the aid of HSP70. Contrarily, 
HSP70 induction by geranylgeranylacetone induces purine enzyme foci (French et 
al. 2013), arguing that the foci are functional multi-enzyme complexes that form 
with the aid of HSP70. However, at the concentration used to induce foci, 
geranylgeranylacetone has also been shown to also induce the unfolded protein 
response and the accumulation of unfolded/misfolded proteins within the ER (Endo 
et al. 2007). The complexities of cell culture and imaging make it difficult to ascertain 
which precise cellular response is observed, thus the apparent induction of purine 




3.6.1.5 Effects of other pharmacophores 
It is argued that the pharmaceutical induction of foci supports their 
functionality. However, the aforementioned effects of CK2 inhibitors on foci 
formation are fully consistent with an alternative interpretation that the foci are 
intracellular aggregates. CK2 has been shown to have crucial roles in clearing general 
protein aggregation and has also been implicated as an anti-stress factor (Watabe 
and Nakaki 2011, 2012). Importantly, CK2 has many protein substrates, and its 
inhibition influences a wide array of cellular activity (Bibby and Litchfield 2005, 
Litchfield 2003). For example, CK2 inhibition is known to induce apoptosis (Slaton 
et al. 2004, Ahmad et al. 2008, Trembley et al. 2009). The chemical inhibitors of 
CK2 are also rather nonspecific (Pagano et al. 2008) and are themselves associated 
with increased apoptosis and increased production of reaction oxygen species 
(Schneider et al. 2009). Thus, possible signal transduction via CK2 does not strongly 
constrain the mechanism underlying purine enzyme foci formation.  
 
The claim that the formation of foci by purine biosynthesis enzymes can be 
controlled by the addition of Gαi agonists or antagonists (Verrier et al. 2011) may 
again be more simply explained by aggregation, rather than functional complex 
formation. Indeed, downstream Gαi targets (e.g., the PI3K/Akt pathway) include 
regulators of various stress-related cellular responses, such as cell survival and protein 
synthesis, which will also influence protein homeostasis and aggregation. Notably, 
Gαi signaling has been implicated in autophagy (a mechanism known to clear 
aggregated proteins) in human cell lines (Petiot et al. 1999, Ogier-Denis et al. 1996), 
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and a molecule which sustains activated Gα has been reported to inhibit the 
formation of autophagic vacuoles (Kadowaki et al. 1994). 
 
These data are fully consistent with a simpler hypothesis that cell stress, 
which may be induced by a variety of factors, might be the trigger for non-specific 
foci formation.  
 
3.6.1.6 Foci constituents disagree with biochemically-identified purine 
enzyme associations 
The constituents of purine enzyme foci as measured by microscopy are in 
many ways in disagreement with biochemically-captured purine enzyme protein–
protein associations. As previously shown through partial co-purification, two folate 
metabolism enzymes (serine hydroxymethyltransferase 1 and 
methylenetetrahydrofolate dehydrogenase 1) associate with the folate-utilizing 
purine biosynthesis enzymes GART and ATIC (Caperelli et al. 1980, Smith et al. 
1980).  GART's catalytic activity actually requires interaction with 
methylenetetrahydrofolate dehydrogenase 1 or its analog (Smith et al. 1980, Smith 
et al. 1981). However, these two folate metabolism enzymes were found to be 





3.6.2 Reliance on transient transfection of recombinant proteins and 
insufficient examination of endogenous proteins 
With one exception (Baresova et al. 2012), all literature evidence for purine 
enzyme foci has thus far relied on transiently expressed recombinant fluorescent 
protein fusion constructs. This may be a consequence of reported difficulties and 
possible artifacts surrounding immunofluorescent labeling of native purine 
biosynthesis enzymes (An et al. 2008, Zhao et al. 2013). For example, it was observed 
that while endogenous GART behaved similarly to the GART fusion construct in 
“purine-depleted” medium, its endogenous behavior did not correspond to that 
observed for its fusion construct in “purine-rich” medium (An et al. 2008). Previous 
efforts using cells stably transfected with GART did not yield visible foci 
(Gooljarsingh et al. 2001), raising the question of whether effects of body assembly 
were promoter-driven artifacts or possibly artifacts due to transient transfection-
associated stresses.  
 
3.6.2.1 Questionable physiological relevance 
These results also raise interesting questions regarding how growth conditions 
and cellular physiology impact the formation of single protein aggregates in general, 
especially proteins altered from their native state, for example whose levels may no 
longer correspond to normal, endogenous levels or which are expressed as fusion 
proteins. While it may be possible that purine enzyme foci may shift to stress body-
like protein complexes with increasing levels of protein expression or varying methods 
of cellular insults, we note that in general, the formation of purine enzyme foci did 
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not vary strongly amongst the different cell lines, and at least for PAICS-RFP, we 
observed the recombinant enzyme to be expressed at levels very similar to the 
endogenous proteins (Figure A-4 in Appendix A). 
 
Due to difficulties with immunofluorescent targeting of endogenous purine 
enzymes and inability to biochemically capture a native intact purinosome, it is 
unclear whether the purine enzyme fusion constructs function similarly to 
endogenous enzymes. Others have observed that fluorescent protein fusions are 
subject to aggregation and form intracellular foci (Garcia-Mata et al. 1999, Landgraf 
et al. 2012). In fact, the observation that “cells transfected with Hsp90 or Hsp70 
alone yielded a diffuse staining pattern” (French et al. 2013) strongly suggests that 
native purine biosynthesis enzymes do not form such bodies. Rather, the Hsp foci 
arise only as a function of the transfected recombinant purine biosynthetic enzymes. 
  
In a similar vein, I have noted numerous unexpected yet striking differences 
on a protein’s subcellular localization and/or interaction partners between similar 
experiments employing different commonly used protein tags or transfection methods 
(some cases are presented in the appendix, and is a theme within the next chapter 
describing TTC4). Here, the study of purine enzyme foci is also a case study in how 
the methods used to query intracellular bodies potentially influence outcomes. The 
sole reliance on microscopy with fusion proteins, and the absence of other physical 
demonstrations of the purinosome as a whole, argues for caution in interpreting the 




The idea of a purinosome has many compelling features. Assorted evidence 
ranging from metabolic flux and channeling considerations to pairwise kinetic or 
physical interactions observed between particular biosynthetic enzymes supports the 
idea of some form of physical association between purine biosynthetic enzymes. Thus, 
there is a substantial body of literature suggesting the existence of the purinosome. 
In the preceding chapters, I addressed confounding issues surrounding the 
interpretation of punctate foci containing purine biosynthetic enzymes. Although 
current observations do not fully negate the possible formation of functional 
purinosomes, they also do not substantiate that foci formed by recombinant purine 
biosynthetic enzymes must be the purinosome. A far simpler explanation is plausible: 
that the purine biosynthetic enzymes can aggregate under conditions of cellular stress 
or recombinant expression. Indeed, it is well known that many other intracellular 
enzymes form aggregates under similar conditions, and purine biosynthetic enzymes 
are not known to be special in this regard. This discrepancy between purine enzyme 
foci interpretations highlights the need for caution regarding reliable methodologies 





3.7 Materials and Methods 
3.7.1 Abbreviations of protein names 
PPAT, phosphoribosyl pyrophosphate amidotransferase; TrifGART, the 
trifunctional enzyme glycinamide ribonucleotide (GAR) synthetase, GAR 
transformylase, and aminoimidazole ribonucleotide synthetase; FGAMS, 
formylglycinamidine ribonucleotide synthase; PAICS, the bifunctional enzyme 
carboxyaminoimidazole ribonucleotide synthase and 
succinylaminoimidazolecarboxamide ribonucleotide synthetase; ADSL, 
adenylosuccinate lyase;ATIC, the bifunctional enzyme aminoimidazolecarboxamide 
ribonucleotide transformylase and IMP cyclohydrolase; GFP, green fluorescent 
protein; RFP, red fluorescent protein; EFGP, enhanced GFP; GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase; GLNS, glutamine synthetase. 
 
3.7.2 Cloning 
The PPAT-EGFP and FGAMS-EGFP expression plasmids were generously 
provided by An and Benkovic (An et al. 2008). The ADSL-EGFP expression plasmid 
was constructed by Gateway cloning into the FGAMS-EGFP expression plasmid, 
modified to introduce the Invitrogen pDEST47 Gateway cassette in place of FGAMS. 
All other cDNAs were obtained from the human ORFeome collection 
(OpenBiosystems) and cloned using Gateway cloning into either the pcDNA-
DEST47 plasmid (Invitrogen) for carboxy-terminal GFP-tagged expression clones or 
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the pTagRFP-N plasmid (Evrogen; modified to introduce the Invitrogen pDEST47 
Gateway cassette) for carboxy-terminal RFP-tagged expression clones. 
 
3.7.3 Cell culture 
To replicate conditions reported by An et al. to give rise to purine enzyme 
foci, HeLa cells obtained from the American Type Culture Collection (ATCC) were 
cultured at 37°C with 5% CO2 in the following medium as previously described (An 
et al. 2008): Purine rich medium: MEM medium supplemented with 10% FBS (fetal 
bovine serum) and 50 µg/mL gentamycin sulfate (Invitrogen); purine-depleted 
medium: RPMI medium supplemented with 5% dialyzed FBS and 50 µg/mL 
gentamycin. FBS was dialyzed against 100-fold volumes of 0.9% NaCl at 4°C for 2-
4 days using a 25 kDa molecular weight cut-off (MWCO) dialysis membrane with 
daily exchange of the dialysis solution. 
 
As a test of alternate cell lines and matched purine-rich and purine-depleted 
media formulations, HEK293 or HEK293T cells obtained from ATCC were cultured 
at 37°C with 5% CO2 in the following media: (1) Optimized purine-rich medium: 
DMEM medium supplemented with 10% FBS and 35 µM hypoxanthine, or (2) 
Optimized purine-depleted medium: DMEM medium supplemented with 10% 
dialyzed FBS. To remove purines but retain other important factors, FBS was 
dialyzed against 100-fold volumes of 0.9% NaCl at 4°C for 2-4 days using a 1 kDa 
MWCO dialysis membrane with daily exchange of the dialysis solution (Yamaoka et 




One day prior to transfection, HeLa cells were plated in 6-well glass bottom 
plates in either purine-rich or purine-depleted medium lacking antibiotics. HEK293 
or HEK293T cells were plated in 96-well glass bottom plates in the optimized purine-
rich medium lacking antibiotics. Plasmids were transfected into cells using 
Lipofectamine 2000 (Invitrogen) and Opti-MEM reduced serum medium (Invitrogen) 
according to the manufacturer’s instructions. The transfection medium was replaced 
with fresh purine-rich or purine-depleted medium 5 hours after transfection. 
Immediately before imaging, cells were washed once with their respective growth 
medium. Cells were imaged in their respective growth medium to minimize stress 
imposed by nutrient shifts. We note that the imaging medium therefore contained 
phenol red, which could potentially reduce the signal-to-noise ratio, but in practice, 
we did not experience problems in detecting and visualizing foci. Live cells were 
imaged ~20-24 hours after transfection. 
 
For MG-132 experiments, HeLa cells were plated in 96-well glass bottom 
plates in DMEM medium supplemented with 10% FBS. Due to the toxic nature of 
MG-132, we opted to use a less toxic transfection reagent than Lipofectamine 2000, 
and therefore, we transfected the PPAT-EGFP-expressing plasmid into cells using 
Fugene HD (Roche Applied Sciences) and Opti-MEM reduced serum medium 
(Invitrogen) using a 2:4.5 DNA to transfection reagent ratio following the 
manufacturer's protocol. The transfection medium was replaced with fresh 




For immunofluorescence experiments, cells were fixed with 3.7% methanol-
free formaldehyde freshly diluted from 16% stock (28908, Thermo Scientific) at 37°C 
for 15-20 minutes, blocked with 5% goat serum in PBS-T buffer for 30-60 minutes 
at room temperature, then incubated with primary antibody overnight at 4°C. Cells 
were washed with PBS buffer, then incubated with secondary antibody for 1 hour. 
Primary antibodies used: HSP70 (ab5439, Abcam), ubiquitin (ab7780, Abcam), 
GAPDH (sc-32233, Santa Cruz Biotech.), glutamine synthetase (sc-9067, Santa Cruz 
Biotech.) Secondary antibodies used: Alexa Fluor 594-conjugated goat anti-mouse 
(Invitrogen), Alexa Fluor 594-conjugated goat anti-rabbit (Invitrogen). All 
antibodies were used at the manufacturer’s recommended concentrations. We 
additionally tested the protocol using 2% methanol-free formaldehyde fixation or 2% 
goat serum in PBS-T block at the appropriate steps to find no appreciable 
differences. 
 
Tested antibodies that proved unsuitable or inconclusive for 
immunofluorescence included the anti-PPAT antibodies sc-101892 (Santa Cruz 
Biotech.) and ab71340 (Abcam), the anti-PAICS antibody sc-16150 (Santa Cruz 
Biotech.), and the anti-TrifGART antibody H00002618-M01 (Novus Biologicals). 
 
3.7.6 Western blot 
For western blotting, cells were grown in DMEM media containing 10% FBS 
and transfected as described above with 1.6 µg or 200 ng DNA (HeLa or HEK cells, 
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respectively), in regular 96-well plates (HEK293 and HEK293T) or 6-well plates 
(HeLa). Cells were washed with cold PBS buffer then extracted with Laemmli sample 
buffer containing 5% beta-mercaptoethanol. Total protein was separated on a 4–15% 
Mini-PROTEAN TGX precast gel (BioRad) and blotted with PVDF membrane. 
Primary antibodies used: anti-PAICS (HPA035895, Sigma) and anti-GAPDH (sc-
32233, Santa Cruz Biotech.). Secondary antibodies: goat anti-rabbit IgG F(ab')2-
HRP (sc-3837, Santa Cruz Biotech.) and goat anti-mouse IgG F(ab')2-HRP (sc-3697, 
Santa Cruz Biotech.). Membranes were scanned with an ImageQuant LAS 4000 (GE 
Healthcare). 
 
3.7.7 Fluorescent cell microscopy 
Live cells were imaged using a Nikon Eclipse TE2000-E inverted microscope 
inside a chamber maintained at 37°C and 5% CO2. Fixed cells were imaged at room 
temperature without CO2 supplement. Images were acquired using a Photometrics 
Cascade II 512 camera and Nikon Plan Apo 40x/0.95, 60x/0.95, 60x/1.40, or 
100x/1.40 objectives. GFP detection was accomplished using a ET490/20x excitation 
filter (Chroma Tech.), ET525/36 m emission filter (Chroma Tech.) and 89100 bs 
dichroic (Chroma Technology), and RFP detection was carried out using a 
ET555/25x excitation filter (Chroma Tech.), ET605/52 m emission filter (Chroma 
Tech.) and 89100 bs dichroic (Chroma Tech.) The same excitation and emission 
conditions were used for each GFP variant. We did not detect notable fluorescence 
emission bleedthrough or photobleaching with these settings. Filter wheels (Sutter 
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Lambda 10-3), motorized stage (Prior H117), and image acquisition were driven by 
NIS Elements AR Imaging software. 
 
3.7.8 Cell counting 
Cell counts measuring penetrance of foci reflect apparently healthy adherent 
cells only. Mitotic cells (identified as rounded cells with a visible rod-like central 
structure spanning the cell’s DIC image accompanied by a corresponding decrease of 
fluorescent signal; see cell m in Figure 3-8C and C-DIC for an example) and dead 
cells were not counted for measuring penetrance of punctate body formation. (For 
the survival rate analyses only, dead HeLa cells were selected based on dramatic cell 
shrinkage, membrane blebbing, and intense fluorescence, e.g. as seen for the cells 
marked by # in Figure 3-8. We note that it is nonetheless possible that only a 
subset of cell death events—those accompanied by marked visible cellular 
reorganization—are counted by this assay.) Cells displaying any morphology of foci 
were counted, regardless of number of foci per cell or ranging sizes of those foci. We 
observed a spectrum of morphologies which were dynamic; for example, over the 
course of unperturbed growth, we observed both increases and decreases in the 
numbers of foci per cell. Future work may address and characterize the different 




3.7.9 Drug treatments 
For all drug treatments, drugs were diluted to their final concentrations in 
pre-warmed cell growth medium then added to cells for the duration of the 
treatment. Hydrogen peroxide was added to cells at a concentration of 1 mM for 0.5-
1.5 hours before imaging. For short-term treatment, geldanamycin was added to cells 
at the indicated concentrations at the time of post-transfection medium replacement, 
and the cells were incubated for 18 hours. For long-term treatment, geldanamycin 
was added to cells at the indicated concentrations 16 hours prior to transfection, for 
a total incubation time of 40 hours. MG-132 was added to cells at a final 
concentration of 20 µM for the indicated time intervals. Cells were fixed at each MG-
132 time point with 3.7% formaldehyde for 15-20 minutes and washed 3 times with 
PBS before imaging. 
 
3.7.10 Immunoprecipitation and mass spectrometry 
HeLa cells in “purine-depleted” media (RPMI + 5% 25kDa dialyzed FBS) 
were transfected with either FGAMS-EGFP or EGFP using Lipofectamine 2000, 
followed by media replacement after 5 hours. The next day, cells were washed once 
in PBS then trypsinized and resuspended in media to inactivate trypsin, spun down 
at 1000-1500 RPM for 5-10 minutes, and then resuspended in 500 µL freshly made 
ice cold lysis buffer (10mM Tris-HCl pH8.0, 10mM KCl, 1.5mM MgCl2, 0.5mM 
DTT, 1X protease inhibitor I (Calbiochem)) for 5-10 minutes before submitting the 
sample to glass dounce homogenization (~30-50 thrusts per sample with pestle size 
“B”). Cell lysate was incubated on rotation at room temperature with Protein A 
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Dynabeads (Thermo Scientific) pre-washed with PBS and bound to anti-GFP 
antibody (Sigma G1544). After washing the Dynabead-antibody-antigen complex 
with PBS, proteins were eluted from the beads in 50 µL 2,2,2-trifluoroethanol (TFE, 
Sigma) at 60°C and then stored at -20°C. For mass spectrometry sample preparation, 
each TFE sample was reduced with freshly made dithiothreitol and heated to 55°C 
for 45 minutes. After cooling to RT, iodoacetaminde was added to 550mM and 
incubated in dark for 30 minutes at RT. Sample was then diluted with 50mM Tris 
with 2mM CaCl2 to 5% TFE and subject to 4-5 hour 1ug trypsin incubation at 37°C. 
Tryptic digest was quenched with 1% vol/vol formic acid and sample was then stored 
at -80°C. Sample was then vacuum dried to 60-100 µL and resuspended in Buffer C 
(95% H2O, 5% acetonitrile, 0.1% formic acid). Samples were cleaned on C18 tips 
(Thermo), resuspended in 100 µL Buffer C, then subject to LC-MS (Orbitrap Velos) 
for 300 minute runs. Fold changes and Z-scores were calculated using pseudo-peptide 
spectral matches (PSM + 1) normalized against total PSMs (calculated from the 
sum of total pseudoPSMs) within each sample. 




mock ∑ ∈ mock⁄
 
 
Where SIP and Smock are the sets of IP and mock pseudo-PSMs, respectively. 
Fold change and Z-scores were calculated as an average of three experiments.  
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Chapter 4: Summary 
Large-scale protein interaction mapping and subcellular localization screening 
provide a wealth of protein characterization data from which researchers can use as 
starting points for discovering protein function. The first part of my work (Chapter 
1) focused on building a new platform for large-scale microscopy on human cells that 
would enable future large-scale functional genetics assays using expression 
constructs, RNA interference, or chemical methods to induce perturbation. The later 
parts of the manuscript attempted to provide deeper characterization on a few 
inferred protein complexes and foci assemblies derived from our large-scale screens, 
specifically focusing on foci formed by fluorescently tagged purine biosynthesis 
enzymes. 
 
 Observations of cytoplasmic puncta or foci may indicate the 
compartmentalization of proteins to specific organelles such as lysosomes, endosomes, 
or autophagosomes. However, the majority of novel cytoplasmic foci-forming proteins 
discovered in our protein localization screen are not known to be localized to any 
organelle (Narayanaswamy, Levy, et al. 2009), and the reasons for their foci 
formation remains largely unexplained. I presented three possible explanations in 
Chapter 2, including functional compartmentalization for improved enzymatic 
regulation and catalytic efficiency, storage depots for inactive enzymes poised for 
rapid mobilization, or aggregates of misfolded and/or dysfunctional proteins as a 
result of stress. Many of these proteins are generally insoluble in foci-forming 
conditions and thus their macrostructure assemblies may be stress-related 
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aggregation, as suggested by a proteome-wide mass spectrometry survey (O'Connell 
et al. 2014).  On the other hand, many foci- and fiber-forming metabolic proteins, 
such CTP synthase and glutamine synthetase, were characterized more in-depth, 
with their macrostructural assemblies in vitro reconstituted and physiologically 
relevant roles of such assemblies proposed. Such example cases suggest exciting 
explanations underlying other foci and fiber structures.   
 
A complex formed by enzymes of the purine biosynthesis pathway 
compartmentalized for catalytic efficiency (purinosome) is an attractive hypothesis. 
Yet, the full purinosome was not found in our large scale protein complex mapping 
efforts by fractionation (Wan et al. 2015). Although, sequential pairwise interactions 
were observed within our dataset (Wan et al. 2015). There is not yet convincing data 
for the existence of the functional multi-enzyme purinosome, and I showed in 
Chapter 3 that the purinosome is not necessarily supported by the observation of 
foci formed by purine biosynthesis pathway members. I demonstrated that this 
observation is likely due to stress-related aggregation and explored the possibility 
that such foci are formed as a by-product of fluorescent tagging. Notably, it is 
important when interpreting experimental observations to consider alternative 
explanations, especially to take into account the methodology used to collect 
observations. Formation of proteinaceous macrostructures such as foci and fibers are 
frequently seen and are in many cases biologically relevant for compartmentalizing 
cellular processes, as explained in Chapter 2; however, as pointed out many times 
throughout the manuscript and further supported by several case observations shown 
later in Appendix B, they may arise due to fluorescent tagging of the proteins of 
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interest. Along the same lines, it is also possible that co-localization of fluorescently 
tagged proteins into the foci may be the result of aggregation; it is known that many 
fluorescent proteins oligomerize and aggregate (Snapp 2005, Snapp 2009, Krasowska 
et al. 2010), driving efforts to produce non-oligomerizing mutagenized variants for 
researchers to use (Baird, Zacharias, and Tsien 2000, Zacharias et al. 2002, Campbell 
et al. 2002, Rizzo, Davidson, and Piston 2009, Costantini et al. 2015). Despite these 
efforts, many “monomeric” derivatives still produce aggregating artifacts (Landgraf 
et al. 2012, Shaner et al. 2013), especially when local concentrations are high such 
as within membranes or within cellular compartments in which the pH is non-optimal 
for the fluorescent protein. An in-depth case of tagging effects on the characterization 






A. Appendix A: Additional figures to accompany Chapter 3 
 
Figure A-1. Immunofluorescence of endogenous PPAT shows high prevalence of 
puncta regardless of purine availability. 
HeLa cells cultured in DMEM + 10% FBS (A) before switching to “purine-depleted” media 
(RPMI + 5% dialyzed FBS) (B) for 16 hours. Cells are fixed with 3.7% formaldehyde and 
permeabilized with 0.2% triton. Antibodies used: anti-Atase (PPAT, sc-101892, Santa Cruz Biotech, 




Figure A-2. FGAMS-EGFP foci dynamics are independent of media formulation, but 
respond to media replacement. 
HeLa cells grown in “purine-rich” medium with FGAMS-EGFP foci (A) may dissolve foci 
after normal culture condition incubation for 2 hours without perturbation (B). However, upon media 





Figure A-3. Purine enzyme foci do not co-localize with lysosomes. 
HeLa cells expressing PAICS-RFP (left column) or FGAMS-EGFP (right column) grown 
in “purine-depleted” media (RPMI + 5% 25kDa dialyzed FBS) are treated with 0.2mM leupeptin for 
19 hours before fixation and immunofluorescence against LAMP2 (anti-LAMP2 antibody, ab25631, 
Abcam). PPAT-EGFP foci also do not co-localize with foci marked by LAMP2 (data not shown). 





Figure A-4. Representative expression levels of PAICS-RFP transfected constructs in 
comparison to the endogenous PAICS protein. 
 
HeLa (A,D), HEK293 (B,E) and HEK293T (C,F), untransfected (U) or transfected with 
PAICS-RFP (T) under representative growth conditions are probed with anti-PAICS antibody. (D-
F) Representative variation of construct expression between independent transfections. Quantified 
expression level ratios of PAICS-RFP construct to endogenous PAICS (G) across all cells, adjusted 
with respective transfection rates (ranging from 6-32%) measured by microscopy, show comparable 
expression (within two-fold) of the construct and endogenous enzyme in transfected cells, under 
conditions (see Methods) in which PAICS-RFP foci are observed. Expression ratios are calculated as 
(PAICS-RFP Western blot intensity)/(endogenous PAICS Western blot intensity * transfection 
efficiency). Bars indicate average +/- 1 s. d. across at least 3 replicates. (H) Representative HEK293 
cells corresponding to the bar in (G) and showing visible foci. (G) Equivalent levels of the expressed 
PAICS construct and the corresponding endogenous protein is in agreement with independent 
experiments observing transiently transfected purine constructs (personal communication with Dr. 
Michael Rosen, UTSW). (I) Expression levels of PAICS-RFP are not strongly altered by hydrogen 




B. Appendix B: Examples of tag-influenced protein localization  
Although immunofluorescence and fluorescent-protein tagging show high 
correlation for protein localization, it is the case that for a substantial portion (20%) 
of proteins, the two methods give disparate results (Stadler et al. 2013). Landgraf et 
al. (2012) have shown that the behavior of recombinant tagged Clp proteases can be 
influenced by the type of fluorescent protein it is expressed with. In this Appendix 
section, I catalog examples of a variety of proteins in which differential tagging 
unexpectedly produced different protein subcellular localization in yeast (Figure 
B-2) and human cells (Figure B-1), and some of these differences seem to be 
independent of the tag, but accrued through the process of tagging (Figure B-1). I 
also show an example of how altering transfection method and staining technique 





Figure B-1. Asparagine synthetase behavior is altered by a single mutation in linker. 
Left: A spontaneous mutation (cca (P)  caa (Q)) in the linker region between asparagine 
synthetase (ASNS) and red fluorescent protein (RFP) tag results in drastically different subcellular 
phenotype of the tagged protein. ASNS cDNA was obtained from the human ORFeome collection 
(OpenBiosystems) and cloned into a modified pTagRFP-N plasmid (Evrogen; modified to introduce 
the Invitrogen pDEST47 Gateway cassette for carboxy-terminal RFP-tagged expression clones). The 
PQ mutation within the linker region lies within the clonase-reactive (attL and attR) sites and was 
presumably introduced during the Gateway LR clonase reaction. Right: HeLa cells treated with 2mM 
DON for 24 hours are probed with anti-ASNS antibody (sc-376151, Santa Cruz Biotech.), showing 
filaments. Secondary antibody: Alexa Fluor goat anti-mouse 488. DON treatment is previously used 




Figure B-2. Fluorescent label-dependent behavior of Ade4 in yeast. 
Ade4 genomically labeled with CFP (A) or GFP (B) were grown in YPD for 6 days. The 
CFP-labeled foci are more prominent than the GFP counterparts. Camera exposures were identical 
and LUTs scaled equally. (C) Ade4p-CFP formed fibers that are noticeable in a small subset of the 
population at 5 days in YPD but becomes prominent within the population at an extended 19 days 
(19 days is shown). A z-stack maximum intensity projection is displayed. (D) A magnification of the 
boxed region in (C). Contrarily, Ade4p-GFP maintains a punctate focus throughout extended growth 
in YPD, examined after up to 21 days (E, 21 days is shown). (F) Haploid yeast with one copy Ade4-
HA showed a mixture of puncta and fiber at 5 days in YPD (although only foci were present in longer 
growths up to 25 days). 5 days is shown. Structures were not an immunofluorescence artifact, 
compared to lack of such in (G) similarly tagged and probed heterologous haploid Ade17-HA strain. 
Yet they were not as prominent as the robust fiber forming Ura7p-MYC in a heterologous haploid 
strain (H). In all cases, cells were grown in YPD at 30°C with continuous shaking. Unique puncta 
morphologies and behaviors were exhibited by other tested tags, such as Ade4p-mCherry (data not 
shown). Images of stationary phase Ade4p-TAP and Ade4p-YFP can be found in Narayanaswamy, 




Figure B-3. Transfected DNA and probe concentration affects TTC4 localization. 
In a 96 well plate, (Left; top) 200ng TTC4-MYC was transfected with 0.6uL FuGENE HD 
and probed with anti-Myc antibody (mouse, sc-40, Santa Cruz Biotech) at 1:200. The cell boundaries 
are drawn in. (Left; bottom) 200ng TTC4-FLAG was transfected with 0.6uL FuGENE HD and 
probed with anti-FLAG antibody (mouse, F1804, Sigma) at 1:200. The cell boundaries are drawn in. 
(Right; top) 40ng TTC4-MYC was transfected with 0.12uL FuGENE HD and probed with anti-
Myc antibody (1:2000). (Right; bottom) 40ng TTC4-FLAG was transfected with 0.12uL FuGENE 
HD and probed with anti-FLAG antibody (mouse, F1804, Sigma) 1:2000. In all panels, nuclei were 
stained with Hoechst 1:1000. Secondary antibodies used: Alexa Fluor goat anti-mouse 488 and Alexa 
Fluor goat anti-mouse 647 (Invitrogen). 
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C. Appendix C: Multi-dimensional characterization of TTC4 
In Chapter 3, I pointed out that the study of foci characterized by purine 
biosynthetic enzymes is a case study in how the methods used to query intracellular 
structures potentially influence outcomes. This Appendix section presents TTC4 as 
another case example of a protein whose characterization has proven difficult due to 
different outcomes depending on the method of investigation. Prior experiments 
investigating TTC4’s subcellular localization and interacting protein partners have 
solely relied on the overexpression of recombinant tagged versions of the protein 
(Dmitriev et al. 2009, Crevel, Bennett, and Cotterill 2008, Dmitriev et al. 2014, 
Huttlin et al. 2015).  
 
The various methods that we used to investigate TTC4 include: tag-free, 
label-free methods including (1) mass spectrometry, (2) RNA sequencing, (3) RNA 
interference, and (4) structural homology prediction; and tag-dependent and label-
dependent methods including (5) immunofluorescence and (6) immunoprecipitation 
with multiple antibodies, and (7) recombinant tagging with various epitopes and (8) 
fluorescent proteins. Surprisingly, many potential TTC4 characteristics uncovered 
by these techniques seem to be unique to each employed technique. Such findings 
urge for caution and critical examination of the biochemical methods before accepting 
results that came from experiments employing said methods. 
 
 For this section, I would like to thank the authors of Wan et al. (2015), and 
in particular, Kevin Drew, who conducted the TTC4 structural homology model 
 
 145 
construction and assisted in data interpretation. Fan Tu designed and conducted all 
frog experiments. Taejoon Kwon kindly provided the frog mRNA expression data. 
John Wallingford generously supported all work on frogs. For the TTC4 knockdown 
transcriptome sequencing experiments, I thank Jessica Podnar and Gabby Huerta at 
the Genomic Sequencing and Analysis Facility who aided in cDNA library 
preparation and sequencing, and especially Anna Battenhouse who aided immensely 
in downstream data processing and analysis. Maria Person and Andre Bui at the 
Proteomics Facility greatly facilitated mass spectrometry data acquisition. My 
contributions to the work in this section include the design and execution of all cell 
culture-based experiments, and processing, analyzing, and interpreting the data. 
 
C1. Introduction 
TTC4, or tetratricopeptide repeat (TPR)-containing domain 4, contains a 
degenerate structural motif identified in many scaffolding proteins that mediate 
protein-protein interactions (D'Andrea and Regan 2003). TTC4 consists of 3 tandem-
repeats of the 34 amino acid residue TPR motif. TPR motif-containing proteins 
typically serve as scaffolds for the assembly of various multi-protein complexes, 
including the anaphase promoting complex, peroxisomal  import receptor, NADPH 
oxidase complexes, and HSP70-Hop-HSP90 complex (Alvira et al. 2014, Scheufler et 
al. 2000, Zeytuni and Zarivach 2012). TPR-containing proteins are involved in a 
variety of biological processes, such as cell cycle regulation, transcriptional control, 
mitochondrial and peroxisomal protein transport, neurogenesis, protein folding 
(D'Andrea and Regan 2003), and ciliogenesis and cilia maintenance (Xu et al. 2015).  
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C2. Possible TTC4 association with retromer 
C2.1 Biochemical co-fractionation of TTC4 with retromer 
The motivation for characterizing TTC4 originated from the proteome-wide 
mapping of conserved physical association networks based on large-scale biochemical 
fractionations (Wan et al. 2015), in which we found endogenous TTC4 across 
multiple species strongly associated with VPS26, VPS29, and VPS35 (Figure C-1). 
VPS26-VPS29-VPS35 is a well-established complex known as the retromer (Hierro 
et al. 2007). The retromer is an endosomal protein sorting complex that is conserved 
across eukaryotes and functions in endosome-to-trans-Golgi network cargo 
trafficking. Recently discovered retromer-interacting proteins such as the WASH 
complex and Wntless/MIG-14 cargo extends its role further in endosome-to-plasma 
membrane sorting and signaling event regulation (Seaman 2012). Retromer 
association with endosomes and its transport by molecular motors requires the 
presence of sorting nexin proteins SNX1, SNX2, SNX5, and SNX6 (Hong et al. 2009, 
Wassmer et al. 2007, Rojas et al. 2007), which were, along with TTC4, also mapped 
to the same complex in our work. Importantly, we also saw conservation of these 
inferred physical interactions preserved across multiple systems, including worm, 
mouse, fly, and human (Figure C-2). Thus, we predicted with high confidence that 





Figure C-1. TTC4 elution profile coincides with that of the retromer complex. 
Representative elution profile of TTC4 clustered with members of the retromer complex 
(VPS26, VPS29, and VPS35 and associated SNX proteins). Peaks indicates protein elution within 
the 120 biochemical fractionations shown here for a HEK293 prep. The highly correlated elution 




Figure C-2. Heat map elution correlation matrix of phylogenetically conserved TTC4-
retromer interactions 
Elution profiles of TTC4 and retromer components were integrated across multiple species 
tested, including worm (C. elegans) larvae, fly (D. melanogaster) S2 cells, mouse (M. musculus) 
embryonic stem cells, sea urchin (S. purpuratus) eggs and human (HEK293/HeLa) cell lines.  
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C2.2 Homology modeling of TTC4 structure 
As previously mentioned, TTC4 contains TPR structural motifs which are 
known to be evolutionarily highly conserved. The TPR domains are composed of 
alpha-helix paired repeats; however, structural information for the rest of TTC4 is 
not available. We used HHpred (http://toolkit.tuebingen.mpg.de/hhpred) to 
produce query-template alignments that were then used for building a 3D structural 
homology model with the MODELLER software (Eswar et al. 2007). The TTC4 
homology model was compared against structures in the Protein Data Bank using 
Dali server (Holm and Rosenstrom 2010) to find structural neighbors that may give 
clues to its molecular function. VPS29 was among one of the identified structural 
neighbors, strengthening our prediction that TTC4 is associated with the retromer 
in some capacity. 
 
C2.3 However, directed experiments do not support TTC4-
retromer complexing 
The three retromer proteins VPS26-VPS29-VPS35 and the associated sorting 
nexins co-localize as foci in the cell cytoplasm (Rojas et al. 2007)(Figure C-3). 
Logically, I asked whether TTC4 would be co-localized with retromer foci. 
Endogenous TTC4 appears as foci in the Human Protein Atlas (HPA) (Uhlen et al. 
2005), which initially seemed like a promising prospect. However, cytoplasmic TTC4 
foci marked by the same HPA antibody (HPA041608) formed foci in HeLa and 
HEK293T cells that were distinct from those marked by retromer proteins (Figure 
C-4). In addition to cytoplasmic foci which were prominent in most cells (Figure 
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C-5), TTC4 was also sometimes marked in the nucleus and cytoskeleton (Figure 
C-6), consistent with observations gleaned from HPA images available online.  
 
Interestingly, while foci marked by TTC4 was morphologically similar to 
those seen by the Human Protein Atlas group (Figure C-5), epitope- and 
fluorescent-tagged TTC4 did not form the same foci, instead showing diffuse signal 
in the cytoplasm (Figure C-7), which is consistent with previous literature on TTC4 
characterization which heavily relies on recombinantly-tagged TTC4 (Dmitriev et 
al. 2009, Crevel, Bennett, and Cotterill 2008, Dmitriev et al. 2014, Huttlin et al. 
2015). We found that GFP-labeled yeast and frog homologues of TTC4 were also 
diffuse their respective systems (data not shown). 
 
Immunoprecipitation of endogenous VPS26 or recombinant VPS26 followed 
by mass spectrometry identified co-purified VPS29 and VPS35, but not SNX proteins 
nor TTC4 (data not shown). Immunoprecipitation of endogenous or recombinant 






Figure C-3. Retromer components VPS26 and VPS35 co-localize into the same foci 
 HeLa cells transfected with VPS35-MYC, VPS26-MYC, or VPS26-FLAG formed foci that 
were marked by endogenous VPS35 or VPS26. The channels are merged in the third column with 




Figure C-4. TTC4 foci do not co-localize with retromer foci 
Foci formed by retromer components VPS35 (A,B) and VPS26 (C,D) generally do not co-
localize with TTC4 foci detected with the HPA041608 antibody. (E) Vary rare occurrence of co-
localization is seen in <1% of cells; it is not clear whether those represent immunofluorescence 




Figure C-5. Endogenous TTC4 shows distinct cytoplasmic puncta. 
In all human cells tested, endogenous TTC4 probed with antibody HPA041608 forms 
cytoplasmic foci. Top row: H-460 large cell lung cancer cells, HeLa cervical cancer cells, HEK293T 
embryonic kidney cells; middle row: CRL-2091 normal fibroblast cells, HBEC30KT immortalized 
normal lung epithelial cells, HCC4017 non-small cell lung cancer cells. Similar results were acquired 
when anti-TTC4 antibody was labelled either with Alexa Fluor goat anti-rabbit 594 (red) or Alexa 
Fluor goat anti-rabbit 488 (green). This agrees with prior work done by the Swedish Human Protein 
Atlas project (Uhlen et al. 2005), shown in the bottom row: U-2 osteosarcoma cells, U-251 MG 
glioblastoma cells, and A-431 epidermoid carcinoma cells. Nuclei are visualized in blue with Hoechst 




Figure C-6. Secondary localization of endogenous TTC4 in nuclei and cytoskeleton. 
In addition to ubiquitous cytoplasmic puncta, TTC4 (probed with antibody HPA041608) 
sometimes show secondary subcellular localization to the cytoskeleton or nucleus. (A) Examples of 
cytoskeletal staining of TTC4 are shown in HeLa cells and CRL-2091 cells, and nuclear staining of 
TTC4 shown in HEK293T cells. This agrees with independent work in which (B) cytoskeletal staining 
was detected in U2-OS cells along with nuclear staining in A-431 and U-251MG cells (Uhlen et al. 






Figure C-7. Epitope and fluorescent-tagged TTC4 is diffuse. 
TTC4 tagged with RFP, emGFP, MYC, or FLAG at either the N-terminus (attempted for GFP) 
or the C-terminus (attempted for all tags) of the protein show diffuse uniform localization in HeLa 
cells. This phenotype agrees with prior work in literature employing the similar methods of detection; 
shown in the grey bottom right panel: GFP-TTC4 from Dmitriev et al. (2009) and TTC4-RFP from 
Dmitriev et al. (2014). 
 
C3. Unbiased search of TTC4 interaction partners 
I then set out to identify whether the TTC4 foci marked by the HPA041608 
antibody (here forth referred to as antibody 1, or ab1) were enriched for other protein 
components. Immunoprecipitation of endogenous TTC4 followed by mass 
spectrometry (IPMS) revealed high abundance of the mRNA decapping machinery 
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known to be present in mRNA processing bodies (p-bodies), specifically EDC4, 
DCP1A, EDC3, PATL1, and part of the LSM ring (Figure C-8C).  
 
Due to the differential subcellular localization of TTC4 that was dependent 
on detection methods discussed earlier (Figure C-5, Figure C-7), IPMS using 2 
additional TTC4 antibodies (ab2, HPA042459; and ab3, SAB1402385) and APMS 
targeting two differently tagged TTC4 constructs was performed (TTC4-FLAG and 
TTC4-GFP). Anti-TTC4 antibody 3 did not pull down any TTC4 and was then 
considered a mock pulldown and subsequently analyzed as a negative control. 
Interestingly, the 4 successful APMS and IPMS methods (endogenous TTC4 via ab1, 
endogenous TTC4 via ab2, recombinant TTC4 with FLAG, and recombinant TTC4 
with GFP) produced 4 strikingly different potential interaction partners (Figure 
C-8). The top ~30 TTC4-interaction partners identified through each method was 
searched for functional protein association linkages among each set using StringDB, 
and for enrichment in gene ontology and biological pathways within each set using 
gProfiler (Figure C-9, Figure C-10). No overlap was found. 
 
Notably, enriched proteins (prey) found with TTC4-FLAG overlaps 
considerably with that from Bioplex, a large-scale human interactome effort 
employing APMS with FLAG-HA-tagged proteins (Huttlin et al. 2015). Of their 
seven significantly enriched preys captured by TTC4-FLAG-HA, four overlap with 
my set (EEF2, FAM203B, HSP90AA1, HSP90AB1). A slightly modified APMS 
protocol (using anti-FLAG bound to Dynabeads, as opposed to anti-FLAG agarose) 
pulled down a fifth shared prey (GCC2; data not shown). The two TTC4 prey from 
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Figure C-8. Various TTC4 bait pulldown techniques with differentially recovered prey. 
(A,B) TTC4 was constructed into epitope-tagged plasmids and transfected into HEK293T 
and/or HeLa cells, from which affinity precipitation followed by mass spectrometry (APMS) protein 
identification was performed on the eluate. The two tags show differential prey proteins. (A) Proteins 
recovered with TTC4-FLAG show high correlation with those prey recovered by the Bioplex group 
(Huttlin et al. 2015). (C,D) Immunoprecipitation followed by mass spectrometry (IPMS) of 
endogenous TTC4 using two different polyclonal antibodies produced in rabbit from the Human 
Protein Atlas (antibody 1 is HPA041608, polyclonal produced in rabbit; antibody 2 is HPA042459, 
polyclonal produced in rabbit). A third TTC4 antibody (antibody 3, SAB1402385, monoclonal 
produced in mouse) was used for IPMS but did not pull down any TTC4. It is included in the above 
dataset within the control sets. Fold change (pFC or pseudo-fold change) on the x-axes are calculated 
as the ratio of pseudoPSMs (peptide spectral matches for each protein + 1) for each protein in the 
pull down set vs. mock pull-down set. Frequency on the y-axes are the number of individual unique 
proteins, plotted in log-scale. A list of the most-enriched proteins per IP is shown. For each AP/IP-




Figure C-9. StringDB interactions of top tagged-TTC4 APMS prey 
Bait (yellow) is tagged-TTC4 (represented as a black bar with grey TPR domains). Top: 
StringDB interactions between TTC4-FLAG (bait, red circle outline) APMS top enriched prey 
proteins are represented with gene names as nodes connected by weighted edges. Darker nodes are 
genes with higher enrichment (fold change; FC) in the pulldown. Green outlined circles present 
significant protein complexes found by gProfiler. cpval is cumulative p-value. Bottom: StringDB 
interactions between TTC4-emGFP (bait, red circle outline) APMS top enriched prey proteins, 




Figure C-10. StringDB interactions of top endogenous TTC4 IPMS prey 
Commercial antibodies were made with immunogen sequences corresponding to different 
regions (yellow) of TTC4 (represented by a black bar with 3 grey TPR domains). Top: StringDB 
interactions between top enriched prey proteins pulled down with “antibody 1” represented with gene 
names as nodes connected by weighted edges. Darker nodes are genes with higher enrichment scores 
(fold change; FC) in the pulldown. Green outlined circles present significant protein complexes found 
by gProfiler, of which one is found: the mRNA decapping complex within p-bodies (cumulative p-
value, or cpval = 1.12e-06). Bottom: StringDB interactions between top enriched prey proteins 
pulled down with “antibody 2” represented similarly. No significant complexes were found. No 
enriched prey proteins are shared between the two pulldowns or with the APMS pulldowns. 
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C4. Possible TTC4 association with p-bodies 
Processing bodies (P-bodies) are cellular structures that regulates the stability 
of cytoplasmic mRNAs. They can be visualized as cytoplasmic puncta and contain 
numerous RNA silencing and degradation factors, including deadenylases and 
decapping complexes. P-bodies are also known as GW bodies, named for the marker 
protein GW182 which contains glycine (G) and tryptophan (W) rich repeats. 
Canonical p-body markers also include decapping complex members EDC4 (also 
known as Ge-1 or HEDLS), EDC3, DCP1A/1B/DCP2, RCK/P54, XRN1, PATL1 
and the Lsm1-7 complex (Zheng, Chen, and Shyu 2011). P-body assembly is 
dependent on HSP90 activity, although HSP90 itself may not be present in p-bodies 
(Matsumoto et al. 2011). P-bodies are frequently physically juxtaposed to stress 
granules (Anderson and Kedersha), which possess stalled translational preinitiation 
complexes that accumulate during cellular stress. 
 
C4.1 TTC4 foci are marked with p-body proteins 
Due to the identification of foci marked by anti-TTC4 antibody 1 (Figure 
C-5) and to TTC4’s physical interaction with decapping proteins identified with 
antibody 1 (Figure C-10), I asked whether foci marked by TTC4 were also marked 
by p-body components. Indeed, many TTC4 foci co-localized with three attempted 
p-body markers: DCP1A, EDC3, and LSM6 (Figure C-11), chosen due to their 







Figure C-11. TTC4 foci co-localize with p-bodies. 
Endogenous TTC4 marked by antibody 1 co-localizes with transiently co-transfected p-body 
markers (top) DCP1A and EDC3, and transfected LSM6 (bottom) in HeLa cells. Nuclei stained 
with Hoechst is shown in the top merged image. LSM6 additionally marks nuclei in the bottom panel. 




C4.2 Like p-bodies, TTC4 foci are distinct from stress granules 
Stress granules are cytoplasmic granules consisting of stalled translational 
preinitiation complexes that accumulate during stress. They are visualized as 
cytoplasmic foci distinct from but frequently juxtaposed to p-bodies (Anderson and 
Kedersha 2009). Some components of p-bodies are shared by stress granules (Decker 
and Parker 2012), and exchange of material between the two mRNP structures are 
known. It has been proposed that mRNA released from disassembled polysomes is 
sorted and remodeled at stress granules, from which selected transcripts are delivered 
to p-bodies for degradation or to polysomes for re-entry into translation (Kedersha 
et al. 2005, Buchan, Muhlrad, and Parker 2008). Consistent with literature, stress 
granules were generally distinct from foci formed by TTC4, similar to behavior 
expected between stress granules and p-bodies (Figure C-12). 
 
 
Figure C-12. TTC4 and EDC4 are distinct from stress granules 
  emGFP-G3BP-marked stress granules are induced in HeLa cells by 500 µM sodium arsenite 
for 1 hour and generally do not co-localize with p-bodies marked by endogenous EDC4 or TTC4. 
Many stress granules are juxtaposed to EDC4 or TTC4 foci, consistent with previous literature on 
the relationship between stress granules and p-bodies.  
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C4.3 Foci disruption by chemical perturbations 
 P-body formation requires Hsp90 activity, and inhibition of that activity by 
geldanamycin is known to disrupt p-body formation (Suzuki et al. 2009). As well, p-
body formation requires its association with RNA, and p-bodies are lost upon 
cycloheximide-induced blockage of translation elongation, which traps mRNAs on 
ribosomes (Teixeira et al. 2005). These two p-body disrupting agents also inhibited 
the formation of TTC4 foci marked by antibody 1 (Figure C-13 and Figure C-14).    
 
It is known that geldanamycin can reduce endogenous and transfected 
expression levels of some p-body components (Johnston et al. 2010).  I determined 
that the effects of geldanamycin and cycloheximide on TTC4 foci disruption was 
minimally due to reduction in its protein expression levels, though geldanamycin had 
a much more pronounced effect on suppressing transfected TTC4-emGFP expression 
(Figure C-15). Measurements of EDC4 expression levels were not successful (could 





Figure C-13. P-body disruption agents also inhibit TTC4 foci formation 
 Cells treated with 10 µM geldanamycin for 20 hours or 20ug/mL cycloheximide for 1 hour 
exhibit markedly reduced EDC4 and TTC4 foci as compared to an untreated control. Antibody signal 
is shown in green. Nuclei are stained with Hoechst in blue. Images within each cell line were taken 




Figure C-14. Geldanamycin inhibits TTC4 foci in patient-derived lung cells 
Patient-matched lung cells HCC4017 (cancer) or HBEC30KT (normal) treated with 10 µM 
geldanamycin for ~20 hours exhibit markedly reduced EDC4 and TTC4 foci as compared to an 
untreated control. Antibody signal is shown in green. Nuclei are stained with Hoechst in blue. Images 





Figure C-15. Geldanamycin and cycloheximide minimally affect TTC4 expression 
U=untreated, D=DMSO (carrier), G=geldanamycin (GA; 10 µM, 20-22hrs), 
C=cycloheximide (20ug/mL, 1hr). (A) Two replicates of HeLa cells or (B) lung cancer HCC4017 and 
patient-matched normal HBEC30KT cells treated with or without p-body disrupting agents and 
probed for endogenous levels of TTC4, shows slight but minimal expression changes in TTC4. In lung 
cancer cells, a small TTC4 product of ~20kDa is detected in the presence of GA. (C) Overexpression 
of TTC4-emGFP is inhibited with GA compared to the DMSO control, but GFP itself is not affected. 
TTC4-GFP was probed with anti-TTC4 (shown) and anti-GFP (not shown) with identical results. 




C5. Subcellular localization of TTC4 is influenced by method of visual 
examination 
As shown earlier, I employed two commonly used approaches to examine the 
subcellular localization of TTC4: transient transfection of recombinant TTC4 
(tagged with fluorescent proteins or small epitopes) and immunofluorescence of 
endogenous TTC4 using one antibody from HPA. The two different methods gave 
very different results. While tagged TTC4 was always uniformly diffuse within the 
cytoplasm with occasional diffuse nuclear signal (Figure C-7), immunofluorescence 
of endogenous TTC4 (by antibody 1) showed distinct puncta within the cytoplasm 
(Figure C-5) with occasional cytoskeletal and nuclear signal (Figure C-6). 
 
Tagging proteins is known to sometimes cause their mis-localization 
(Ramanathan, Ayyavoo, and Weiner 2001, Skube, Chaverri, and Goodson 2010, 
Landgraf et al. 2012, Palmer and Freeman 2004, Snapp 2005). Due to the possibility 
of tag-induced mischaracterization of TTC4, I decided to further consider the 
antibody-based data gathered for endogenous TTC4. The second HPA antibody 
targeting TTC4 (antibody 2; HPA042459) identified TTC4’s uniformly diffuse 
distribution within the cytoplasm, although cells also frequently contained one or 





Figure C-16. Anti-TTC4 antibodies ab1 and ab2 give unique staining patterns 
 Mock knockdowns (OptiMEM: transfection media only, RNAiMAX: transfection media and 
carrier reagent only, scrambled siRNA: transfection with negative control siRNA) and TTC4 
knockdown (transfection with anti-TTC4 siRNA) is immunostained and with anti-EDC4 antibody 
(top row), and with anti-TTC4 antibodies 1 and 2 (middle and bottom row, respectively), shown in 
green. Nuclei are stained with Hoechst in blue. Interestingly, foci containing EDC4 and foci containing 
TTC4 marked by ab1 were inhibited with scrambled siRNA mock knockdown but not with TTC4 
knockdown. Diffuse TTC4 marked by antibody 2 was notably decreased in the TTC knockdown 
compared to all mocks. All images within each row were captured under identical conditions and 




C6. Integrity of materials 
Due to a lack of consensus between immunofluorescence and IPMS results 
obtained with different anti-TTC4 antibodies (namely ab1 and ab2, corresponding 
to reagents HPA041608 and HPA042459, respectively), an important concern is 
whether the antibody actually targets TTC4 as advertised, as well as the possibility 
of differences arising due to potential secondary targeting, or off-targets. These two 
antibodies were designed against two non-overlapping regions of TTC4 outside of its 
TPR domains (Figure C-17A). The immunogen sequence for ab1 does not 
significantly align to any other protein human (by blastq). The immunogen sequence 
for ab2, however, does significantly align with TCPR2 and SRGAP2, although 
neither were captured in the IP using ab2. For completeness, the immunogen 
sequence for ab3, due to its partial inclusion of the TPR domain, also significantly 
aligns to a few other proteins. The immunogen sequences are provided in the 
Methods. In addition to immunoprecipitation discussed earlier, I employed 
experimental approaches to further address specificity of the antibodies: by western 
blot against TTC4 overexpression and depletion, and immunofluorescence against 
TTC4 depletion.  
 
By western blotting, antibody 1 shows a major band at the expected TTC4 
size (47 kDa) that is lost when TTC4 is knocked down by siRNA, and also detected 
overexpressed recombinant TTC4 (Figure C-17B). However, antibody 1 did not 
show loss of foci by immunofluorescence during TTC4 knockdown (Figure C-16). 
Similarly, TTC4 knockdown did not affect foci formed by EDC4 (Figure C-16), 
suggesting that TTC4 is not critical for p-body formation. It is not immediately clear 
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why EDC4 and TTC4 foci were reduced in the mock knockdown with scrambled 
siRNA. (Although one likely possibility is that, because p-bodies are also sites of 
RNA interference, target-less siRNAs may cause disruption of the RNAi machinery 
leading to p-body disassembly.)  
 
By western blotting, antibody 2 shows several major bands in addition to that 
corresponding to the expected migration pattern for TTC4, although the major 
bands do not seem to be reduced in the TTC4 knockdown (Figure C-17). However, 
antibody 2 detects recombinant TTC4. Immunostaining with antibody 2 shows 
cytoplasmic diffuse staining pattern that is diminished in signal intensity during 
TTC4 knockdown.  
 
Antibodies 1 and 2 were both demonstrated to successfully target TTC4 by 
at least two orthogonal methods. Due to antibody 3’s inability to immunoprecipitate 
TTC4 or detect the expected sized band on western blot (Figure C-17B), it was 
not further considered. However, due to the general non-consensus between 
antibodies 1 and 2 in TTC4’s characterization, I decided to further analyze 





Figure C-17. Western blot detection of TTC4 using various commercial antibodies. 
(A) Schematic of TTC4 (387 a.a.s), with its three TPR domains in grey (residues 79-112, 
117-150, 151-184). Immunogen sequence regions for the production of each antibody are indicated: 
antibody 1 (ab1, HPA041608, Sigma), antibody 2 (ab2, HPA042459, Sigma), and antibody 3 (ab3, 
SAB1402385, Sigma). (B) Each anti-TTC4 have different western blot band patterns. TTC4 is ~45 
kDa. Ab1 and ab2 both detect recombinant TTC4-emGFP (lysate was diluted due to its high 
expression), but ab1 gives the cleanest signal and the major band is reduced upon TTC4 knockdown 
by siRNA (anti-CDK2 is shown as loading control). Ab3, which fails to immunoprecipitate TTC4, 
does not seem to be a successful antibody for western either. The “ab1” and “ab2” gel was run on a 
Bolt 4-12% Bis-Tris precast gel (Thermo Scientific). “Ab3” gel was run on a 7.5% Mini-PROTEAN 
TGX precast gel (BioRad).   
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C7. RNAseq of TTC4 revisits its association with p-bodies 
Using transcriptome sequencing, I looked for global mRNA changes upon 
TTC4 depletion by siRNA (depletion quantified; Figure C-20) to identify candidate 
functionally associated genes in a tag-free, label-free manner. Along with the 
expected TTC4 transcript depletion, the transcript abundances of many other genes 
were also reduced, including quite notably those of EIF4G2 and KIAA0430 (Figure 
C-18 and Figure C-19). The top three strongly affected genes (excluding TTC4), 
EIF4G2, KIAA0430, and SREK1IP1, are all known to be associated with or directly 
involved in mRNA processing and RNA splicing (Heese et al. 2004, Bloch et al. 2014, 
Costello et al. 2015). EIF4G2 and KIAA0430 have previously been found in p-bodies. 
 
 
Figure C-18. Differential transcript abundances during TTC4 depletion 
Volcano plot of all differential transcript abundances during siRNA-TTC4 knockdown in 
HEK293T cells. x-axis: beta is a bias estimator (analogous to a log-based measure of fold change). y-
axis: qval is the false discovery rate (FDR) adjusted pvalue using Benjamini-Hochberg. Significant 




Figure C-19. Transcriptome profiling upon TTC4 knockdown 
HEK293T cells were subject to RNAi against TTC4 followed by transcriptome analysis. The 
genes for which the multiple hypothesis-corrected p-value (qval) was <0.01 are ranked by qval; all 33 
genes under this condition are shown. All 4 TTC4 transcripts (3 are shown here, bolded) are reduced 
in the knockdown group. Multiple EIF4G2 transcripts are also reduced (3 are shown here, blue). 4 
replicates comprised the knockdown group, and 4 replicates consisting of 2 “untransfected” and 2 
“mock-transfected” replicates comprised the control group. RNAseq reads were mapped with Kallisto 
(Bray et al. 2016) and analyzed with sleuth (http://pachterlab.github.io/sleuth/about.html). Qval = 
FDR adjusted p-value; b = beta (a bias estimator) analogous to fold change; se_b = standard error 
of b; mean_obs = mean of observations used for smoothing; var_obs = variance of observations.  
Transcript ID Gene qval b se_b mean_obs var_obs
1 ENST00000371284 TTC4 2.08E-14 -1.3206 0.147 7.102627 0.53518
2 ENST00000532120 EIF4G2 2.14E-13 -0.9475 0.109 6.590462 0.26548
3 ENST00000621511 KIAA0430 2.99E-09 -4.8031 0.645 3.467837 7.07113
4 ENST00000525681 EIF4G2 7.36E-08 -0.9427 0.135 10.13287 0.26213
5 ENST00000513458 SREK1IP1 3.06E-07 -0.7072 0.105 7.278053 0.15665
6 ENST00000484181 PCCB 3.85E-05 -5.3599 0.899 1.986829 8.27518
7 ENST00000261798 CSNK1A1 4.66E-05 -0.7952 0.135 7.940307 0.212
8 ENST00000361815 PSMD10 4.66E-05 -1.1602 0.197 5.700122 0.45129
9 ENST00000369042 BEND3 7.03E-05 0.6478 0.112 6.463144 0.13317
10 ENST00000396525 EIF4G2 7.03E-05 -0.9302 0.161 6.941308 0.26791
11 ENST00000412431 CSNK1A1 0.0001213 -0.956 0.169 6.904841 0.3099
12 ENST00000282344 USP12 0.0001222 -0.5932 0.105 7.429968 0.11411
13 ENST00000486621 TTC4 0.0002504 -0.7342 0.133 5.331031 0.18197
14 ENST00000356978 CALM1 0.0004031 -0.5775 0.107 7.6507 0.11103
15 ENST00000394989 SNCA 0.0004031 5.5434 1.026 2.318746 8.88553
16 ENST00000374704 CCNY 0.0005751 -0.6057 0.114 6.855507 0.127
17 ENST00000396222 LDHA 0.0006012 -5.1125 0.964 1.863099 7.66219
18 ENST00000536441 SESN3 0.0006012 -0.6606 0.125 8.067674 0.15133
19 ENST00000371281 TTC4 0.0009182 -1.7358 0.333 6.278466 1.05125
20 ENST00000295958 SMIM14 0.0009222 -0.6118 0.118 5.956021 0.1307
21 ENST00000256925 CABLES1 0.0015411 0.5453 0.107 6.756533 0.10266
22 ENST00000438909 G2E3 0.0015411 -0.5889 0.116 6.99348 0.12209
23 ENST00000327570 RWDD4 0.0016274 -5.2646 1.039 1.939158 8.10203
24 ENST00000305123 IRS1 0.0030015 0.5654 0.115 5.258038 0.10832
25 ENST00000489294 UHMK1 0.0030015 -0.567 0.115 8.580466 0.10519
26 ENST00000366687 CCSAP 0.0037829 -0.7612 0.156 7.942574 0.20729
27 ENST00000367097 TULP4 0.0053786 -0.5182 0.108 6.848835 0.08663
28 ENST00000335327 WASF3 0.0061833 -0.6421 0.135 6.95309 0.14893
29 ENST00000298130 SPTSSA 0.008031 -0.4932 0.105 6.812264 0.07305
30 ENST00000578386 SMURF2 0.0085882 -4.9125 1.049 1.763113 6.94794
31 ENST00000533683 SAMD1 0.0088715 0.5497 0.118 6.223507 0.11006
32 ENST00000328268 CRELD2 0.0093147 -0.7237 0.155 6.359092 0.19086
33 ENST00000351017 MLLT4 0.0099046 1.1219 0.242 4.639511 0.46001
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Figure C-20. TTC4 knockdown efficiency for RNAseq 
Two sets of reverse-transfected knockdown experiments in HEK293T cells are performed for 
RNAseq. (A)  Western blot of untransfected (OptiMEM only) cells, mock knockdown (scrambled 
siRNA), and TTC4 knockdown (TTC4 siRNA) cells. TTC4 is detected by anti-TTC4 antibody 1, 
and equal loading is detected with actin. (B) Plot of TTC4 levels normalized to actin for ‘mock 
knockdown’ and ‘TTC4 knockdown’ samples relative to TTC4 levels normalized to actin of 
‘untransfected’ samples. Bars represent average +/- 1 s.d. across 2 replicates. By definition, the 
relative TTC4 levels for ‘untransfected’ is 1. Quantified western blot signal was acquired with ImageJ. 
 
C7.1 Functional association of TTC4 with EIF4G2 
Eukaryotic translation initiation factor 4-Gamma 2 (eIF4G2) is also known 
as DAP-5 (death-associated protein 5), p97, and NAT1. Unlike EIF4G1 (a 
scaffolding component of the EIF4F mRNA cap binding complex and involved in 
eukaryotic translation initiation) which supports cap-dependent and independent 
translation, EIF4G2 functions as a general repressor of both cap-dependent and 
independent translation by forming translationally inactive complexes (Imataka, 
Olsen, and Sonenberg 1997). EIF4G2, which exhibits 27% identity to the C-terminal 
two-thirds of EIF4G1, binds to EIF4A and EIF3, but not to EIF4E (Imataka, Olsen, 




As previously mentioned, stress granules and p-bodies are spatially, 
compositionally, and functionally linked. Although translation initiation factors 
(with the exception of EIF4E) known to be associated with stress granules were 
historically considered to be absent from p-bodies (Kedersha et al. 2005, Kedersha 
and Anderson 2007, Kedersha et al. 2008), studies have shown that translation 
initiation factors including EIF4G2 localize to p-bodies under certain environmental 
or growth conditions (e.g., during glucose deprivation and stationary phase in yeast) 
(Brengues and Parker 2007). It is hypothesized that the EIF4G2-containing mRNPs 
seen associated with p-bodies conditionally is actually formed during normal cycling 
of mRNAs between p-bodies and polysomes, but is too transient to be detected under 
normal cell conditions (Brengues and Parker 2007).  
 
Interestingly, EIF4G2 (as well as EIF4G1) seem to form cytoplasmic foci in 
A-431 cells (Human Protein Atlas subcell atlas). Additionally, its known binding 
partner, EIF3B (a component of EIF3 complex), strongly immunoprecipitated with 
TTC4 by antibody 2. Future work can involve further examination of the functional 
association between TTC4 and EIF4G2.  
 
C7.2 Functional association of TTC4 with KIAA0430/LMKB 
KIAA0430, also known as murine MARF1 (Meiosis arrest female 1), and its 
human orthologue Limkain B1 (LMKB1, also known as LKAP), is localized to p-
bodies (Bloch et al. 2014). Although it is not considered a canonical p-body marker, 
LMKB formed cytoplasmic puncta that co-localized with EDC4 and DCP1, and the 
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immunoprecipitation of either LMKB or EDC4 co-precipitated the other (Bloch et 
al. 2014). Large-scale protein interaction mapping approaches have also found 
KIAA0430 strongly associated with p-bodies (Hein et al. 2015). 
 
C8. TTC4 role in embryonic development 
Whether TTC4 is associated with p-bodies or the retromer complex (or both) 
implicates its potential involvement in embryonic development. P-body components 
are known to have many roles in early stages of embryonic development (Schneider 
et al. 2006, Noble et al. 2008, Squirrell et al. 2006, Gallo et al. 2008). The retromer 
complex plays an important role in Wnt secretion by recycling Wntless (Belenkaya 
et al. 2008, Eaton 2008, de Groot et al. 2013), and proper Wnt signaling is essential 
for many stages of development. Thus, we decided to explore whether TTC4 is 
necessary for proper embryonic development using the frog X. laevis model system. 
 
C8.1 Embryonic TTC4 expression  
 TTC4 mRNA is expressed in all stages of early embryonic development, as 
are p-body components (Figure C-21). We then used in situ hybridization to look 
for tissue-specific expression of TTC4 (Figure C-22). We found that TTC4 
expression in NF stage 15 embryos was localized to areas involved in the formation 
of neural patterning. As expected, in later stage embryos, we found that TTC4 
expression was strongly localized to the head and spinal column regions, suggesting 




Figure C-21. Levels of TTC4 and p-body markers in developing X. laevis  
mRNA expression levels of TTC4 and p-body markers DCP1A, DCP1B, DCP2, EDC3, and 
EDC4 are measured by RNA sequencing. X. laevis is allotetraploid; many genes are duplicated as 
homeologs. L and S correspond to homeologs from laevis subgenomes (long and short chromosomes, 
respectively). A and B designation are for cases where sub-genome determination has not been 






Figure C-22. TTC4 expression in embryonic development 
Whole-mount in situ hybridization of TTC4 transcripts during X. laevis development with 
indicated Nieuwenkoop-Faber stages 9-30. TTC4 expression is indicated by digoxigenin-labeled 
riboprobe. Stages 9-12, left to right: animal view, vegetal view, ventral view, dorsal view. Stages 9, 
10: TTC4 expression is evenly distributed in the animal top. Stage 12: TTC4 expression is enriched 
in neural pattern formation. Anterior is to the left in ST15+. Stage 15, left to right: dorsal view, 
lateral view, anterior view. Stage 25, left and right: dorsal view and lateral view. Expression is seen 
in the neural tube in stage 15, in the head region in stage 25, and prominent in the head and spinal 
cord in stage 30 embryos.  
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C8.2 TTC4 is indispensable for head and eye formation 
TTC4 knockdown during early embryogenesis produced embryos with severe 
morphological defects (Figure C-23). Most notably, eyes were absent in these 
embryos. Further experimentation should address the mechanisms and pathways in 
which TTC4 is involved during embryonic development.  
 
 
Figure C-23. Knockdown and overexpression of TTC4 in frog embryos. 
 Top: Knockdown analysis. Compared to controls (A), knockdown of TTC4 (B) with 8ng 
anti-sense morpholino injected into the dorsal cells at the 4-cell stage produced viable late-stage 
embryos that lacked eyes and displayed slightly abnormal overall morphology. All were injected or 
co-injected with 100pg memGFP mRNA. Bottom: Overexpression analysis. Embryos injected at the 
4 cell stage with 100pg memGFP (C) or with 500pg GFP-TTC4 (D) look similar. (E) Positive control 
embryos injected with 50pg DKK1-GFP (dickkopf wnt signaling pathway inhibitor 1; a wnt 
antagonist) show severe developmental defects. All injections were done at the dorsal side of the 4-





Protein tagging is a powerful and widely used method to study protein 
localization, interaction, and function.  Through the efforts of characterizing TTC4, 
I demonstrated that the many commonly used fluorescent and small epitope tags 
may have interfered with the system that was being studied. Whether by 
immunofluorescence imaging to determine subcellular localization or by biochemical 
assays such as co-purification to determine interaction partners, tagged TTC4 
produced vastly different results compared to the untagged form of the protein. 
Fluorescent imaging of tagged homologous TTC4 proteins in other systems (yeast 
and frog) suggests that the tag may be problematic as well, although this has not 
been studied in depth to the extent shown here for human cells. Past literature 
characterizing the TTC4 protein product have all used tagged recombinant TTC4, 
and should be reconsidered. For the same reasons, many localization datasets or 
interactome maps employing fluorescent tags (Huh et al. 2003, Hein et al. 2015) or 
small epitopes (Huttlin et al. 2015) should be carefully considered.  
 
Orthogonal tag-free, label-free methods characterizing endogenous TTC4 has 
also produced confounding data. The biochemical fractionations that motivated us 
to characterize TTC4 inferred that TTC4 physically interacts with retromers, 
however RNAseq under TTC4 depletion suggested genetic interactions with a 
number of proteins previously shown to associate with mRNA processing bodies. 
This latter association between TTC4 and p-bodies is supported by several 
immunologic assays shown here, which suggests that TTC4 and p-bodies are likely 
a biologically true association.  
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Although interactions between retromer and TTC4 were not observed in any 
experimental capacity presented here, it does not necessarily rule out their possible 
interaction suggested from the large-scale biochemical fractionation dataset. For a 
variety of reasons, such as the inability of some interactions to survive our 
experimental conditions post-cell lysis, failure to observe many protein interactions 
is to be expected. For example, co-fractionation of canonical p-body members were 
not observed in our large-scale biochemical fractionations. Another limitation due to 
the methodology used in our fractionation experiments results in the poor 
observation of membrane complexes, for example, the robust nuclear pore complex 
was not observed.  
 
However, it is also the case that some physical interactions inferred from the 
co-elution profiles are false positives, meaning their inferred interactions have no true 
biological basis.  Two functionally unrelated or non-interacting proteins may have 
correlated elution profiles simply due to chance that they exhibit similar biophysical 
properties (properties that are exploited to achieve protein complex separation). 
While this may be the case for the TTC4-retromer observation, it is also possible 
that, like many moonlighting proteins, TTC4 participates in many biological 
processes, and that the experimental data presented here only samples a 
subpopulation or a context-dependent role of TTC4. Immunoprecipitation of TTC4 
also strongly co-precipitated numerous uncharacterized proteins, such as TPP2 and 
TEX2, providing interesting starting points for further characterization. Further 
experiments can also focus on whether the different antibodies that produced 
differential results—within this manuscript and the differential antibody-derived 
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 Human cDNAs were obtained from the human ORFeome collection 
(OpenBiosystems) and cloned using Gateway cloning into either the Vivid Colors 
pcDNA6.2/C-EmGFP-DEST Vector (Thermo Scientific) for carboxy-terminal GFP-
tagged expression clones, or the Vivid Colors pcDNA6.2/N-EmGFP-DEST Vector 
(Thermo Scientific) for amino-terminal GFP-tagged expression clones (both emGFP 
vectors gifted by Dr. Kyle Miller), or the pTagRFP-N plasmid (Evrogen; modified 
to introduce the Invitrogen pDEST47 Gateway cassette) for carboxy-terminal RFP-
tagged expression clones, or the pcDNA3-6MYC plasmid modified to introduce the 
Invitrogen pDEST47 Gateway cassette for carboxy-terminal MYC expression clones 
(acquired from Dr. Zhihua Li), or the pcDNA3-3FLAG plasmid modified to introduce 
the Invitrogen pDEST47 Gateway cassette for carboxy-terminal FLAG expression 
clones (acquired from Dr. Zhihua Li).  
 
For in situ hybridization, digoxigenin (DIG)-labeled RNA probes against X. 
laevis TTC4 were generated with the following primers: 
TTC4 forward primer: caccATGGATCCAAAAGACCAAGAGG 




For TTC4 over-expression in X. laevis, the same TTC4 primers above were 
used to clone TTC4 from a cDNA library (generated by in vitro reverse transcription 
of total RNA extracted from frog embryos) that was then cloned into the pENTR/D-
TOPO kit (Thermo Scientific) and then into the expression vector 223-pCS-EGFP-
DEST (Addgene).  
 
C10.2 Human cell culture 
HeLa, HEK293T, and CRL-2091 cells were obtained from the American Type 
Culture Collection (ATCC) were cultured at 37°C with 5% CO2 in DMEM medium 
(Sigma D6429) supplemented with 10% FBS (fetal bovine serum). H-460, HCC4017, 
and HBEC30KT cells were gifted from Dr. Deepak Nijhawan (UT Southwestern) 
and cultured in RPMI with 10% FBS. Cells were treated with geldanamycin, 
cycloheximide, sodium arsenite, or mocks, as described in the text. 
 
C10.3 Transfections 
For plasmid transfections: One day prior to transfection, HeLa or HEK293T 
cells were plated in 96-well or 6-well glass bottom plates (for imaging) or normal 
plates (for lysate collection). Plasmids were transfected into cells using FuGENE HD 
and cells were imaged the next day.  
 
For RNAi transfections, both forward and reverse transfections were 
attempted with similar knockdown efficiencies. For forward transfections, HeLa or 
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HEK293T cells were plated the previous day in 96-well or 6-well glass bottom plates 
(for imaging) or normal tissue culture plates (for sample collection). Transfection 
was carried out with Lipofectamine RNAiMAX or 2000 (Thermo Scientific) the 
following day according to the manufacturer’s manual. For reverse transfections, 
HEK293T cells were plated onto transfection mixtures following the manufacturer’s 
protocol with Lipofectamine RNAiMAX or 2000. HEK293T samples collected for 
transcriptome profiling were all transfected in the reverse fashion with RNAiMAX 
in 6-well tissue culture plates. Samples were collected ~27-29 hours post-transfection. 
siRNAs used were: anti-TTC4 (human, sc-88730, Santa Cruz Biotech.) and Silencer 
Negative Control No. 1 siRNA (AM4611, Thermo Scientific).  
 
C10.4 Immunofluorescence  
For immunofluorescence experiments, cells were fixed with 3.7% methanol-
free formaldehyde freshly diluted from 16% stock (28908, Thermo Scientific) at 37°C 
for 15-20 minutes, blocked with 5% goat serum in PBS-T buffer for 30-60 minutes 
at room temperature, then incubated with primary antibody overnight at 4°C. Cells 
were washed with PBS buffer, then incubated with secondary antibody for 1-2 hours. 
Primary antibodies used: anti-TTC4 (HPA041608, Sigma), anti-TTC4 (HPA042459, 
Sigma), anti-TTC4 (SAB1402385, Sigma), anti-EDC4 (HPA041164, Sigma). The 
immunogen sequences for anti-TTC4 antibodies are listed below. Secondary 
antibodies used: Alexa Fluor 488-conjugated goat anti-rabbit (Invitrogen), Alexa 
Fluor 647-conjugated goat anti-rabbit (Invitrogen). All antibodies were used at the 
manufacturer’s recommended concentrations.  
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Anti-TTC4 Ab 1 (HPA041608, Sigma) immunogen sequence: 
AQSDFISAFHEDSRFIDHLMVMFGETPSWDLEQKYCPDNLEVYFEDEDRAEL
YRVPAKSTLLQVLQHQRYFVKALTPAFLVCVGSSPFCKNFLRGRKVYQI 
Anti-TTC4 Ab 2 (HPA042459, Sigma) immunogen sequence: 
LEMRAKADKLKRIEQRDVRKANLKEKKERNQNEALLQAIKARNIRLSEAACE
DEDSASEGLGELFLDGLSTENPHGARLSLDGQGRLSWPVLFLYP 




C10.5 Western blot 
For western blotting, cells were washed with PBS buffer then sampled 
collected with Laemmli sample buffer containing 5% beta-mercaptoethanol. Total 
protein were separated on commercial precast gels, then blotted with PVDF 
membrane, followed by blocking with 5% milk in TBS-T (tris-buffered saline with 
0.1% Tween 20). Primary antibodies used include those listed above, and 
additionally: anti-End-binding protein 3 (EB3, AB6033, Millipore), anti-Lamin A 
(sc-20680, Santa Cruz Biotech.), anti-actin (sc-1616, Santa Cruz Biotech.) Secondary 
antibodies: goat anti-rabbit IgG F(ab')2-HRP (sc-3837, Santa Cruz Biotech.) and 
goat anti-goat IgG F(ab')2-HRP (sc-3697, Santa Cruz Biotech.), and donkey anti-
goat IgG F(ab')2-HRP (sc-3851, Santa Cruz Biotech.) Primary antibodies were 
incubated overnight at 4°C or at ambient temperature for 1-2 hours. Secondary 
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antibodies were incubated at ambient temperature for 1-2 hours, with TBS-T washes 
before and after. Signal was illuminated with luminol and film-developed. 
 
C10.6 Fluorescent cell microscopy 
Live cells were imaged using a Nikon Eclipse TE2000-E inverted microscope. 
Images were acquired using a Photometrics Cascade II 512 camera and Nikon Plan 
Apo 40x/0.95, 60x/0.95, 60x/1.40, or 100x/1.40 objectives. The 89000 - ET - Sedat 
Quad (Chroma Tech.) filter set was used for all fluorescence detection. Image 
acquisition were driven by NIS Elements AR Imaging software.  
 
C10.7 Immunoprecipitation and mass spectrometry 
HeLa or HEK293T cells were transfected with appropriate expression vectors 
for APs or left untransfected for endogenous IPs. The next day, cells were washed 
once in PBS then trypsinized and resuspended in media to inactivate trypsin, spun 
down at 1000-1500RPM for 5-10 minutes, and then resuspended in 1X cell lysis buffer 
(Cell Signaling) supplemented with 1X protease inhibitor I (Roche) for 10-30 minutes 
before sonicating with Diagenode Bioruptor until at least ~90% of cells were visibly 
broken. Cell lysate was incubated on rotation at room temperature with Protein A 
Dynabeads (Thermo Scientific) pre-washed with PBS and bound to the appropriate 
antibody. Antibodies used include those previously mentioned, in addition to anti-
GFP (G1544, Sigma) and anti-FLAG (F1804, Sigma). After washing the Dynabead-
antibody-antigen complex with PBS, proteins were eluted from the beads in 2% SDS 
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in 0.1M Tris/HCl pH7.6 with 100mM DTT at 60C and then stored at -20°C. For 
FLAG pulldowns, anti-FLAG M2 affinity gel (A2220, Sigma) was also used and gave 
better results than the antibody/Dynabeads method. For anti-FLAG gel, proteins 
were eluted with 3X FLAG peptides.  
 
For mass spectrometry sample preparation, DTT was added to 0.1M to each 
sample, and washes of the sample in 8M urea (UA; in 0.1M Tris/HCl pH8.5) were 
passed over Amicon Ultra 30 kD spin filtration columns (pre-conditioned with by 
washing with 0.5% PEG20K). Iodoacetaminde was then added to 55mM and 
incubated in dark for 40 minutes at RT. Sample was then washed again in UA, then 
equilibrated with washes of 0.05M ammonium bicarbonate (ABC). Samples were 
then subject to overnight trypsin digest at 37°C. Tryptic peptides were filtered 
through the spin filtration columns and bound, washed, and eluted from HyperSep 
C18 SpinTips (Thermo Scientific). Eluted peptides were dried by speed-vac and 
resuspended in Buffer C (5% acetonitrile, 0.1% formic acid) for analysis by LC-
MS/MS. For LC-MS/MS analysis, peptides were subjected to separation by C18 
reverse phase chromatography on a Dionex Ultimate 3000 RSLCnano UHPLC 
system (Thermo Scientific). Peptides were loaded onto an Acclaim C18 PepMap 
RSLC column (Dionex; Thermo Scientific) and eluted using an acetonitrile gradient. 
Eluted peptides were directly injected into an Orbitrap Classic or Orbitrap Elite 
mass spectrometer (Thermo Scientific) by nano-electrospray and subject to data-




Spectra were searched against a human protein sequence database and 
common contaminant proteins (MaxQuant using SEQUEST (Proteome Discoverer 
1.4; Thermo Scientific)). Fully-tryptic peptides were considered, with up to two 
missed cleavages. High-confidence peptide-spectral matches (PSMs) were filtered at 
<1% false discovery rate determined by Percolator (Proteome Discoverer 1.4; 
Thermo Scientific). Fold changes for each protein were calculated as the ratio of 
pseudo-PSMs (PSM + 1) in the pulldown sample over that in the mock.  
 
C10.8 Transcriptome sequencing of human cells 
RNA was extracted from HEK293T cells grown in 6 well-plates using the 
Trizol-chloroform method. Sets of OptiMEM-only, scrambled knockdown, and TTC4 
knockdown samples were prepared as described above and collected twice on separate 
occasions. 8 individual samples were subject to RNAseq, including 4 control samples 
consisting of two OptiMEM-only and two mock knockdown with scrambled siRNA, 
and 4 TTC4 knockdown samples. Samples were depleted of DNA by DNase 
extraction and RNeasy column purification. Eluted RNA was processed with Ribo-
Zero Gold rRNA removal kit (Illumina) followed by additional RNeasy MinElute 
clean up. RNA quality was evaluated with Agilent Bioanalyzer (Agilent 
Technologies). cDNA libraries were constructed using NEBNext® Ultra™ 
Directional RNA Library Prep Kit for Illumina. Single-end (1 x 75 base) sequencing 
was performed using a NextSeq 500 instrument (Illumina). RNA-seq data was 
processed with Kallisto (Bray et al. 2016) to generate abundances which were then 
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analyzed and mapped to transcript identities using sleuth 
(http://pachterlab.github.io/sleuth/).  
 
C10.9 In situ hybridization 
X. laevis embryos from various developmental stages were fixed in MEMFA 
overnight and in situ hybridization and data acquisition was performed as previously 
described (Hayes et al. 2007).  
 
C10.10 Xenopus laevis perturbation experiments 
For live animal perturbation experiments, frog embryos were injected with 
100pg memGFP or indicated concentrations of recombinant constructs into dorsal 
cells at the 4-cell stage. Morpholinos (MOs) were injected in the same manner.   
Anti-TTC4 ATG-MO: TCAATGGTTTTCACGATTTCTGCAC 
Anti-TTC4 SP-MO: TACTATGGCATCTCCCTTACCTAAA 
 
C10.11 Xenopus laevis RNA-seq 
Collection of large scale J-strain X. laevis transcriptome resources 
We complemented the genome sequence with more than 1 billion RNAseq 
reads that sample a useful range of developmental stages and adult organs and 
tissues, as summarized in Table S6.  For RNAseq, RNA was extracted from a series 
of developmental stages, or from a collection of adult tissues. Both stages and tissue 
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samples were collected twice independently. Embryos from fourteen different 
developmental stages (including 3 oocyte stages, unfertilized egg, and st8 to NF stage 
40) (J-strain 34th generation, cultured at 20 degrees) were collected from one pair of 
33rd generation frogs. Thirteen adult tissues and oocytes of different stages (stages 
I & II, III & IV, V & VI) were collected from a single female, and a testis was 
harvested from a single male (J-strain 33rd generation).  
 
RNA-seq 
Total RNA was extracted using Isogen (Nippon Gene). Quality of the total 
RNA was evaluated by a spectrophotometer and Agilent 2100 Bioanalyzer (Agilent 
Technologies). cDNA libraries were constructed using Illumina Truseq RNA sample 
prep kit V2 (Illumina), with the standard non-strand specific mRNA library 
preparation protocol. Independent samplings were performed from embryos of two 
crossings or from two female and male adults, separately, providing cDNA library 
sets for Taira201203_stage, Taira201203_tissue, Ueno201210_stage, 
Ueno201210_tissue series of RNAseqs. Additionally, to add reads to 
Ueno201210_stage (for stage 35), their siblings were analyzed to produce 
Ueno201302_stage series.  
 
Paired-end (100 bp × 2 101 bp × 2) sequencing was performed using an 
Illumina HiSeq 2000 instrument (Illumina). Datasets of the short reads were 
deposited in NCBI Gene Expression Omnibus (GEO) database (accession number 
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GSE73430  for stages, GSE73419  for tissues). These RNA-seq data were used for 
expression analysis described below.   
 
Quantification of gene expression levels with RNA-seq 
We analyzed gene expression of the RNAseq data described above for a 
developmental time series and selected adult tissues. After filtering (1) reads with 
no call (‘N’) and (2) reads with low complexity (not having all of ‘A’, ‘C’, ‘G, and 
‘T’) from raw J-strain RNA-seq reads, we mapped them to primary transcript 
sequences using bwa mem (version 0.7.10) with paired-end option. We quantified the 
expression of each transcript using Transcripts Per Million (TPM) values estimated 
by RSEM (version 1.2.19) (Li and Dewey 2011). 
 
To prevent the noise derived from reads of homeologous transcripts, we 
removed hits either (1) with additional targets including homeologs, or (2) with 
partial alignment with insertions/deletions (indels), before running RSEM. As a 
result, we used highly specific reads mapped only on one copy of homeolog transcripts 
in this analysis. This approach may underestimate the expression of homeologous 
transcripts by ignoring reads from identical regions, although the expression of most 
homeologs can be measured by taking advantage of paired-end reads. All redundant 
sequences were removed in the database before mapping, to measure at least group-
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